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ABSTRACT

Bioinformatic Solutions to Complex Problems
in Mass Spectrometry Based
Analysis of Biomolecules

Ryan M. Taylor
Department of Chemistry and Biochemistry, BYU
Doctor of Philosophy

Biological research has benefitted greatly from the advent of omic methods. For many
biomolecules, mass spectrometry (MS) methods are most widely employed due to the sensitivity
which allows low quantities of sample and the speed which allows analysis of complex samples.
Improvements in instrument and sample preparation techniques create opportunities for large
scale experimentation. The complexity and volume of data produced by modern MS-omic
instrumentation challenges biological interpretation, while the complexity of the instrumentation,
sample noise, and complexity of data analysis present difficulties in maintaining and ensuring
data quality, validity, and relevance. We present a corpus of tools which improves quality
assurance capabilities of instruments, provides comparison abilities for evaluating data analysis
tool performance, distills ideas pertinent in MS analysis into a consistent nomenclature, enhances
all lipid analysis by automatic structural classification, implements a rigorous and chemically
derived lipid fragmentation prediction tool, introduces custom structural analysis approaches and
validation techniques, simplifies protein analysis form SDS-PAGE sample excisions, and
implements a robust peak detection algorithm. These contributions provide improved
identification of biomolecules, improved quantitation, and improve data quality and algorithm
clarity to the MS-omic field.

Keywords: bioinformatics, quality assurance, mass spectrometry, lipidomics, proteomics,
machine learning, lipid fragmentation, simulated dataset
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Chapter 1
1.1

Introduction

Biomolecules make life possible

Nearly all known living organisms share certain common features, regardless of their diverse
habitats. These common characteristics include: carbohydrates as storage molecules and
signaling moieties; lipids as signaling molecules, structural components of membranes, and
energy storage; nucleic acids as genetic storage and transmission molecules, as well as catalytic
activity relating to gene expression; and proteins as molecular machinery which makes signal
transduction, nucleic acid replication and transcription, and oxidative phosphorylation possible
as well as forming structural components of both cells and tissue. These are the biomolecules
which make life, as we know it, possible.
1.2

The rise of ‘omics

Biomolecules can be dauntingly diverse. While nucleic acids are composed from a relatively
simple 4 letter alphabet of nucleotides from which all genetic material is composed, proteins are
comprised of a ~20 letter alphabet of amino acids. However, due to the polymeric nature of
macromolecules derived from amino acids and nucleotides, there is no limit to the possible
molecular uniqueness. Carbohydrate derived macromolecules are polymeric as well, and due to
the number of different ways they can be joined, they comprise an effectively limitless set of
possible components and thus present with complexity orders of magnitude greater than that of
proteins.1 More than 35,000 lipids are structurally known, but the lipidome is estimated to
contain more than 125,000 unique species. The metabolome refers to any cellular metabolite
generally, and thus is comprised of chemically diverse small molecules which have highly
variable physical properties, comprising some ~8000 species. 2

1

Recent trends in scientific research demonstrate the drive to increase the rate of discovery. As
grant acceptance rates have dropped by 50% in the last 8 years,3 scientific research can be
facilitated by reducing costs, especially by using the greater data gathering capacity of omic style

Figure 1.1: Rise of the omic research fields. Genomics, proteomics, metabolomics, lipidomics, and
interactomics are all showing signs of sharp growth as research fields. Y axis is log10 transformed. Sourced
from Pubmed search results.

experimentation to complement more established procedures. Analysis of keyword frequency
amongst published scientific research curated in Pubmed demonstrate the dramatic rise of omic
publications in primary literature (see Figure 1.1).
Genomics has enabled the rise of modern proteomics. Original genomics projects were laborious
undertakings until the development of high throughput instrumentation (next generation
sequencers) which enable routine, organism level genomic analysis. Proteomics, lipidomics, and
glycomics have required similar, high throughput instrumentation.
1.3

Mass Spectrometry enables analysis of biomolecules

In 2002, the Nobel prize in chemistry was awarded for the development of mass spectrometry
(MS) ionization methods which are compatible with biomolecules. 4 These innovations have
enabled modern identification analysis of biological macromolecules.

2

Mass spectrometry analysis is typically performed in two steps: survey scans, and fragmentation
scans. Survey scans determine all ions which are being introduced to the instrument at any given
point. These scans are often acquired at high resolutions which ensures that all ions are
separately identifiable in the spectra. Survey scans show the greatest number of species, as even
intensity differences of several orders of magnitude can be detected. However, not all ions can
be distinguished by survey scan alone. Some of these identification collisions arise by
instrument limitations; that is without infinite resolution, some non-isomeric compounds cannot
be differentiated. Isomeric amino acid residues (leucine and isoleucine) and other isomers are
also indistinguishable. Even with the very best in instrumentation, at a mass accuracy of < 1
ppm in survey scans, mass accuracy is not sufficient to exclude alternative ion identities from
subsequent analysis for more than 60% of possible peptides.5,6 To increase the coverage of
analysis, orthogonal separation techniques are employed to reduce the complexity of ions eluting
to the mass analyzer concurrently, including: liquid chromatography, 2D liquid chromatography,
offline fractionation, and 2D gel filtration separations.
Fragmentation scans are performed by isolation of selected ions discovered in a survey scan for
subsequent fragmentation. This often produces characteristic fragmentation patterns to aid in
identification of biomolecules. These secondary (MS 2) scans can provide diagnostic ions which
describe the structural characteristics of the ion. Some instrumentation is capable of subsequent
rounds of fragmentation, MSN, to further differentiate similar compounds and to produce
additional diagnostic ions. Fragmentation scans can typically be acquired at a rate of several per
second, although some instruments acquire them at 30+ scans/second. Fragmentation data is

3

capable of elucidating complex structural characteristics and can provide robust identifications
for any type of biomolecule.
1.4

State of Proteomics

Proteomics is the most advanced MS based omic field. Proteomics is successful because 1)
protein digestion into peptide fragments simplifies downstream analysis; 2) proteins are a
product of the genetic code, which has provided, since 2001, a human protein dictionary7; and 3)
the basic rules which govern protein fragmentation are well characterized and understood, and
fairly simple. Proteomics has enabled identification of 10,000 proteins from a single sample, 8
and routinely provides the capacity to elucidate identifying, structural, and even functional
details of protein biomolecules.
1.5

State of Lipidomics

Lipidomics is a field which is confronting several major challenges. With the rise of mass
spectrometry based omics, the diverse roles of lipids in physiology and molecular biology has
become more appreciated. While lipids were thought to comprise some several hundred species
at most only a few decades ago,9,10 conservative estimates suggest >125,000 distinct lipid species
exist.11 Further, while genomics, transcriptomics, and proteomics are based on a defined
vocabulary which provides both known identities and a sequence driven ontology, lipids are
composed of diverse structures which are in no way constrained by nomenclature or repeatable
structural units. While most lipids originate from two biochemical pathways, the breadth and
diversity of their structural features arise from the multitudinous enzymatic pathways devoted to
their modification, cyclization, and oxidation.12–15 Lipidomic studies remain especially
challenging as analysis tools are still in their infancy,16 and are not yet capable of even routine
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analysis.17–21 These limitations are understandable given the expanded complexity relative to
other biomolecules studied by MS analysis.
1.6

Data analysis is the major bottleneck

Despite the considerable advantages of MS based omic studies the primary bottleneck is the
analysis of the massive volume of data generated.16,22 Proteomics has been benefitted by large
scale, proprietary and open-source algorithms which provide capabilities of identification and
even quantitation of labelled and label-free data.23–29 Even so, proteomics data analysis only
identifies some 60% of MS/MS spectra,30 which are only ~10% of the ions observed in survey
scans.31 The limitations of lipidomic and metabolomics analysis further demonstrate the
limitations of current data analysis techniques in predicting complex ion fragmentation behavior
within mass spectrometers.
Data analysis challenges in MS fields are primarily related to identification or quantitation. One
challenge arises because of a lack of an established canonical terminology for data analysis
algorithms. Even for the tools which are published, many are never utilized and comparisons are
rarely published,32 leaving even superior algorithms relatively poorly utilized. Nomenclature
used in MS have been standardized by IUPAC and HUPO-PSI,33,34 but these terms are largely
designed for use in wet lab sample preparations and instrumentation descriptions. We introduce
a MS algorithm nomenclature solution in Chapter 2.
1.6.1

Challenges in Identification Analysis

Traditional identification workflows depend upon known gene coding regions of a genome. The
known protein sequences enable routine analysis of the protein from a complex biological
sample. We present an example of this workflow in Chapter 3 in application to a novel virus
5

characterization. In this example, we also demonstrate the challenge of identifying which open
reading frames discovered by analysis of the viral genome encode protein.
While protein identification has largely become routine, studying structure by MS remains quite
challenging due to the large number of combinations possible, the relative reduction of ion
counts, and increased overlap between fragmentation products. Interactomics, or the study of
protein-protein interactions, often relies on crosslinkers to connect proteins which interact. The
complex fragmentation patterns exhibited by these crosslinked proteins make identification
nontrivial.35–61 Further applications lie in analysis of cysteine rich regions of proteins, which are
often indicative of highly important structural characteristics. 62,63 By careful optimization and
iterative development coupled to customized data analysis workflows, complex and challenging
structural details can be elucidated by mass spectrometry64 as demonstrated in Chapter 4. I was
also involved in the characterization of a chaperonin complex by MS analysis which further
demonstrates the ability of a targeted analysis to provide meaningful structural information. 65
Successful lipid analysis fragmentation prediction algorithms have relied upon ‘divide-andconquer’ approaches to segment the lipidome and therefore reduce the required search space. 19,20
Lipids are classified by a manually curated lipid classification system introduced by the LIPID
MAPS consortium66 which provides a systematic and unified mechanism for discussing lipids
specifically and unambiguously, and a reasonable system for segmentation of the lipid
fragmentation problem.
In Chapter 5 I introduce an on-the-fly lipid classification system that empowers complete
lipidome search tools to segment the fragmentation space even for novel lipids.

6

1.6.2

Challenges in Quantitative Analysis

Quantitation of MS datasets is necessary for comparative studies and is typically accomplished
by either 1) label based quantitation, or 2) label-free quantitation. Label based methods rely
upon introduction of covalent or isotopic modifications to the analytes directly which then enable
differentiation of identified species between one or more experimental conditions. These labels
provide reporter ions or mass shifts to analytes to determine which experiment they represent.
Labeling can provide absolute quantitation, but decreases the rates of identification, greatly
reduces ion intensity, and requires experimental conditions capable of isotopic label introduction
or sample treatment labeling.
Label free quantitation methods require no special sample preparations or considerations
experimentally and can therefore provide quantitation upon any sample. These methods are
capable of both relative and absolute quantitation between case and control. 67 While several
competing implementations exist, the best performers consider peak identification and area under
a curve as quantifying characteristics and thus enable robust and accurate quantitation with no
special effort beyond data analysis. Many of these implementations are benefited from more
accurate peak extraction algorithms. We introduce one implementation and comparison to
existing algorithms in Chapter 7.
1.6.3

Challenges in Quality Control

The tremendous capabilities of modern mass spectrometers are entirely dependent upon the
performance of the instrumentation. Assessing the quality of a produced dataset is very
laborious and typically relies upon experienced technicians. Mass spectrometers are known to
exhibit variable performance at times. Many instruments rely upon subjective evaluation of
quality by instrument operator based on limited data sampling and inspection of visual indicators
7

of quality. Hence, operator time is forfeit and scientific reproducibility are suspect under such
constraints.68 In Chapter 8, I describe a complete automated workflow for quality control
tracking and an encouragement to MS scientists to practice better performance monitoring.
Data analysis toolkit comparisons are necessary as means to select the highest quality analysis
method and therefore ensure the greatest accuracy. However, the typical methodologies are
dependent upon either human curation of annotated ‘gold standard’ datasets, or combining
previous analyses to form a crowd-sourced truth. While these methods give some understanding
of relative performance, a better mechanism is to simulate a dataset where the actual identities
and quantities are known a priori as we introduce in Chapter 9.
Quantitative and reproducible metrics of instrument performance and simulated ‘known’ data
sets for data analysis quantitation and comparison together provide capabilities to benchmark
both instrument and data analysis performance to ensure conclusions drawn from data are valid.
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Chapter 2
signal 1

Improving nomenclature to uniquely map molecular entities to mass spectrometry

0F

Author’s Note: This chapter outlines unambiguous terminology for MS based data analysis. I
contributed to the ideas and preparation of the manuscript. This document is in submission to
BMC Bioinformatics.
2.1

Abstract

Background: The comparison of analyte MS1 signal is central to many proteomic (and other omic) workflows. Standard vocabularies for mass spectrometry exist and provide good coverage
for most experimental concepts, however their terms for data concepts and algorithms are either
ambiguous or missing. Without a standard, unambiguous nomenclature, literature searches,
algorithm reproducibility, and algorithm evaluation for MS-omics data processing are nearly
impossible.
Results: We show how terms from current official ontologies are too vague or ambiguous to
explicitly map molecular entities to MS signals, and we illustrate the inconsistency and
ambiguity of current colloquially used terms. We propose a set of terms for MS1 data
processing which consists of a limited number of base terms along with qualifier terms allowing
a vast number of MS1 data concepts to be succinctly, precisely, and intuitively described.
Conclusions: We suggest this nomenclature as a beginning to, not the culmination of, the
standardization process.
Keywords: Controlled vocabularies; LC-MS; Peak detection; Feature detection; Proteomics

1

Publication authors are Smith R, Taylor RM, and Prince JT.
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2.2

Background

Liquid-chromatography mass spectrometry (LC-MS) is a ubiquitous platform for proteomic (and
other "omic") investigations.30 MS signal from hundreds to millions of ions can be
quantitatively compared across experimental conditions in a fairly robust and repeatable way.31
Analyte quantities are captured directly in MS signal (aka MS1), while analyte identities are
often elucidated or confirmed using MS/MS (aka MS2) fragmentation spectra. 31 Confidently
matching MS1 analyte signal between runs ("correspondence") is difficult with complex
samples,69 so a variety of approaches to circumvent this problem have been explored. Multiple
reaction monitoring (MRM) can be effective for monitoring a relatively small number of preselected analytes with a high degree of confidence, but it is unsuited to discovery-based
experiments. MS/MS based approaches (e.g. iTRAQ 70 and spectral counting 71) are also popular
alternatives. However, due to low MS/MS capture rates (10-20%) and low database match rates
(<60%),31 MS/MS driven approaches lack sensitivity compared to MS1-based approaches. And,
although a data independent acquisition (DIA) approach may address some of the sensitivity
deficiencies of MS/MS for identification, DIA does not of itself address difficulties in
correspondence and quantitation. Hence, despite the availability of alternative approaches, the
ability to match MS1 signal across experimental conditions is still highly desired.
Numerous efforts, large and small, have focused on using MS1 signal to compare analyte
quantities. Ideally, solutions would focus on one of the several complex individual steps for data
processing.72 However, most are released as end-to-end solutions (e.g., SuperHirn,73
MaxQuant,74 XCMS,75 and Skyline76). This makes comparison to other competing algorithms
virtually impossible, and is at least partially responsible for the lack of critical evaluations in the
literature,32 since testing a subcomponent of a full software system requires re-implementing that
10

portion of the algorithmic pipeline. Our awareness of this problem has been accentuated as we
have recently undertaken a survey in each of several of the modular subproblems of LC-MS
quantification, including isotope trace detection, isotopic envelope detection, and
correspondence. When one must distinguish the algorithmic details of several methods, or
worse, implement them in code, one becomes painfully aware of the ambiguity in the terms
currently used in MS data processing descriptions.
The lack of standard terminology has stagnated LC-MS data processing progress. Without
consistent, clear terminology researchers have no handles for searching the literature, requiring
onerous literature searches which fail to capture all relevant publications. Besides lack of access
to possibly improved results, this leads to massive duplication of effort and few cross-tool
evaluations since researchers are unaware of related efforts. A well defined vocabulary and
problem domain also encourage and aid new-comers to the field—which currently poses a
significant learning curve30—improving solutions to difficult data processing challenges. It is
also much easier to re-implement solutions when both the what and how of a process are clearly
understood. Hence, an increase in term clarity has immediate impact on reproducibility—a
requirement firmly enforced for sample preparation and wet-lab processing protocols but which
is almost completely unenforced for data processing descriptions. 32 What's more, it is virtually
impossible to glean the algorithmic differences from a paper without a clear nomenclature so as
to be aware of statistical biases imputed into the results of the algorithm. Without understanding
the assumptions made in the algorithm, a practitioner is likely to overstate the significance of and
confidence in experimental results.

11

What about using terms from existing HUPO-PSI77 and IUPAC78 controlled vocabularies (CVs)?
Current CVs fail to adequately describe key data processing concepts precisely, precluding
experimental reproducibly. The terms they do contain are ambiguous at best. There is a general
lack of granularity that creates a gaping hole that ought to be addressed. The details of what
terms the PSI and IUPAC committees choose to fill the present need will be a long process. As a
small but critical first step towards eventual standardization, we have identified core data
concepts and algorithms necessary for MS data processing that fulfill the general system we
propose. We also propose a nomenclature to describe them which is constructed of a limited
number of base terms along with qualifier terms. This combinatorial design allows a vast
number of data concepts to be succinctly, precisely, and intuitively described. With precise
terminology in hand, we are then able to show how terms from current official ontologies are too
vague to explicitly map molecular entities to MS signals, and we illustrate the inconsistency and
ambiguity of current colloquially used terms.
2.2.1

Colloquial Terms and Usage

Inconsistencies and ambiguities in colloquial terms has long been recognized as a problem.
Consider, for instance, the usage of two of the most common labels for MS-omics data concepts.
These lists are by no means exhaustive in references or instances.
The term feature is used for:


An isotopic envelope.73,79–81



A deisotoped integrated isotopic envelope.82,83



An integrated isotopic trace.31

The term peak is used for:
12



A profile.74



A centroid.80,84,85



An isotopic trace.79,80,85,86



A deisotoped integrated isotopic envelope.31,87



An isotopic envelope.80



An integrated isotopic trace.80,83



An isotope.88



An instantaneous isotopic envelope.89

It should be abundantly clear that these terms convey very little useful information—certainly
insufficient information for reproducibility. Even terms with consistent use, there is a general
lack of scope. For example, monoisotopic peak, meaning the most abundant isotopic trace in an
isotopic envelope,77 cannot convey exactly what level of data processing has been used on the
signal. Do the authors mean the isotopic trace of the most abundant isotopic trace in an isotopic
envelope,79 the integration of that trace,89 or the summation of an entire isotopic envelope into
one centroid?80,90 All of these uses fit the original definition, but none are specific enough to
readily discern from just the term.
These examples briefly illustrate the ubiquity of overloading (using one term to mean more than
one concept). Overloading treats a term as a variable, whose meaning must be defined in detail
for the scope of each publication it appears in. An adequate definition takes significant thought,
some descriptive text, and usually a descriptive image. There simply isn't ample space in each
manuscript to define a custom set of terms for MS-omics data processing. This results in
insufficient definitions for terms or no definitions at all.
13

For example, the terms isotopic peaks and isotopic multiplets do not convey a clear meaning and
are undefined in the manuscript where they appear. 91 It is unclear if a peak/multiplet is dealing
with an isotopic trace, an integrated isotopic envelope trace, a max isotopic envelope trace, or an
instantaneous isotopic envelope trace. The paper describes a decharging algorithm for isotopic
envelopes, but depending on what definition you adopt for these terms, you will get a very
different result.
As another example, consider a review paper that describes the algorithmic composition of
several approaches to data processing problems.85 To allow for the use of mathematical
algorithm descriptions, the author provides a key where symbols are defined for certain MS data
constructs. These include symbols for peak area, number of chromatograms, peak maximum,
peak end, peaks detected in a mass channel, raw height of peak, and peaks detected in a
chromatogram. But what is a peak? What is a chromatogram? As seen from the citations in
this paper, these terms are not universally defined, and the author does not define them.
Subsequently, the algorithms in the paper are irreproducible unless the reader is able to correctly
guess the definition of these terms intended by the author.
Reproducibility is, in fact, at the heart of the nomenclature problem. An algorithm description is
rendered useless if the data structure terms used within it are ambiguous or undefined. In a
modular approach to pipeline algorithm creation and testing,72 data processing methods prior to
the pipeline module of interest have to be exactly describable with concise terms. In evaluating
algorithms, knowing the exact format of the input data informs interpretation of the algorithm. If
the data format is known, as well as the process used to transform, segment, and/or reduce the
original, one can know what biases are intrinsic in the algorithm, as well as immediately suggest
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improvements. For example, an algorithm that uses the whole isotopic envelope signal has more
information to distinguish differences in a correspondence task than one that has reduced the
whole signal to a single point representation. Do current CVs capture the required degree of
descriptive specificity?
2.2.2

Why current CV terms are insufficient

IUPAC78 and HUPO-PSI77 are organizations that specialize in standardizing nomenclature. Their
significant and useful controlled vocabularies address all aspects of MS experimentation. To
date, most of the thousands of terms in these overlapping controlled vocabularies are focused on
wet lab protocol and instrumentation. Although there are a few terms relevant to data
processing, they seem to be a mix of canonized colloquial terms and terms that came directly out
of a specific software platform rather than a consistent, coherent, and intuitive system.
2.2.2.1 Current CV MS data processing terms are ambiguous and inconsistent.
The HUPO-PSI-MS OBO has more MS data processing terms than IUPAC. Most are generic to
the point of extreme ambiguity. For example, the term mass spectrum refers to any segment of
data with m/z and abundance axes: “a plot of the relative abundance of a beam or other
collection of ions as a function of the mass-to-charge ratio (m/z)." This could refer to a host of
different data segmentations, and seems to be a synonym for another term, profile spectrum,
defined as “A profile mass spectrum is created when data is recorded with ion current (counts per
second) on one axis and mass/charge ratio on another axis" (see Figure 2.1).
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Figure 2.1 Ambiguity in current nomenclature. Any of the boxed signal in this figure can correctly be called a
chromatogram, a mass spectrum, or a profile spectrum as defined by existing CVs. Additionally, the IUPAC terms
isotope pattern and isotope cluster can refer to the signal in box 1, 2, or 3. It is clear that these terms pertain to too
many distinct concepts to be clear. Note that existing nomenclatures have no way of distinguishing between these
distinct data concepts, which can include parts of one or more combined signals. Box 4 represents a temporal
snapshot of the spectrum. Arrow 5 refers to the process of generating an integrated isotope trace.

An equally ambiguous complementary term is provided to refer to the time and abundance axes:
chromatogram, defined as “the representation of detector response versus time." This definition
is not scoped at all with respect to the molecular entities whose signals are being measured. The
term applies equally at any scope. In other words, any plotted entity that shows RT vs intensity
qualifies as a chromatogram. Likewise, the term total ion current chromatogram, defined as the
“chromatogram obtained by plotting the total ion current detected in each of a series of mass
spectra recorded as a function of retention time" fails to imply any sort of scoping, and, worse,
can correctly apply to any entity that qualifies as a chromatogram.
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The term peak is defined in the PSI CV as “a localized region of relatively large ion signal in a
mass spectrum." As defined this term cannot discriminate between a host of distinct data
concepts (see Figure 2.2). Among other associations, the term peak is used as a qualifier to
describe a process officially named peak picking, when profile data is converted to centroid data.
Thus, a peak can be any signal region (large or small) that consists of one or more centroids,
which means any size subset of any data in any projection could be called a peak. The term has
absolutely no specificity. The term area peak picking has a very unclear definition: “spectral
peak processing conducted on the acquired data to convert profile data to centroided data. The
area defined by all raw data points that belong to the peak is reported." Intuitively, one would

Figure 2.2: The PSI CV states that a peak is “A localized region of relatively large ion signal in a mass spectrum."
Note that each of the numbered data segmentations in this figure qualify as a peak according to the PSI CV. In the
literature, each of the illustrated concepts can also be found referred to as a feature.

assume that area peak picking has to have a different meaning than regular peak picking, yet the
distinction is not evident from the definitions, given the only difference is the addition of “The
area defined by all raw points that belong to the peak is reported." What is meant by “peak"?
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Reported to what? This is one example of how some of the PSI CV terms seem more like
unrelated combinations of terms from specific software user manuals than a curated collection of
a data concepts.
It is unclear what a centroid spectrum is. The definition states "processing of profile data to
produce spectra that contains discrete peaks of zero width. Often used to reduce the size of
dataset." However, a spectrum, as defined, can only have two dimensions: m/z and intensity.

Figure 2.3: The PSI controlled vocabulary has over 2,400 entries. Only ten or so of these entries provide data
processing concepts related to MS processing. Far from trying to compete with PSI or IUPAC, which are fullpurpose controlled vocabularies, our proposal in this manuscript is to question the small subset of terms they
provide for utility in describing MS processing. We propose a set of terms for MS1 data processing constructed of a
limited number of base and qualifier terms that allow a vast number of MS1 data concepts to be succinctly,
precisely, and intuitively described. The current ambiguous nomenclature yields situations where a given term
refers to more than one concept and/or distinct terms refer to the same concept. An unambiguous nomenclature is
composed of terms which refer to only one concept each, and no two terms refer to the same concept.

Since a spectrum cannot have an RT dimension, a centroid spectrum must be the same thing as a
peak. It is assumed that instead they mean a peak picked profile signal summed through RT. It's
all very confusing.
Finally, the inconsistency of the PSI CV is apparent. For example, the term feature is used in at
least 25 definitions, but it is never defined. It is used to refer to at least a few different concepts,
including the idea of a program parameter (MS:1000498, MS:1001760, MS:1002426), the
isotopic envelope (MS:1001826, MS:1001827, MS:1002163), a PSI-CV mass spectrum
(MS:1002166, MS:1002167, MS:1002168), and probably others (probably because it is unclear
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what is being described in the other 16 definitions). Another term, mass trace, is similarly used
in several definitions yet never defined. The implied use, like feature, overlaps the definitions of
peak and chromatogram, making for considerable ambiguity (see Figure 2.3).
In addition to these generic terms, the PSI CV provides two specific data concepts: deisotoping
and charge deconvolution. Deisotoping is referred to as “the removal of isotope peaks to
represent the fragment ion as one data point and is commonly done to reduce complexity. It is
done in conjunction with the charge state deconvolution." The concept described is worthy of a
definition, but the one provided can be improved upon. A fragment ion is not a data signal, but a
molecular object. However, deisotoping is an operation on a data signal. Additionally, this term
should not be specific to MSn fragment ions, but also applies to non-fragmented MS1 data, such
as an MS1 isotopic envelope. Our nomenclature expands this term to include the logical wider
use. Charge deconvolution is defined as “the determination of the mass of an ion based on the
mass spectral peaks that represent multiple-charge ions."
Deconvolution is already a widely used signal processing term (also used in MS processing 92) for
resolving two overlapping signals into their constituent parts (see Figure 2.4, top right). The PSI
definition redefines an already widely used term to mean something other than what it means in
all other contexts. What's more, the definition focuses on mass determination, not signal
manipulation. It should be replaced.
2.2.2.2 Current CVs don't describe all necessary data concepts for MS data processing.
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Crucial concepts for MS data processing are missing from the current CVs. Most of these relate
to more specific concepts at higher granularity than is currently offered by the PSI and IUPAC

Figure 2.4: The terms profile and centroid in combination with the other terms proposed allow distinction
between a low resolution convolved signal created by instances of a single molecule charge state
combination and the same concept in data from a high resolution instrument. These distinct concepts are
indistinguishable under the IUPAC, HUPO-PSI, and colloquial term peak.

CVs. A rigorous CV should allow for unique terms to describe signals from a
peptide/lipid/metabolite down to individual data points. With the current nomenclatures, it is
impossible to describe data processing algorithms' details using standard terms.
Explicit mapping of molecular entities to the signal their detected ions produce is essential to
achieve clarity at all scopes of granularity. The PSI and IUPAC terms do not quite do this. For
example, the best term to refer to a host of loosely related concepts is ion: “an atomic, molecular,
or radical species with a non-zero net electric charge." Ion is a proper and correct term that is
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general to science, and this is the widely used definition. However, this term applies to a
charged item of any size, and cannot distinguish among the instances of interest (e.g. proteins in
a proteomics experiment, lipids in a lipidomics experiment) and the smaller molecular charged
units that are detected in a mass spectrometer experiment. How does one distinguish between
the signal from the detection of a single isotope in a peptide, the signal from the detection of
multiple isotopes of multiple instances of a given charged peptide, and the signals from all the
charge variants of a peptide? What's more, as mentioned above, the term ion should never be
applied to signal as it is in multiple instances in the PSI CV; an ion is a physical entity, and a
signal can comprise a summary of the detection of one or more ions of one or more types (or
noise). For instance, a standard isotopic envelope is the accumulation of signal detection from
many instances of one type of molecule (say, a peptide) at one charge state.
2.2.2.3 An incomplete CV impedes algorithm implementation/comparison.
Writing code is a mathematically precise activity. Reproducibility requires the exact same
equation, as it were, to be reproduced. Reproducibility requires specificity and clarity. Any
ambiguity, overloading, or lack of detail makes the process impossible.
Frequently, it becomes necessary to code up a published algorithm. This could be because the
algorithm was published independent of a software platform, or because you want to see the
results of one particular module of a full-service program. As a case study, we recently
attempted to code up one module of the MaxQuant algorithm74 in order to compare results of a
feature detection algorithm. The following text is the pertinent portion, and demonstrates just
how difficult it can be to parse through an algorithmic description without a good nomenclature,
even in a well-written, top-tier-published manuscript:
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...peaks are detected in a conventional two-dimensional (2D) way by first searching for
local maxima of the intensity as a function of m/z. The lower and upper limits of the m/z
interval for a 2D peak...are then determined by moving from the maximum position to
smaller and larger m/z values, until either the intensity has dropped to zero, or a local
intensity minimum has been reached....The centroid position of a 2D peak is then
determined...If the peak consists of only one raw data point, then the m/z value of that
point is taken as the centroid position. If there are two raw data points in a peak, then the
centroid position is defined as the average of the two raw m/z values, weighted by the
raw intensities....the 2D peaks in adjacent MS spectra are assembled into 3D peak hills
over the m/z-retention time plane. Two peaks in neighboring scans are connected
whenever their centroid m/z positions differ by less than 7 ppm. If for a given centroid in
MS scan n no matching centroid is found in scan (n+1) in the ±7 ppm mass window, then
it is checked if there is a centroid in scan (n+2) in the same mass window to continue the
peak in time. We adjusted the window size to 7 ppm by visual inspection of many very
low abundant peaks....A 3D peak is defined as the maximal chain of 2D peaks that results
from connecting the centroids in time direction in the described way. At least two
centroids have to be matched together to form a 3D peak, i.e. centroids that cannot be
matched to centroids in the two previous or the two next scans are discarded....If a
minimum is found whose value is 1/1.3 of the lower of the two local maxima the 3D peak
is split into two at the minimum position...
With unclear terms, translating a manuscript into code is very difficult, and very unlikely to
produce what the author intended.
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Ambiguity also affects practitioners who do not write code; in the process of writing an
exhaustive LC-MS correspondence survey,69 we recently parsed over 50 manuscripts describing
correspondence algorithms, attempting to describe distinctions between them. Each manuscript
had its own unique ill-defined vocabulary. It was very difficult to discern what data concepts the
algorithm was operating on, which is essentially the bulk of the difference between those 50 or
so methods. We had far more time for that exercise than a normal practitioner would when
evaluating which method to employ in their experiment.
2.2.2.4 An incomplete CV impedes literature reviews.
Ambiguity also leads to manuscript bloat. While working on the correspondence survey, as well
as several other surveys in progress, it became very apparent that most of the algorithms shared
previously published approaches and failed to make a novel algorithmic contribution. This is a
real problem, as it creates even more methods that must be compared against and even more
papers to read. For example, there seems to be no difference between TracMass2—a recently
published algorithm featuring isotope trace detection93—and the uncited feature detection
module of MaxQuant. Neither the authors nor the reviewers noticed the similarity of the two
algorithms. As documented in this case and others described in, 69 unintentional plagiarism is
happening all over MS data processing. Clear nomenclature alleviates the burden of discerning
differences in algorithms.
Having conducted extensive literature searches for LC-MS correspondence (published), isotope
trace detection (unpublished), and isotopic envelope detection (unpublished), we can say with
surety that the lack of unique terms makes the literature search nearly impossible to achieve a
comprehensive search.
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2.2.3
Community awareness and an immediate, intermediate response is the correct
way of addressing this need.
All controlled vocabularies are works in progress. Standards committees are best at crystallizing
and refining accepted practice, but the onus to invent or select appropriate terminology lies
foremost with the community itself. A good example of this was the creation of a standard
spectrum exchange format. The mzXML format was created and published by a small group of
researchers.94 After several years of use the HUPO PSI mass spectrometry working group
produced the mzML format which was able to draw upon the experience gained from use of the
mzXML format. Although a data format and not a CV, the success of mzML shows the good
that can come of a manuscript-driven approach. mzXML was originally published as a
manuscript, the sole product of a small group of researchers who noticed a problem and
forwarded a solution. This was the genesis of community traction that culminated in the mzML
standard, a significant step forward for all mass spectrometry users. An official nomenclature
culminates with IUPAC78 and HUPO-PSI77 standards but the community cannot realistically
expect nomenclature to begin there.
At present, the controlled vocabularies simply do not have coverage in the terms related to data
processing. Because the problem is so extensive, and because opinions run strong in the domain
of nomenclatures, this problem is best solved by drawing attention to shortcomings while
providing a framework for unambiguous terms. A manuscript to draw attention to areas that can
be improved are a viable means of correcting them, as demonstrated in other CVs.95 As we have
shown by enumerating collisions, inconsistencies, and gaps in current terms, no small group of
experts can successfully bring about a CV independent of an active, involved community,
particularly when data processing represents only a small subset of the larger experimental
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community. It is unfair to represent the data processing portion of the current PSI CV as the
calculated and careful end product of a long, focused deliberation. Inspection of the terms makes
it clear that this is not only a living, changing document, but (at least in terms of the data
processing terms) seems to be, at least in part, an uncoordinated amalgamation of terms from
different software groups. We submit that fostering community discussion in a peer-reviewed
venue is at least as valid as open, uncoordinated, and seemingly minimally curated submissions
to a standard.
2.3

Results and discussion

The PSI CV data processing terms are scant, inconsistent, and ambiguous for describing MS data
processing. We propose a system for generating terms that allows greater unambiguous
coverage of currently addressed concepts in a consistent and intuitive manner, facilitating
reproducibility, comprehension, and searchability of data processing algorithms. The motivation
at the heart of our proposed nomenclature is to explicitly map causal molecular entities to the
signals they produce. In order to maximize the information communicated in a term, we have
created base terms, which describe the general concept under consideration, as well as qualifier
terms, which specify any additional information possible about the genesis of the data concept.
An overview of all terms is presented in Figure 2.5.
2.3.1

Base Terms

Generic terms allow us to refer to a specific data structure without necessarily adding detail
about how it was processed. These terms are useful for algorithms that will take data structured
in a certain way, no matter how it came to be in the current format.
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Figure 2.5: In this partial overview of the proposed nomenclature, the relationship between base concepts and
some qualifier terms is demonstrated. The qualifier trace adds a time dimension to a base concept. An envelope is
a set of related instances across the m/z dimension. An isotope is a molecule at a particular charge state with a
certain number of neutrons. An isotopic envelope is the unique impulse signal (at a specific RT) generated by one
molecule/charge state combination consisting of one or more isotopes equally spaced m/z 1/z apart. A molecular
envelope is the set of unique isotopic envelopes generated by one molecule across multiple charge states. An
isotopic trace is the unique whole (meaning throughout RT) signal generated by the accumulation of instances of a
given molecule at a given charge state whose molecular formula contains the same isotopic composition. An
isotopic envelope trace is the unique whole signal generated by one molecule/charge state combination consisting
of one or more isotopic traces equally spaced m/z 1/z apart. A molecular envelope trace is the set of whole isotopic
envelopes generated by one molecule across multiple charge states.
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Molecule - The unit that accepts charge; a lipid in a lipidomics experiment or a peptide in a
bottom-up proteomics experiment.
Isotope - An isotope in this context consists of a molecule, at a particular charge state, with a
certain number of neutrons (no distinction is made in this context among molecules where the
neutron is associated with different atoms or kinds of atoms) (see Figure 2.5).
2.3.2

Qualifiers

Obviously, the most specific term possible should be used in each instance. For this purpose, we
have introduced a set of qualifying terms that add specificity to the above-defined generic terms.
The use of qualifiers allows us to encode previous processing steps into the term used to identify
a data structure.
Profile
Profile refers to the continuous signal produced by a mass spectrometer (see Figure 2.4). The
qualifier profile allows us to specify concepts that are otherwise conflated between lowresolution and high-resolution data. For instance, in 2-d terms, an isotope profile is the data
distribution thought to be a single isotope, and is found in high resolution profile data, while a
deisotoped isotope envelope is the implicit convolution of several isotope profiles as a result of a
low-resolution instrument (see Figure 2.4).
Centroid
Centroid is the qualifier that indicates a consolidation of the cumulative signal from an isotope
profile into an impulse representation of the isotope, positioned at the center of mass of the
profile signal. A convoluted profile signal, depending on how it is processed, may also produce
multiple centroids (see Figure 2.4). This qualifier allows us to disambiguate between distinct
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concepts such as an isotopic envelope centroid and an isotopic envelope profile. Note that the
assumption is that all data is centroided unless otherwise stated and that the term only applies in
the m/z dimension.
Envelope
An envelope connotes a discrete collection of things across the m/z dimension. For example,
when we couple envelope with isotope, we get isotopic envelope, the unique impulse (meaning at
a specific retention time (RT)) series generated by one molecule / charge state combination

Figure 2.6: Integrated isotopic trace - the isotope produced by summing all constituent points in an isotopic trace.

consisting of one or more isotopes equally spaced m/z 1/z apart (see Figure 2.5). By coupling
molecule with envelope, we get molecular envelope, the set of unique isotopic envelopes
generated by one molecule across multiple charge states (see Figure 2.5).
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Trace
A trace implies a signal that extends into the RT dimension. For example, when we combine
isotopic envelope and trace, we get an isotopic envelope trace, which is the unique whole
(meaning throughout RT) accumulated (meaning throughout a run) signal generated by one
molecule / charge state combination consisting of one or more isotopic traces equally spaced m/z
1/z apart (see Figure 2.5). Likewise, in an isotopic trace, the unique whole (meaning throughout
RT) signal generated by the accumulation of instances of a given molecule at a given charge state
whose molecular formula contains the same isotopic composition (see Figure 2.5). A molecular
envelope trace is the set of whole (meaning throughout RT) isotopic envelopes generated by one
molecule across multiple charge states (see Figure 2.5).
Integrated
An integrated object has been summed through the RT dimension. For example, if we take an
isotopic trace and sum its constituent centroids (or profile points), we will end up with a single 3tuple consisting of m/z, RT, and intensity that can accurately be called an isotope (see Figure
2.5). However, by calling it an integrated isotopic trace, we retain a unique description of the
original data structure as well as the transforming process used (see Figure 2.6). An integrated
isotopic envelope trace is the sum of the constituent points in the isotopic traces contained in the
isotopic envelope trace. In appearance, it is identical to the isotopic envelope in Figure 2.5.
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Average
The data concepts described by the qualifier average are, in appearance, the same as those in
integrated, however the process to generate them involves taking the average of the intensity of
the composite points, not the sum.
Instantaneous
The qualifier instantaneous implies that this object is a spectral slice of a trace object at a given
RT. The instantaneous objects look exactly like those that are integrated; however, this qualifier
indicates that we are looking at a slice of the data structure in time, not a summation or average
of the data through time.

Figure 2.7: Deisotoped isotopic envelope - the composition of all isotopes in an isotopic envelope.

Max
The qualifier max implies that this object is the spectral slice of a trace object at the RT of
greatest intensity. Max objects look exactly like those that are integrated; however, this qualifier
indicates that we are looking at a slice of the data structure in time, not a summation or average
of the data through time.
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Deisotoped
The qualifier deisotoped implies that the isotope envelope has been combined through the m/z
dimension, such as a deisotoped isotopic envelope, the consolidation of all isotopes in an isotopic
envelope (see Figures 2.7 and 2.8).
Reduced
The qualifier reduced implies that the object has been combined through reducing charge states
to the lowest common charge state. For instance, a reduced molecular envelope is the set of the
composition of all isotopic envelopes in the molecular envelope (see Figure 2.5, bottom left to
middle left). \
2.3.3

Clearer than colloquial terms

Our suggested vocabulary eliminates most if not all of the ambiguity in the current naming
schemes employed in the literature. The following examples illustrate how the proposed
vocabulary untangles the currently obfuscated terms in use.
Isotopic envelope trace describes a concept for which the following terms have all been used: an
eluting isotopic distribution,96 a chromatogram,85 an isotope series,85 an isotope pattern,74 an
isotope-resolved mass spectrum,97 an ion series,98 and an isotopic cluster.90,92 None of these
terms differentiate between the concepts we refer to as isotopic envelope trace, instantaneous
isotopic envelope, max isotopic envelope, etc.
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Isotopic traces have been referred to as eluting isotopes,96 single ion chromatograms,85
peaks,74,85,86 mass spectra,88 and peak hills.74 Each of these terms are unclear. The problem with
the term chromatogram is that is does not specifically refer to the elution profile of a single
isotope. For example, an extracted ion chromatogram is an m/z slice of data that can extend
across an entire run's RT. Any term that uses peak is bound to be confusing due to the overuse
of the term. Like chromatogram, a mass spectrum can technically stretch across an entire m/z

Figure 2.8: Deisotoped molecular envelope - the set of the composition of all isotopes in each isotopic
envelope in a molecular envelope

range and therefore does not specifically describe the m/z window of a specific molecule.
Integrated isotopic envelope has been called an isotope pattern.86 However, many other
concepts can accurately be called isotope patterns, such as a max isotopic envelope or an
averaged isotopic envelope.
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Using this nomenclature, it is much simpler to clearly and unambiguously describe an MS data
processing algorithm. The following text is the translation of the above quoted MaxQuant text
translated into the proposed nomenclature.
Overlapping and/or contiguous profiles are deconvolved by bisecting all contiguous
profiles with a local maximum bordered by local minima. Each profile is centroided by
taking the weighted average of the m/z values of the points comprising the profile.
Isotope traces are constructed from centroids by the following method: For each scan,
each centroid within 7 ppm of an isotope trace from the previous scan or penultimate
scan is aggregated to the closest (in ppm) isotope trace. All other centroids are
considered new isotope traces for future scans. Any isotope traces with only one centroid
after all scans are included are culled. A postprocessing mechanism to address
erroneously appended isotope traces splits the trace anywhere a centroid is found with
intensity less than or equal to 1/1.3 of the lesser intensity of two surrounding local
maxima.
Not only does this text more readily reduce to code, it is easier to understand and takes up about
half the text of the original. No term is used to mean more than one specific concept. The terms
have a one to one mapping to the concept they refer to.
2.4

Expected Objections

Having discussed this nomenclature with many of our colleagues, we anticipate some objections
and will address the most common here.
This nomenclature competes with PSI/IUPAC. We are not advocating for a replacement of either
IUPAC or PSI controlled vocabularies, rather arguing that the subset of terms relevant to data
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processing have insufficient coverage and are ambiguous where defined (see Figure 2.3). We are
arguing that those terms relevant to data processing discussed here ought to be replaced, and
those missing ought to be added.
Why don't you submit these to PSI? We are planning on doing so. However, this manuscript is
not an attempt to change PSI. Standardizations do not drive the community, the community
drives standardizations. There is a current dearth of appropriate terms to describe MS data
processing. We have provided solid evidence that this is a problem, and we have proposed a
nomenclature that solves that problem. We do not have a stake in PSI and cannot control their
nomenclature. However, as a manuscript, individuals can begin using this nomenclature now no
matter how long PSI takes to modify their CV (or whether they do or not).
You have no data format. The community does not recognize a controlled vocabulary and a data
format (XML schema) as the same thing, as demonstrated by the fact that PSI has data formats
and a CV, and they are separate products. The first step is establishing terms that describe these
concepts. Producing a data format that represents these data concepts is a different problem that
will have to be addressed in the future. Having a data format before establishing that this is a
problem, let alone before coalescing on an industry-wide acceptable solution, is a mistake. It
would require that any software tools coded between now and then be redone. Instead, we focus
on the first problem, which is establishing that there is a problem. We propose a nomenclature,
but expect and look forward to many constructive criticisms to improve upon it. Meanwhile, this
manuscript serves as a cite-able lexicon for anyone who has the need to describe these concepts
(for example, in an algorithm manuscript) yet has no available way of doing so within page
limits.
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You should be improving mzQuantML or mzIdentML instead of doing this. mzQuantML and
mzIdentML are not CVs, they are data formats (see previous objection).
2.5

Conclusion

The ever-increasing number of MS-omics experiments drives a thriving MS-omics data
processing algorithms field. However, the lack of an unambiguous vocabulary for MS-omics
data concepts has created serious challenges for reproducibility and evaluation of data processing
algorithms. In this paper, we have highlighted the ambiguity of current vocabulary for MSomics data processing. We propose an unambiguous vocabulary together with a visual lexicon
for the proposed terms. By adopting these terms, authors can facilitate reproduction of their
algorithms succinctly by providing a crystal-clear set of meanings for terms they use, vastly
improving the reproducibility of their work.
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Chapter 3
Sequence and Structural Characterization of Great Salt Lake Bacteriophage
CW02, a Member of the T7-Like Supergroup 2
1F

Author’s Note: This chapter describes characterization of a novel halophage virus discovered in
the Great Salt Lake. I contributed by development of the mass spectrometry sample preparation
technique for gel fragment preparation for LC/MS, MS analysis, and in determining if the viral
capsid contained anything other than DNA. These results were published in the Journal of
Virology.99
3.1

Abstract

Halophage CW02 infects a Salinivibrio costicola-like bacterium, SA50, isolated from the Great
Salt Lake. Following isolation, cultivation, and purification, CW02 was characterized by DNA
sequencing, mass spectrometry, and electron microscopy. A conserved module of structural
genes places CW02 in the T7 supergroup, members of which are found in diverse aquatic
environments, including marine and freshwater ecosystems. CW02 has morphological
similarities to viruses of the Podoviridae family. The structure of CW02, solved by cryogenic
electron microscopy and three-dimensional reconstruction, enabled the fitting of a portion of the
bacteriophage HK97 capsid protein into CW02 capsid density, thereby providing additional
evidence that capsid proteins of tailed double-stranded DNA phages have a conserved fold. The
CW02 capsid consists of bacteriophage lambda gpD-like densities that likely contribute to
particle stability. Turret-like densities were found on icosahedral vertices and may represent a
unique adaptation similar to what has been seen in other extremophilic viruses that infect
archaea, such as Sulfolobus turreted icosahedral virus and halophage SH1.

Publication authors are Shen PS, Domek MJ, Sanz-García E, Makaju A, Taylor RM, Hoggan R, Culumber MD,
Oberg CJ, Breakwell DP, Prince JT, and Belnap DM.
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3.2

Introduction

Tailed double-stranded DNA (dsDNA) bacteriophages (order Caudovirales) account for nearly
95% of all documented phages and probably comprise the majority of the viruses on the
planet.100 Recent estimations place the global number of virus particles on the order of 10 31 to
1032, outnumbering the total number of host cells by a factor of 10. 101 The ubiquity of phages
suggests an ecological, predatory role in recycling organic matter, especially in extreme
environments, where eukaryotic predators, primarily protozoal grazers, are rare. 102 Phages also
affect the genetic diversity of their environments by facilitating horizontal gene transfer between
host cells.103 The sheer abundance of phages in aquatic environments may supply the greatest
selective pressure exerted on host organisms.101
Bacteriophages of the order Caudovirales are divided into three morphologically distinct
families. All consist of isometric or prolate heads that encapsulate linear double-stranded
(dsDNA) genomes, but phages of the Myoviridae family have a long, contractile tail (e.g.,
bacteriophage T4); viruses of the Siphoviridae family consist of a long, noncontractile tail (e.g.,
bacteriophage lambda); and phages within the Podoviridae family exhibit a short, noncontractile
tail (e.g., bacteriophage T7). Recent high-resolution capsid structures of tailed dsDNA phages
revealed a conserved fold that is shared among all three phage families. The first of these
structures was solved for bacteriophage HK97,104 and subsequent structures of Caudovirales
phages have been shown to adopt the HK97- like fold.105–108 The limited identity between
primary structures of HK97-like capsid proteins is a prototypical example that structure is more
conserved than sequence.
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Halophage CW02 is a bacteriophage isolated from the south arm of the Great Salt Lake (GSL)
and infects a euryhalophilic Salinivibrio costicola-like bacterium, SA50, also isolated from the
GSL. At least two other tailed phages of S. costicola, UTAK109 and G3,110 have been reported;
however, only general features of the structures and genomics of these phage are known. Here
we characterized halophage CW02 to determine its relatedness to other dsDNA bacteriophages.
Based on negative stain transmission electron microscopy, CW02 is morphologically similar to
viruses of the Podoviridae family. Genomic analysis and mass spectrometry (MS) of CW02
genes and proteins revealed the strongest sequence similarities to Pseudomonas phage PA11,111
roseophage SIO1,112 vibriophage VpV262,113 and cyanophage Pf-WMP3,114 all of which are
distant relatives of bacteriophage T7 but members of the T7 supergroup. The 16-Å resolution
structure of CW02, solved by cryogenic electron microscopy (cryo-EM) and three-dimensional
(3D) reconstruction, permitted fitting of the HK97-like fold into the capsid density, thereby
supporting the observation that the capsid proteins of tailed dsDNA phages adopt a common
ancestral fold.
3.3

Materials and methods

Cultivation and purification. Host bacteria and bacteriophage were isolated from the GSL in
Utah. Sediment and water samples were collected between May and November 2008 in shallow
waters along the north shore of Bridger Bay on Antelope Island of the GSL. Salinity was
measured at 8% by evaporation. (Salinity is known to vary seasonally due to fresh water inflow
and evaporation; see http://ut.water.usgs.gov/greatsaltlake/salinity/.) The pH ranged between 7.5
and 8. The host bacterium, SA50, was first isolated on Halobacteria Medium (per liter of
solution, 80 g NaCl, 10 g MgSO4 · 7H2O, 5 g casein hydrolysate, 5 g KCl, 3 g disodium citrate,
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1 g KNO3, 1 g yeast extract, and 0.2 g CaCl2 · 6H2O), which was modified from the original
22% NaCl115 to 8% NaCl and pH 7.5.
The 16S rRNA gene of SA50 was amplified using bacterium-specific primers (27F, 5= AGA
GTT TGA TCM TGG CTC AG 3=; 1492R, 5= ACG GYT ACC TTG TTA CGA CTT 3=). 116
The reaction mixture contained 200 nM each primer, the deoxynucleoside triphosphates at 250
μM each, 0.2 mg ml-1 bovine serum albumin, 1 U Taq DNA polymerase, and the diluted reaction
buffer (Promega, Madison, WI). The amplification parameters were 94°C for 3 min; 25 cycles
of 94°C for 45 s, 57°C for 1 min, and 72°C for 2 min; and a final extension step of 72°C for 7
min. Approximately 1,350 bp were sequenced (Molecular Research Core Facility, Idaho State
University, Pocatello, ID) and queried against the GenBank database by use of the BLAST
search tool. The isolate showed 99% sequence identity with S. costicola subsp. costicola strain
ATCC 33508 (NR_027590.1). The isolate was maintained in Halobacteria medium.
CW02 was initially isolated by the use of a plaque assay of filtered GSL water with SA50 as the
host strain. CW02 was recovered from plaques by removal from the soft agar overlay with a
sterile Pasteur pipette. The agar was transferred to a sterile 8%salt solution, vortexed, and
incubated for 30 min to release phage from the matrix. CW02 was then amplified by inoculation
into a broth culture of SA50 and incubated on a shaker at 30°C. Phage replication caused lysis
of the host cells and clearing of the broth culture after 18 h. After clearing, the broth culture was
centrifuged at 5,000 × g for 10 min and passed through a 0.2 μm filter to remove bacteria. Host
bacteria and bacteriophage filtrate stocks were stored frozen (−20°C) in 20% glycerol.
The bacteriophage was further purified by isopycnic ultracentrifugation (64% [wt/vol] CsCl) at
~125,000 × g for 24 h at 4°C. A single viral band was extracted from the gradient. CsCl was
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removed by dialysis in either pure water or pH 8 buffer containing 1.35M NaCl, 48 mM MgSO 4·
7H2O, 1 mM CaCl2, and 2 mM Tris-Cl. Finally, purified CW02 was washed and concentrated
by centrifugal filtration (100-kDa molecular mass cutoff filters; Sartorius Stedim Biotech,
Bohemia, NY) to be made suitable for cryo-EM.
3.3.1

Genome isolation and sequencing

The DNA was isolated as follows from 100 ml of bacteriophage filtrate. The filtrate was
concentrated by centrifugal filtration (Amicon Centricon 100,000 molecular weight cutoff filter;
Millipore Corp., Billerica, MA) to approximately 2 ml. Contaminant nucleic acids in the
concentrated bacteriophage solution were removed by addition of DNase I (1 μg/ml) and RNase
A (1 μg/ml) (Sigma- Aldrich Corp., St. Louis, MO), incubated at 37°C for 1 h, and then
centrifuged at 110,000×g for 2 h. The pellet was suspended in 2 ml of SM buffer (5.8 g NaCl, 2
g MgSO4 · 7H2O, 50 ml 1 M Tris [pH 7.5], and 5 ml 2% gelatin per liter of distilled water) and
treated with proteinase K (50 μg/ml; Sigma-Aldrich Corp., St. Louis, MO) and 0.5% sodium
dodecyl sulfate (SDS; Sigma-Aldrich Corp., St. Louis, MO) at 56°C for 1 h to remove the
capsid. The DNA was then extracted through phenol-Tris-Cl, followed by a 50/50 mixture of
phenol-chloroform, and finally through pure chloroform. The DNA was ethanol precipitated and
resuspended in Tris-EDTA buffer. Genomic DNA was sequenced at the Brigham Young
University (BYU) DNA Sequencing Center using a Roche Genome Sequencer FLX instrument
and employing the GS FLX Titanium Sequencing XLR70 kit (Roche Diagnostics Corporation,
Indianapolis, IN).
3.3.2

Sequence analysis

Putative open reading frames (ORFs) of the CW02 genome were determined using
GeneMarkS117 and numbered according to whole-genome homology with bacteriophage
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PA11.111 CW02 protein homologues were determined by PSI-BLAST analysis (http://blast
.ncbi.nlm.nih.gov/Blast.cgi). All protein sequences for pairwise alignments were obtained from
GenBank (http://www.ncbi.nlm.nih.gov/GenBank/), including sequences of enterobacterial
phage T7 (NC_001604), VpV262 (NC_003907), SIO1 (NC_002519), Pf-WMP3 (NC_009551),
and PA11 (NC_007808). Sequence alignments were performed using ClustalW2. 118 Protein
secondary structures were predicted using Psi-pred,119 COILS,120 BetaWrapPro,121 or Phyre.122
3.3.3

Electron microscopy and image reconstruction

For negative staining, 3.5 μl of purified CW02 was adsorbed onto a glow-discharged,
continuous- carbon-coated copper grid, blotted, and then washed. The grid was blotted again,
stained with a solution of 1% uranyl acetate, and then blotted a final time and allowed to dry.
For cryo-EM, 3.5 μl of purified CW02 was placed on a glow-discharged, holey-carbon-coated
copper grid, blotted, and plunge frozen in liquid ethane with an FEI Vitrobot (FEI, Hillsboro,
OR). Specimens were transferred to a Gatan 626 cryoholder (Gatan, Inc., Pleasanton, CA)
cooled with liquid nitrogen. Cryo-EM images were acquired at 200 keV and at ×39,000
magnification via low-dose methods at objective lens underfocus levels ranging between 0.2 and
2.8 μm. Focal pairs were taken 1.0 μm apart. Images were recorded either by a Gatan chargecoupled device camera (1,024 by 1,024 pixels) or on Kodak SO-163 film in an FEI Tecnai F30
transmission electron microscope (FEI, Hillsboro, OR). Electron micrographs recorded on film
were digitized on a Nikon Super Coolscan 9000 ED scanner.
Particle images were extracted from scanned electron micrographs using X3DPREPROCESS. 123
Contrast transfer function (CTF) signal and decay parameters were determined from and applied
to the images by the use of Bsoft124 (bshow and bctf functions) and the algorithm of Conway and
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Steven,123 except that images within a focal pair were not combined during CTF correction.
Origins and orientations of the extracted particles were determined by use of the model-based
technique of PFT2,125 which was adapted to use phase and amplitude information in orientation
selection.126 A reference model for PFT2 analysis was generated by the random-model method
with imposed icosahedral symmetry.127 The final 3D reconstructions were calculated using
EM3DR2.128,129 In displayed images, contour levels are given in terms of σ, which was
calculated as the number of standard deviations relative to the average map density.
For size calibration, poliovirus (160S form) was used as an internal standard. Poliovirus
particles were mixed with CW02. The combined sample was imaged via cryo-EM, and
separated images of poliovirus and CW02 were used to compute 3D image reconstructions. A
previously calibrated map of 160S poliovirus130 was used to determine the size of the poliovirus
reconstruction131 and, hence, the sampling size of the CW02 reconstruction. Bsoft124 (bshow
function) was used to measure capsid dimensions.
3.3.4

Handedness determination

Tilt experiments were performed as described previously. 132 Briefly, pairs of micrographs of
CW02 were recorded with the same field of view, under the same conditions, but with the
specimen at different tilt angles. The first micrographs of the tilt pairs were recorded at 0° tilt,
and the second micrographs were recorded at 5° tilt. The origins and orientations of the untiltedparticle images were determined using the PFT2 model-based method described above, after
which the Bsoft program dhand124,133 was used to predict the orientations of the tilted particles
(for either handedness), compute tilted projections from enantiomers of the 3D reconstruction,
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and compare the projections to the experimental images of tilted particles. The correct
handedness was the handedness that compared the best.
3.3.5

Structural modeling

The atomic coordinates of HK97 capsid protein134 (Protein Data Bank accession no. 1OHG)
were fitted as separate pentameric or hexameric units. Only the Cα chain of axial (A) and
peripheral (P) domains were used in the fitting. Pentamers and hexamers were first fitted
manually as a rigid body into the electron density map of CW02 by use of the program UCSF
Chimera,135 after which the fitting was refined by automated fitting using the same program. All
surface renderings of the reconstruction were done at a 1-σ contour level, which is defined by the
sum of the average and standard deviation of map densities. Segmentation of individual subunits
(via UCSF Chimera135) was also carried out.
Attempts were made to reconstruct the turrets from cryo-EM images. We used a procedure
adapted from a method developed previously by Briggs et al..136 After icosahedral
reconstructions were computed, turrets were re-extracted from the 2D images using only vertices
that did not overlap the densities of the capsid shell. Reference-free class averages (SPIDER137),
and asymmetric and symmetric (C2, C3, C4, C5, C6, C7; Cn is cyclic n-fold symmetry)
reconstructions using random models as the initial reference, were computed. Additional class
averages were also generated from cryo-EM pictures by masking the capsid shell according to
the radius. In addition, we tested if turrets were found on all 5-fold vertices by performing
asymmetric and C5-symmetric reconstructions using as the initial reference a CW02 capsid with
a cylindrical density on a single vertex.
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3.3.6

MS

CW02 virions were subject to SDS-polyacrylamide gel electrophoresis (SDS-PAGE) to separate
individual proteins. The gel was stained using Coomassie blue reagent, after which individual
gel bands were excised and then shredded by spinning gel fragments through micropipette tips.
To capture all of the proteins in solution, whole virions were also prepared for MS analysis by
forgoing SDS-PAGE. Proteins were prepared for analysis by MS by use of a modified filteraided sample preparation protocol adapted from reference 57. Briefly, the gel fragments were
destained using a 1:1 mixture of acetonitrile and 8 M urea, in 0.1 M Tris-HCl (pH 8.5). The
denatured proteins were subsequently reduced with 0.1 M dithiothreitol in UA buffer (8 M urea,
0.1 M Tris-Cl, pH 8.5) and then carboamidomethylated with 50 mM iodoacetamide in UA
buffer. Each solution was washed by filtration through a 10-kDa molecular mass cutoff filter
(Sartorius Stedim Biotech, Bohemia, NY). The urea and iodoacetamide were then replaced with
50 mM ammonium bicarbonate. Proteins were finally digested with sequencing grade trypsin
(Promega) and then acidified by the addition of formic acid to 1% of the volume.
Acidified peptide samples were loaded onto a nanoAquity C18 column (75 μm by 15 cm; Waters
Corporation, Milford, MA) and eluted by a 100-min binary gradient of Optima grade solvent A
(5% acetonitrile, 0.1% formic acid) and Optima grade solvent B (0.1% formic acid, 99.9%
acetonitrile) (Thermo Scientific, San Jose, CA) at 425 nl/min composed of the following steps.
From a baseline of 95% solvent A, an 8-min gradient to 90% solvent A was performed, followed
by a 65-min gradient to 65% solvent A, a 7-min gradient to 5% solvent A for 8 min, and a 3-min
return to a 95% solvent A baseline for 9 min.
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Column effluent was directed to a nanoelectrospray ionization source on an LTQ-Orbitrap XL
(Thermo Scientific, Waltham, MA). Data-dependent acquisition was performed by coupling a
60,000 resolution survey scan in the Orbitrap with up to the top seven subsequent collision
induced dissociation tandem MS (MS/MS) scans acquired in the ion trap (signal threshold of
1,000, normalized collision energy of 35%, isolation width of 2 m/z, with a two-count dynamic
exclusion in a 3-min window). A lock mass of a polysiloxane compound atm/z 445.120025 was
used as an internal mass calibration standard. 138
MS/MS spectra were converted to the Mascot generic format by the MsConvert program
(http://proteowizard.sourceforge.net/pubs.shtml). Mascot searching was queried against a
database of ORFs derived from the CW02 genome. The peptide search space was expanded by
concatenating the CW02 database with a comprehensive database of the Escherichia coli ATCC
8739 proteome (GenBank accession no. YP_001723016.1). Search results were filtered against
a decoy database to a 1% false discovery rate confidence at the peptide level, corresponding to
Mascot ion cutoff scores of 22 to 27.
3.3.7

Nucleotide sequence and structural accession numbers

The CW02 genome, 3D reconstruction, and fit of HK97 coordinates into the CW02 capsid have
been deposited in the GenBank database (JQ446452), the EM Data Bank (5388), and the Protein
Data Bank (3J1A), respectively.

45

Table 3.1: CW02 putative ORFs and analysis of proteins determined by LC-MS and detected homologues. aThe first value in each column corresponds to data
from SDS-PAGE band excision (see Figure 3.2). The second value, if present, corresponds to data from whole, non-SDS-PAGE-treated virions. bPercentage of
amino acid sequence observed. cSummary of hits found via PSI-BLAST analysis. Protein sources are in parentheses. Conserved domains are underlined.
d
Secondary structure prediction programs are underlined.
Identification

# amino acid
residues

Molecular
mass (kDa)

+

78

8.7

gp2

+

215

24.2

gp3

+

437

48.8

% Coverageb

Direction

gp1

Unique
peptides

ORF

by LC-MSa
BLAST hits and conserved domainsc

E

Putative function and structure

value

predictiond

Hypothetical protein ORF001 (Pseudomonas phage PA11)

7e-45

Amidotransferase

Glutamine amidotransferase (Bacillus sp. strain B14905)

1e-13

Hypothetical protein ORF004 (Pseudomonas phage PA11)

4e-45

Glutamine amidotransferase (enterobacterial phage

4e-21

Amidotransferase

φEco32)
gp4

+

64

7.2

Hypothetical protein ORF005 (Pseudomonas phage PA11)

1e-85

gp5

+

267

30.0

gp6

+

77

8.7

gp7

+

77

8.6

gp8

+

190

21.1

Hypothetical protein ORF006 (Pseudomonas phage PA11)

6e-05

gp9

+

266

30.7

Conserved amidoligase_2 domain

46

Amidoligase

Hypothetical protein ORF007 (Pseudomonas phage PA11)
gp1

+

159

17.6

+

71

7.9

+

252

28.6

1e-37

0
gp1
1
gp1

Conserved ATP-grasp domain

ATP-grasp protein

2

gp1

+

73

8.2

+

77

8.9

+

60

6.9

+

126

14.0

Hypothetical protein ORF008 (Pseudomonas phage PA11)

1e-63

ATP-grasp enzyme (enterobacterial phage φEco32)

1e-26

3
gp1
4
gp1
5
gp1

Conserved AIG-2 like domain AIG-2 protein

6
Conserved YtfP/UPF0131 protein (enterobacterial phage
φEco32)

47

8e-25

gp1

+

97

10.6

+

82

9.8

+

532

60.0

7
gp1
8
gp1

TOPRIM and P-loop_NTPase superfamily

DNA primase/helicase

9

gp2

+

87

10.2

+

161

19.3

Hypothetical protein ORF011 (Pseudomonas phage PA11)

0.0

DNA primase/helicase (enterobacterial phage T7)

1e-23

0
gp2

Sigma70_r2 superfamily

RNA polymerase sigma factor

1

gp2

+

67

7.6

+

629

72.6

Hypothetical protein ORF012 (Pseudomonas phage PA11)

1e-15

RNA polymerase sigma-70 factor (Kordia algicida OT-1)

2e-07

2
gp2

DNA polymerase A superfamily

DNA polymerase

3
Hypothetical protein ORF013 (Pseudomonas phage PA11)

48

0.0

Putative DNA polymerase (Roseobacter phage SIO1)

gp2

3e-23

DNA polymerase (enterobacterial phage T7)

5e-07

3e-36

+

69

8.0

+

270

29.6

Hypothetical protein ORF015 (Pseudomonas phage PA11)

+

215

24.7

PIN_SF superfamily

4
gp2
5
gp2

5’–3’ exonuclease

6

gp2

+

74

8.6

+

117

13.2

+

129

15.0

+

256

29.7

Hypothetical protein ORF018 (Pseudomonas phage PA11)

3e-65

5’–3’ exonuclease (Pseudomonas phage LUZ24)

1e-25

Hypothetical protein ORF020 (Pseudomonas phage PA11)

3e-03

7
gp2
8
gp2
9
gp3
0

Conserved 3’–5’ exonuclease domain of family B DNA

3’-5’ exonuclease related to DNA

polymerases

polymerase, epsilon chain

Hypothetical protein ORF021 (Pseudomonas phage PA11)

49

8e-87

Exonuclease related to epsilon chain of DNA polymerase

3e-34

(Xanthomonas phage Xp10)
gp3

+

115

12.8

Hypothetical protein ViPhICP2p65 (Vibrio phage ICP2)

1e-25

Transcriptional repressor (Pseudoalteromonas phage

3e-16

Transcriptional repressor

1

H105/1)
gp3

+

63

7.2

+

191

21.6

+

62

7.2

−

608

64.9

2
gp3

Conserved poly(A) polymerase head domain

Poly(A) polymerase

Conserved phage tail repeat-like domain

Possible tail fiber

3
gp3
4
gp3

19/18

49/43

5
Collagen triple helix repeat protein (Victivallis vadensis

8e-06

ATCC BAA-548)

gp3

−

102

11.5

Putative tail fiber (Acinetobacter baumannii 1656-2)

6e-05

Hypothetical protein (Vibrio phage ICP2)

2e-13

6

50

gp3

−

118

13.3

−

144

15.4

7
gp3

ORF-B (predicted transmembrane helix, suspected holin;

Transmembrane helix (Psipred)

VpV262)

8
gp3

8e-29

−

684

73.7

24/25

41/44

Coiled coils (COILS)

−

1413

156.4

38/42

42/47

ORF-U (VpV262)

2e-34

−

153

16.0

1/2

9/19

gp26 (Roseobacter phage SIO1)

2e-13

−

98

11.8

−

741

82.0

9/11

16/19

Hypothetical protein ORF038 (Pseudomonas phage PA11)

0.0

9
gp4

Putative tail sheath

0
gp4
1
gp4
2
gp4

Putative tail appendage, 2 righthanded

3

-helices (BetaWrapPro)

gp4

−

64

6.9

gp27 (Roseobacter phage SIO1)

8e-74

ORF-P (VpV262)

3e-24

Hypothetical protein ORF038 (Pseudomonas phage PA11)

9e-05

4

51

gp4

−

251

29.2

3/4

17/27

Hypothetical protein ORF040 (Pseudomonas phage PA11)

1e-109

gp28 (Roseobacter phage SIO1)

7e-26

ORF-Q (VpV262)

9e-10

Head fiber protein (Bacillus phage B103)

6e-05

5

gp4

−

114

12.0

2

41

−

150

15.4

5/3

36/25

Possible head fiber

6
gp4

Putative tail fiber, β-structure
(Psipred), right-handed β-helix

7

(BetaWrapPro)
gp4

−

312

34.7

25/5

92/32

Hypothetical protein ORF044 (Pseudomonas phage PA11)

2e-137

ORF-K (VpV262)

2e-36

P22 gp6-like protein (Clostridium phage CP26F and 39-O)

1e-02

Hypothetical protein ORF045 (Pseudomonas phage PA11)

1e-27

Major capsid protein

8

gp4

−

264

29.1

(Psipred)

9

gp5

Scaffold protein, helical structure

−

82

9.6

gp30 (Roseobacter phage SIO1)

6e-09

ORF-J (coiled coil; scaffold protein; VpV262)

8e-09

Hypothetical protein ORF046 (Pseudomonas phage PA11)

4e-10

0

52

Coiled coil (COILS)

gp5

−

592

67.5

20/19

33/39

Hypothetical protein ORF047 (Pseudomonas phage PA11)

0.0

ORF-H (VpV262)

1e-78

gp3, gp5 (Roseobacter phage SIO1)

1e-63

gp8 (Phormidium phage Pf-WMP3)

4e-09

Hypothetical protein ORF049 (Pseudomonas phage PA11)

0.0

Portal protein

1

gp5

−

535

61.6

enzyme/terminase

2
ORF-G (VpV262) 1e-113
gp1, gp2, gp4 (Roseobacter phage SIO1) 1e-97
Terminase (Pf-WMP3) 6e-16
Terminase (enterobacterial phage T7) 4e-06
gp5

−

165

19.5

−

636

68.1

21/28

53/66

−

191

21.1

1

11

−

68

8.0

Hypothetical protein ORF050 (Pseudomonas phage PA11)

3e-62

Hypothetical protein ORF052 (Pseudomonas phage PA11)

7e-37

3
gp5
4
gp5
5
gp5

DNA packaging

6

53

gp5

−

97

11.1

+

210

23.4

+

76

8.2

+

116

13.2

+

69

7.8

+

58

6.6

+

158

18.7

7
gp5
8
gp5
9
gp6
0
gp6
1
gp6
2
gp6

(Acetohalobium arabaticum DSM5501)

3
gp6

Conserved hypothetical protein Acear_1218

+

74

8.2

+

73

8.4

+

125

14.2

4
gp6
5
gp6

54

3e-21

6
gp6

+

121

14.3

Conserved hydrolase_2 domain

Cell wall hydrolase

7

gp6

+

144

16.4

+

152

16.9

+

503

56.2

Cell wall hydrolase, SleB (alphaproteobacterium BAL199)

4e-09

Hypothetical protein ORF070 (Pseudomonas phage PA11)

3e-03

8
gp6
9
gp7
0
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Figure 3.1: The conserved structure module arrangement of the T7 supergroup. Genomic segments of phages T7,
VpV262, Pf-WMP3, and CW02 are shown. The division of the T7 supergroup (dashed line) is characterized by
inverted directionality of the genes in T7 compared to the VpV262-like cluster, as discussed.114 Numbering
indicates base pair positions from the 5’ to the 3’ end of the coding strand. Scale bar, 1 kb.

3.4

Results and discussion
3.4.1

CW02 is a member of the T7-like phage supergroup

The genome of phage CW02, determined by 454 pyrosequencing, had an average read length of
405.47 bp with 44,463 reads and a contig length of 49,391 bp. This corresponded to 366-fold
coverage of the genome. The CW02 genome consists of linear dsDNA with a GC content of
47.67%. Analysis of the sequence suggests the genome contains at least 70 ORFs (Table 3.1)
and a single tRNA (Arg; anticodon = AGA). Thirty-six of the ORFs appear to be unique to
CW02, as PSI-BLAST analysis did not reveal significant matches.
The CW02 genome is similar to the genomes of T7-like phages. PSI-BLAST analysis of
putative CW02 ORFs resulted in matches to T7-like phages, including Pseudomonas phage
PA11,111 roseophage SIO1,112 cyanophage Pf-WMP3,114 and vibriophage VpV262.113 The
genomes of CW02 and PA11 have at least 24 homologous ORFs in common (Table 3.1), though
the functions of the PA11 gene products have not yet been determined. A gene for a T7-like
DNA polymerase (gp23) was identified in the CW02 genome by PSI-BLAST analysis,
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suggesting an evolutionary relationship between CW02 and T7. However, the genus definition
of “T7-like phages” includes the presence of an RNA polymerase encoding gene,139 which was
not detected in the CW02 genome. The genomes of SIO1 and VpV262 also lack an RNA
polymerase gene.113 Another attribute of the “T7-like phage” genus is the presence of terminal

Figure 3.2: Protein composition of mature wild-type CW02 particles as determined by SDS-PAGE and
identified by LC-MS. gp39 and gp43 have similar sizes and were not separated in the gel. See Table 3.1 for
properties of gene products. Lane MW contains molecular size markers. Peptide fragments from four unique
ORFs (gp41, gp46, gp47, and gp55) were detected in the two lowest MW bands (asterisk).

repeats on either end of the viral genome, 139 though SIO1 lacks terminal redundancy.112 The
CW02 genome also lacks terminal redundancy. The discrepancies of VpV262 and SIO1 with the
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definition of the “T7-like phage” genus led to the proposal of a broader, ancestral T7-like
supergroup that predates the divergence of phages with and without an RNA polymerase gene, 113
here referred to as “T7-like viruses” and “VpV262-like viruses,” respectively.
The arrangement of structural genes suggests that CW02 belongs to the VpV262-like cluster
within the T7 supergroup.113 A characteristic feature of the T7 supergroup is the presence of a
conserved module of late structural genes involved in the assembly of the capsid head. 113 The
head structure module of the VpV262-like cluster is arranged such that the genes encoding the
terminase, portal, scaffold, and capsid proteins are consecutively ordered and separated by few,
if any, gaps (Figure 3.1). The tail structure module is generally encoded leftward of the head
module.113 The structure module of T7-like viruses is related to the VpV262-like viruses by
inversion, with the portal, scaffold, and capsid proteins sequentially ordered, though the
terminase ORF is rearranged. In general, the genomes of T7-like viruses contain early (e.g.,
replicative genes) and late genes along the same strand, whereas the replicative and structural
genes of VpV262-like viruses are on opposite strands.113,114 Bioinformatic analysis of the CW02
genome revealed the same genomic arrangement as other VpV262-like viruses, including
VpV262113 and Pf-WMP3114 —a conserved terminase (gp52), portal (gp51), scaffold (gp49), and
capsid protein (gp48) closely grouped in sequential order (Figure 3.1) and in the order opposite
from that of replicative genes, including the putative DNA polymerase and helicase genes (Table
3.1). Several large ORFs (gp35 to gp47) are found leftward of the head module, and by virtue of
the module arrangement and sequence analysis, these genes may be involved in tail assembly
(Table 3.1). Based on these observations, CW02 likely belongs to the VpV262-like cluster
within the T7 supergroup.
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3.4.2

Proteins in the mature CW02 particle

Twelve unique proteins were identified in the mature CW02 virion (Table 3.1). Proteins
associated with the virion were analyzed by liquid chromatography (LC)-MS following the
excision of detected SDS-PAGE bands. Ten bands were excised and then treated by in-gel
trypsin digestion (Figure 3.2). The gel slice corresponding to the lowest-molecular- weight
proteins revealed peptide fragments from four unique ORFs (gp41, gp46, gp47, and gp55). Ten
of the 12 proteins identified by gel-excision LC-MS were further confirmed by LC-MS of whole,
non-SDS-PAGE-treated virions (Table 3.1). Three of the gel bands were identified as the same
protein (gp48), and one gel band revealed two proteins of similar sizes (gp39 and gp43). Five
proteins present in the virion (gp39, gp41, gp47, gp54, and gp55) did not have detectable
homologous counterparts via PSI-BLAST analysis, and their functions remain unknown (Table
3.1).
Proteins in the CW02 head structure module. We identified gp48 as the major capsid protein
because gp48 was clearly the most abundant CW02 protein identified by SDS-PAGE (Figure
3.2). PSI-BLAST analysis revealed that gp48 shows some similarities to the putative P22-like
coat proteins of Clostridium phages CP26F and 39-O,140 although the E values were only on the
order of 10−2 (Table 3.1). Pairwise sequence alignment of gp48 and the major capsid protein of
T7 (gp10) showed just ~18% identity (55 of 312 residues). Nevertheless, PSI-BLAST analysis
revealed that gp48 shows more significant similarities to the putative capsid protein of VpV262
(ORF-K; E value, 3e-31).113
Despite poor pairwise sequence alignments, secondary structure prediction methods suggested
that gp48 is related to capsid proteins of the T7-like supergroup and other tailed dsDNA phages
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in general. We used the Phyre Protein Fold Recognition Server, 122 which predicted that gp48
adopts the same fold as the major capsid proteins of HK97 and P22 (P = 0.05). This prediction is

Figure 3.3: Coiled-coil prediction profiles of CW02 gp49 and the scaffold protein of phage T7 (gp9).
The probabilities of a coiled coil in either protein were determined using the program COILS.

significant because pairwise alignment of the HK97 and P22 capsid protein sequences showed
just 17% identity. Pairwise alignments of gp48 with the major capsid proteins of HK97 and P22
were similar—just 13% and 20% sequence identities, respectively. This is consistent with
observations that the HK97-like fold is more conserved than its sequence.105–108Based on
sequence comparisons, we propose that gp49 encodes the CW02 scaffolding protein. gp49 lies
in the predicted position of the scaffold protein in the head structure module (Figure 3.1). PSIBLAST analysis of gp49 identified similarities to other putative scaffold proteins (Table 3.1).
Many viruses require scaffolding proteins to direct the proper assembly of virus capsids. The
proteins are integral components of phage proheads but are not detected in the mature phage
particle.141 As expected with phage scaffold proteins, gp49 was not detected by LC-MS of
mature virions. Secondary structure prediction algorithms predicted gp49 to consist of an
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entirely helical structure (data not shown), which is consistent with the crystal structure of phage
29 scaffolding protein.108 Although the sequences of gp49 and the scaffolding protein of
bacteriophage T7 share only ~15% sequence identity (41 of 264 residues), both proteins are
predicted to have two or more regions that can form coiled-coil arrangements (Figure 3.3). The
predictions differ in length and probability, but they suggest that the two proteins have structural
similarities.
Based on sequence comparisons, CW02 gp51 appears to be a portal protein. Tailed dsDNA
phages encode portal proteins that enable DNA passage during packaging and ejection. The
portal also functions as a connector between the capsid and tail proteins. PSI-BLAST analysis of
gp51 showed a conserved domain belonging to the head-tail connector superfamily. The
sequence of gp51 is strongly conserved with the putative portal proteins of VpV262, SIO1, and
Phormidium phage Pf-WMP3/4 (Table 3.1). We used secondary structure prediction methods to
investigate possible similarities between gp51 and the portal protein of phage T7 on the
structural level and found the profiles to show some resemblance (data not shown).
Sequence comparisons suggest that CW02 gp52 is the terminase protein. Phage terminases are
enzymes that facilitate packing of the viral genome into the phage proheads and, like scaffold
proteins, are not found in the mature virion.142 As expected, gp52, was not detected by LC-MS
of mature CW02 particles. CW02 gp52 had weak sequence similarity to the terminase protein of
phage T7 but stronger sequence similarity to the putative portal proteins of VpV262 and SIO1.
Secondary structure prediction of gp52 showed an arrangement similar to that of the terminase of
phage T7 (data not shown), suggesting that their functions are conserved.
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3.4.3

Proteins in the CW02 tail structure module

Putative tail proteins were observed leftward of the head structure module. This placement is
consistent with tail genes in the known T7-like supergroup. 113 A number of large ORFs are
found in an appropriate location of the CW02 genome that could reasonably be thought to
encode tail-associated proteins. For instance, PSIBLAST analysis of gp35 revealed a conserved

Figure 3.4: Electron microscopy of CW02 by negative stain (A) and cryogenic (B) methods. Stubby or thin tail-like
features are marked by white arrowheads. Collapsed, empty particles are shown by black arrowheads. The inset in
panel B shows examples of particle images used in computing the 3D reconstruction (black scale bar, 50 nm).
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“phage tail-like repeat” domain. Also, gp40, encoded by the largest putative ORF in the CW02
genome, is a 1,413-amino-acid protein—consistent with the large sizes of phage tail sheath
proteins. Trimeric structures of coiled coils and β-helices are a common motif in tail-associated
proteins, such as the tail spike protein of P22 (homotrimers of β-helices)143 and tail fibers of
bacteriophage T7 (triple-stranded coiled coils). 144 The presence of coiled coils and β-helices in
candidate ORFs within the putative tail structure module was examined. The BetaWrapPro
program revealed right-handed-helical motifs in gp43 and gp47, whereas the COILS program

Figure 3.5: Cryo-EM-based reconstruction of CW02. (A) Stereo image of the CW02 capsid surface rendered at a
1-σ contour level. Structures are shaded from light to dark, corresponding to the radius. (B) The central slice of
the reconstruction (perpendicular to a 2-fold symmetry axis). Black represents protein or DNA density. Bar, 25
nm. Black arrowheads indicate turrets. The arrow indicates potential capsid-dsDNA contacts. (C) Plot of
average density with respect to the radius of the reconstruction. DNA and capsid density peaks are labeled.

detected coiled-coil motifs in gp39 and gp41.
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3.4.4

Electron microscopy of CW02 particles

CW02 virions are morphologically similar to members of the family Podoviridae. Negatively
stained CW02 particles were visualized by transmission electron microscopy and revealed
particles with icosahedral heads and a short, tail-like feature (Figure 3.4A). However, the taillike structures showed inconsistencies among individual particles. For example, a short, stubby
tail was observed in some of the particles, whereas in other particles, a short, thin, fiber-like
feature was more apparent. Cryo-EM was used to visualize CW02 particles in the solution state
(Figure 3.4B). Although similar stubby and thin-fiber tails were observed, tail-like structures
were more difficult to discern in cryo-EM micrographs, which may be a consequence of
decreased contrast in samples with high salt concentrations. 145
3.4.5

T = 7 levo icosahedral capsid lattice

Cryo-EM images of CW02 were used to compute a 3D reconstruction. The 3D reconstruction of
the CW02 head was determined to a 16-Å resolution using 8,695 particle images (out of a total
of 10,677 particle images) and applying icosahedral averaging to maximize the signal-to-noise
ratio (Figure 3.5A).
The head of CW02 is arranged in a T = 7 icosahedral lattice (Figure 3.5A). T = 7 lattices have
two possible arrangements that are mirror images of each other. Because transmission electron
microscopy images are 2D projected views, information about the object handedness is lost in its
3D reconstruction. The structures of all currently known T = 7 bacteriophages, including
lambda,146 HK97,104 and T7,105,147,148 are of the levo orientation. We performed tilt experiments
to determine the handedness of the CW02 capsid. This method relies on the cross-correlation of
images of tilted specimens with projections of the tilted model of either handedness. 132 Like that
of the other T = 7 phages, the handedness of CW02 was determined to be of the levo orientation.
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For particles showing a clear difference between left- and right-handed T = 7 lattices (i.e.,
correlation coefficient difference of ≥ 0.10), the average correlation coefficient was 0.41 ± 0.06

Figure 3.6: Rigid-body fit of the HK97-like fold 134 into the CW02 capsid. (A) Ribbon diagram of the HK97 protein with
pertinent helices and domains labeled. Yellow, N terminus; green, cross-linking arm; blue, A domain; red, P domain.134
Yellow, green, light red, and light blue indicate coordinates omitted from the CW02 fitting. (B and C) Frontal (B) and
side (C) views of the HK97 A and P domains (chains A to G) fitted into CW02 hexamers (purple, red, yellow, green, teal,
and blue, chains A to F, respectively) and pentamers (orange, chain G). Each subunit is colored according to
conventions used previously.134 Solid lines in panel B outline the wedge-like conformation of the A domain. (D) Central
section of the CW02 reconstruction fitted by multiple copies of the HK97-like fold. The white arrowhead points to
concentric layers of the DNA genome. In all of the panels; representative gpD-like densities are indicated by stars; the
A and P domains are labeled in italics; symmetry and hexamer axes (dashed lines) are labeled with pentagons (5-fold),
triangles (3-fold), ovals (2-fold), and a hexagon (local 6-fold, in panel C only); and turret densities were omitted.

for T = 7 levo handedness and 0.26 ± 0.06 for T = 7 dextro handedness (n = 40).
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3.4.6

Architecture of the CW02 head

The diameters of the CW02 head measured 691 Å, 627 Å, and 585 Å along the icosahedral 5 fold, 3-fold, and 2-fold axes, respectively. The average thickness of the capsid shell is
approximately 37 Å. Sixty hexamers and 12 pentamers comprise the icosahedral head.
We postulate that the CW02 capsid has a conserved structure with that of the T7 capsid and other
phages of the Caudovirales order. To date, the capsids of all tailed dsDNA bacteriophages
appear to adopt the HK97-like fold. For instance, the pseudoatomic capsid structure of phage
T7, solved by cryo-EM and modeling methods, showed the conserved fold. 105,147 The centers
between two hexameric capsomeres of the CW02 reconstruction are separated by approximately
140 Å, which is a characteristic feature of the HK97-like fold.106,149,150 The fold consists of two
domains: the axial (A) domain and the peripheral (P) domain (Figure 3.6A).104,134 The A domain
is a compact, wedge-like structure with two α-helices (α5 and α6) and a four-stranded β-sheet.
The P domain is elongated, consisting of a long helix (α3) accompanied by a long β-sheet.
Together, the domains form an L-shaped protein with a continuous hydrophobic core. 134 The
HK97 capsid protein also bears an extended amino-terminal arm and a cross-linking loop (Figure
3.6A), but these segments are not as conserved in other tailed dsDNA phages.
To further investigate the similarities between CW02 and HK97-like capsids, we performed
rigid-body fitting of the HK97A and P domains into the CW02 reconstruction (Figure 3.6B to
D). The Cα backbones of the A and P domains were fitted into the density map as either
hexamers or pentamers. Flexible loops were omitted from the fitting, leaving 128 to 130
residues in the fitted core structure. Similar results were obtained by fitting hexameric and
pentameric capsomeres, e.g., the agreement between the characteristic slants of the α5 and α6
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helices into the cryo-EM densities (Figure 3.6B, solid lines). The elongated α3 helix and
accompanying P domain β-sheet also fit snugly into the CW02 densities (Figure 3.6C). The P
domains interact in a 3-fold fashion at the 3-fold and quasi- 3-fold regions. Our fit showed
agreement between the P domain coordinates and the CW02 map, though voluminous triangular
densities were found above each of the P domain fits (Figure 3.6B and C, star). The overall fit is
consistent with previous studies that showed the intracapsomere stabilization role of the A
domain and the intercapsomere contacts made by the P domain. 134
Other than the main fold, other elements of the HK97 capsid protein appear to be missing from
CW02. The HK97 capsid protein structure consists of a cross-linking loop and extended Nterminal arms that stabilize interactions within each capsomere. 104,151 No evidence of crosslinking is seen in CW02 due to the absence of gp48 oligomers in SDS-PAGE analysis (Figure
3.2). The HK97 cross-linking loop and N-terminal arms fit poorly into the intercapsomere space,
suggesting that CW02 has different means of intercapsomere contacts (data not shown).
3.4.7

gpD-like densities at the 3-fold and quasi-3-fold axes

Other densities in the CW02 reconstruction were not accountable by the HK97-like fold. Most
prominently, the intersection of every three capsomeres is bridged by a triangular body found on
the 3-fold and quasi-3-fold axes (Figure 3.5 and stars in Figure 3.6B and C). Both types of
triangular densities showed consistent structures, despite icosahedral averaging, suggesting that
the proteins on the 3-fold and quasi-3-fold axes are identical.
The functions of the triangular densities are unknown, but their structures are reminiscent of the
auxiliary protein gpD trimer of bacteriophage lambda (Figure 3.7).107,146 Similar to the gpD
trimer, the positions of the triangular densities in CW02 on the 3-fold and quasi-3-fold axes
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suggest an intercapsomere stabilization role107 and its positions coincide with the covalent crosslinks formed by the HK97 capsid protein. 104 The P domains of the HK97-like fold form
intercapsomere contacts directly beneath the triangular densities (Figure 3.6). In other HK97like phages, intercapsomere interactions by the P domain are accompanied by more extensive
intercapsomere interactions from additional accessory proteins (including gpD of lambda 146 and
hoc of T4152), covalent cross-links (as in HK97104), or additional domains as part of the capsid
protein. For instance, the pseudoatomic structure of bacteriophage Φ29 showed that the major
capsid protein consists of the HK97-like domain and an additional immunoglobulin-like
domain.108 Bacteriophage P22 also consists of extra globular densities on the outermost surface
of the capsid.106 However, unlike the densities seen in CW02, the additional domains in Φ29 and
P22 do not form trimeric structures.The triangular densities likely belong to a separate domain of
CW02 gp48 and are not a separate, minor capsid protein. If the triangular densities of CW02
represent separate protein subunits, then 405 to 420 copies of the protein would be required per
capsid (i.e., the same number of major capsid protein subunits), as is the case with gpD of
lambda.107 Yet, SDS-PAGE analysis of mature CW02 particles did not reveal other proteins as
abundant as gp48, arguing against the presence of a separate gpD-like protein (Figure 3.2).
BLAST analysis of the CW02 genome did not reveal the presence of a gene like that for gpD.
Thus, the triangular densities of CW02 most likely represent an additional, non-core domain of
gp48, similar to the amino-terminal arm and cross-linking domain in HK97 (Figure 3.6A),104,134
the Ig-like domain of Φ29,108 and the additional globular domains of P22.106 The additional ~180
CW02 gp48 residues unmodeled in our fitting not only connect pieces of the core domain but
also likely form the additional gpD-like domain observed above the fitted core HK97 structure
(Figure 3.6).
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3.4.8

Lack of tail density in 3D reconstructions

The presence of a tail structure module in the CW02 genome (Table 3.1) and apparent tail-like
features in the EM images (Figure 3.4) suggests that each capsid is associated with a short tail.
From these images, the tail appears to be a stubby cylindrical component centered on a thin,
short rod.

Figure 3.7: Segmented views of the subunits that make up the CW02 (A) and lambda107 (B) capsids. Representative
hexameric and pentameric capsomer subunits of the asymmetric unit are colored as in Figure 3.6B. Representative
trimeric, gpD-like densities at the intersection of every three capsomeres are pink. The turret density of CW02,
located along the 5-fold axis, is brown.

Yet, despite the use of asymmetry or cyclic 5-fold (C5) symmetry during the reconstruction
process, none of our reconstructions produced a tail-like structure. The addition of artificial,
cylindrical, tail-like (short and stubby or short and thin) or portal-like densities to a single vertex
of the CW02 capsid as an orientation-refining fiducial marker did not produce different
structures (data not shown). One noteworthy difference between the pentameric and hexameric
capsomeres is the presence of an exterior bulge stemming from the center of the pentamers
(Figure 3.5). The bulge may correlate with an additional protein complex and may be part of the
tail apparatus. Alternatively, the tail-like material observed in negative stain and cryo-EM
images (Figure 3.4) may be partial discharge of DNA or discharge of protein from the capsid. In
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many of our preparations of negatively stained and frozen-hydrated particles, tail-like densities
were not observed in the electron micrographs (data not shown). Nevertheless, considering all of
the evidence, we think that CW02 most likely contains a tail that was “hidden” in our cryo-EM
3D analysis by the decreased contrast of the high-salt buffer.145
3.4.9

Structure of the encapsidated dsDNA and lack of internal membrane

HK97-like phages appear to have conserved mechanisms of dsDNA packaging, such that the
viral genome is cylindrically spooled within the capsid interior. 153,154 We observed at least eight
concentric layers of densities within the icosahedrally averaged head of CW02 (Figure 3.5C and
D). Each layer is spaced approximately 24 Å apart, similar to the dsDNA densities observed in
other bacteriophage structures, including T7 148,153 and lambda.154 The layering pattern is
consistent with the DNA spooling model established for T7. 153 Weak densities are also observed
at the interface between the outermost DNA layer and the capsid (Figure 3.5C), indicating
possible interactions between the capsid protein and dsDNA core.
Some turreted, extremophilic viruses of the PRD1-like lineage, including Sulfolobus turreted
icosahedral virus and SH1, encase an internal lipid membrane that is thought to aid in the
injection of the genome into the host cell. 155 Reconstructions of CW02 did not show any
evidence of material other than dsDNA within the capsid.
3.4.10

Presence of turrets on 5-fold vertices

On each icosahedral vertex, the CW02 reconstruction showed the presence of turret-like
structures that extend ~40 Å beyond the capsid head. The turret densities appear disconnected
from the capsid, suggesting that the linker between the turret and capsid is disordered or
incompatible with 5-fold symmetry. To investigate whether the turrets are unique to a single
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vertex or if they are positioned at each of the 12 5-fold vertices of the capsid, we computed
reconstructions of CW02 without any imposed symmetry (in both the orientation finding and 3D
image reconstruction processes). These reconstructions also showed the presence of
disconnected turrets on all vertices (data not shown). The 3D reconstructions and class averages
from the turrets (see Materials and Methods) showed inconclusive results, but control
experiments with images of poliovirus complexed with antibodies to the 5-fold region (J. Lin et
al., unpublished data) produced correct results. Therefore, CW02 turrets appear to lack a
consistent order. The function of the CW02 turrets and the gene encoding the turret protein
remain unknown, but the turrets may be unique appendages similar to those seen in other
extremophilic viruses, including the archaeal viruses Sulfolobus turreted icosahedral virus 155,156
and halovirus SH1. 145 Other icosahedral viruses with protein turrets or spikes on vertices include
adenovirus157 and bacteriophage PRD1. 158 The function of turrets is thought to be to assist in
host adsorption.145 Collectively, turreted viruses belong to the PRD1-like lineage and consist of
capsids with a single or double β-jellyroll fold, unlike CW02. Thus, the presence of turrets on
CW02 could represent structural features conserved between viruses of the PRD1-like and
HK97-like lineages.
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Chapter 4
Resolving double disulfide bond patterns in SNAP25B using liquid
chromatography–ion trap mass spectrometry 3
2F

Author’s Note: This chapter introduces a novel structural analysis of a complex disulfide
bridged peptide sequence, capable of elucidating disulfide bonding patterns. I assisted in
algorithm development, mass spectrometry, and document preparation. These results were
published in the Journal of Mass Spectrometry. 159
4.1

Abstract

Complex disulfide bond patterns in synaptosomal-associated protein of 25 kD B (SNAP25B) are
thought to regulate neurotransmitter release in response to oxidative stress. However, the steric
feasibility of each possible disulfide pattern in SNAP25B has not been assessed. To assess the
steric feasibility of hypothesized closely spaced complex disulfide patterning in SNAP25B and
also the feasibility of identifying complex disulfide bond patterns with MS, we have developed a
novel probabilistic analysis to unambiguously resolve complex double disulfide bond patterns by
using an ion trap mass spectrometer. We analyzed fragmentation patterns of singly linked
peptides to determine likely fragmentation events in an ion trap mass spectrometer and observed
double and single backbone cleavage along with heterolytic cleavage of the disulfide bond. We
modeled these same events in the doubly disulfide linked SNAP25B peptide and used a
cumulative hypergeometric distribution with top–down scoring to both identify and differentiate
these bonding patterns. Because of the presence of unique MS/MS peaks, two of the bonding
patterns were directly identified. The third was assigned on the basis of full chromatographic
separation and confirmed by modeling triple breakage fragments. In total, this work
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demonstrates the feasibility – and also limitations – of identification of complex intradisulfide
patterns by using ion trap-based collision-induced dissociation-based fragmentation methods.
4.2

Introduction

Disulfide bonds stabilize native protein conformation but are hypothesized to function as a redox
buffer and sensor of oxidative stress conditions. At the synapse, neurotransmitter release is
mediated by soluble N-ethylmaleimide (NEM)-sensitive fusion factor attachment protein

Figure 4.1: Disulfide bond patterns in SNAP25B. Complex disulfide bond formation in closely spaced
cysteine-rich region in SNAP25B (residues 84–94). Three double disulfide bond patterns can form; open,
parallel,
and cross-over.
receptor
(SNARE)
proteins. In the presence of calcium ions, SNARE proteins assemble into a

catalytic SNARE complex and stimulate the release of neurotransmitters. Under oxidative
conditions, the SNARE complex is thought to become dysfunctional, contributing to symptoms
of neurodegenerative disease such as Parkinson’s and Alzheimer’s. 160,161 One of the SNARE
proteins, synaptosomal-associated protein of 25 kD B (SNAP25B), is a known target of
oxidation, and oxidation of SNAP25 inhibits the formation of the SNARE complex. 162
The regulation of SNARE complex formation by SNAP25 is likely controlled by the oxidation of
a regulatory sequence composed of four closely spaced cysteine residues, by some combination
of differential palmitoylation and oxidation. Complete oxidation results in one of the three
possible configurations (Figure 4.1) for any peptide containing four cysteines. Molecular
dynamic simulation has shown that the inhibition of the SNARE complex could be caused by a
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change in structural conformation of SNAP25 via formation of disulfide bonds among the four
cysteine residues in SNAP25.163 These cysteines of SNAP25 are established to be a site of
differential palmitoylation and known to play a role in subcellular localization and membrane
anchoring of SNAP25.63,164 These competing modifications suggest that identification and
characterization of disulfide bond patterns can be crucial to understanding the regulation of
SNARE complex formation.
Current methods for disulfide bond order determination are fairly limited. Protein structure
determination using NMR can be used to identify the location of specific disulfide bonds but
requires a large amount of pure sample and is therefore prohibitive for complex mixtures.165 MSbased methods are ideal for isolating and characterizing samples in a complex mixture. 166 The
typical protocol involves a two-step tagging process, separated by a reduction step. With this
method, unbound cysteines are labeled with one irreversible alkylating reagent (typically Nethylmalamide), and the other pair of bonded cysteines is reduced and then labeled by another
irreversible alkylating reagent (typically iodoacetamide). Cysteines modified with the same
compound are deductively found to be paired. While effective for single disulfide bonds, this
method fails to elucidate the bonding pattern if multiple disulfide bonds are present. The
identification of the pairing pattern has been accomplished, however, through clever application
of the reduction/ alkylation methodology by stepwise methods where cysteines are partially
reduced and then differentially alkylated after each reduction step. Although effective for
identifying complex disulfide bond pairing patterns, the method has drawbacks: it is not a direct
detection of disulfides and thus cannot differentiate disulfide bonds from other oxidative
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modifications; it is not effective when the disulfide bonds have the same reduction potential; and
it still requires a large amount of protein.167,168
An alternative approach to the partial reduction protocol is nonreduced/nonalkylated mass
spectrometric analysis of disulfide bond patterns. This method relies on cleavage of both the
disulfide bonds and opening of the disulfide loop by breaking internal peptide bonds through
collision-induced dissociation (CID).169–171 This technique is particularly effective when proline
is present within the disulfide loop because of increased fragmentation efficiency at X-Pro
linkages.160 Excellent tools to facilitate identification of simple disulfide-bonded peptides have
been introduced, such as MassMatrix, but are unable to search more complex disulfide patterns
that require opening of the disulfide loop for identification. 172
Most previous disulfide bond linkage identification efforts were performed in collision cells at
higher energies171,173 to enable amino acid sequencing within the disulfide loop region. Recently,
a group used ion trap-induced CID to successfully generate internal fragments in a toxin that
contains disulfide bonds62 and characterize a triple disulfide bond-containing peptide toxin.
Unlike collision cells, fragmentation within an ion trap is expected to result in double or even
triple cleavage products at normal energies because cyclic cleavage products experience
sustained excitation until fragments dissociate.
Using conotoxins as an example, one group has demonstrated that an identification of complex
intradisulfide bonds may be feasible by modeling double backbone cleavage and disulfide bond
breakage.174 Although this is a significant breakthrough, a method of resolving complex
intramolecular disulfide bonds has not yet been achieved – there is no systematic or statistical
scheme to unambiguously resolve disulfide bond patterns. The development of a scheme that
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convincingly differentiates among possible disulfide patterns is crucial because the intensity of
MS/ MS spectra from the double backbone cleavage or disulfide bond cleavage is lower than
conventional fragmentation ions and therefore difficult to distinguish from the noise. Here, we
report CID-based mass spectrometric determination of all three distinct double disulfide bond
patterns possible in the cysteine-rich region of SNAP25B by using chromatographic separation
and statistical analysis of shared and unique MS/MS peptide fragments, including double
fragmentation events. This work suggests the feasibility and also limitations involved in
identification of complex intradisulfide patterns by using liquid chromatography (LC) and ion
trap mass spectrometers.
4.3

Materials and method
4.3.1

Protein and synthetic peptide preparation

The recombinant SNAP25B clone was expressed as a glutathione S-transferase (GST) fusion
protein in Escherichia coli and purified following the published protocol 175 with minor
modification. During the induction step, optical density of the media was kept at 0.8~1 A.U. to
optimize the protein synthesis for SNAP25B. The final concentration of the purified protein was
~0.1 mg/ml. Identity of SNAP25B was confirmed by Western blot analysis and MS (Polyclonal
SNAP25B, Abcam, Cambridge, MA). The SNAP25B plasmid was a generous gift from J. E.
Rothman (Memorial Sloan-Kettering Cancer Center, NY). Synthetic peptides of sequence
FCGLLVLPCNK and FLGLCVCPLNK were purchased from Genescript Inc. (Piscataway, NJ).
These peptides are identical to the tryptic fragment of the cysteine-rich region from SNAP25B
except for the replacement of two cysteines with leucines.
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4.3.2

Sample preparation

Synthetic SNAP25B peptides were suspended in water and incubated ~1 h in air to oxidize.
Peptides were subsequently acidified in 1% formic acid. One picomole of peptide was injected
in LC–MS/MS. Purified SNAP25B was run on standard sodium dodecyl sulfate polyacrylamide
gel electrophoresis (4–20% gel with antioxidant). The excised SNAP25B band was subjected to
a published in-gel tryptic digestion protocol,176 altered by skipping reduction by dithiothreitol
and replacing the iodoacetamide solution with 80mM solution of NEM instead. This alkylation
step, which does not affect peptides with two disulfide bonds, increased the mass of singly
disulfide-bonded peptides to prevent spectral overlap between the single and double disulfide
species. Sodium dodecyl sulfate polyacrylamide gel electrophoresis was performed using
commercially available equipment and protocols (Pierce, Rockford, IL). Trypsin was purchased
from Promega, Madison, WI.
4.3.3

Liquid chromatography and MS

A sample (27 picomoles) was loaded via an Ultra2D UPLC/ autosampler system (Eksigent,
Dublin, CA) to a 0.17 ml bed volume C-18 stem trap (Optimize Technologies Inc., Oregon City,
OR) at 3 ml/min in 95% Buffer A (95% water, 5% acetonitrile, and 0.1% formic acid), 5%
Buffer B (0.1% formic acid in acetonitrile) for 10 min. Elution was carried out at 325 nl/min
through a 20-cm, 75-mm ID NanoAcquity C18 column (Waters Corporation, Milford, MA) by
running from 98 to 88% Buffer A over 5 min, 88 to 65% Buffer A over 120 min, a 5-min ramp
to 5% Buffer A for 12 min, and a 4-min ramp to 95% Buffer A for 6 min to equilibrate the
column for subsequent runs. Column eluent was ionized via nanospray (2.0 kV, capillary) and
analyzed by the LTQ Orbitrap XL (Thermo Fisher Scientific Inc., Waltham, MA). Survey scans
were conducted at 60,000 resolution in the Orbitrap mass detector. Peaks were then selected for
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further ion trap CID fragmentation if they were on an inclusion list or were of the highest
intensity from the preview survey scan. The inclusion list consisted of all possible parent masses
for the charge state +2 tryptic fragment representing FCGLCVCPCNK. CID was carried out at
35% normalized collision energy.
4.3.4

Spectra analysis

RAW data files were converted to mzML files via ProteoWizard.26 MS/MS spectra were
extracted via mspire.177 We wrote a software package for predicting cross-link cleavage events
and analyzing extracted MS/MS spectra (freely available at
https://github.com/princelab/double_disulfide_searcher) in the Ruby programming language. An
overview of the program is provided in supplemental material (S1). All MS/MS fragmentations
were carried out on z = +2 precursor mass. Because of the low intensity of the multiply cleaved
peptide peaks, we analyzed only z = +1 peaks for both the MS/MS spectra of trypsin digested
SNAP25B and synthetic peptide mutants. The mass tolerance parameter for all the MS/MS
experiments was set at 0.3, yielding a bin size of 0.6 Thomson (Th) for both experimental and
predicted spectra.
For the analysis of the synthetic peptides FCGLLVLPCNK and FLGLCVCPLNK, experimental
MS/MS spectra were averaged for each using Xcalibur (Thermo Fisher Scientific Inc., Waltham,
MA). We confirmed that there is no intermolecular disulfide bridge (dimer) between the
peptides in our preparation by ensuring that no higher charge states existed at the given Th value.
For the peptide FCGLLVLPCNK in the +2 state, there was a complete chromatographic
separation between the reduced ((MW + 2)/2) and oxidized (MW/2) forms. For the peptide
FLGLCVCPLNK, the chromatogram showed overlap between the reduced and oxidized form.
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However, we confirmed the absence of cross contamination between the oxidized and reduced
MS/MS through manual examination of the spectra. The reduced species b and y series ions
were not observed in the MS/MS spectra of the oxidized species indicating that the 1 Th
difference between the reduced and oxidized species was sufficient to resolve the two
completely.
We eliminated the possibility of spectral contamination for the tryptic-digested samples by
treating them with NEM, which causes a 250-Da shift to the single disulfide species and a 500-

Figure 4.2: CID cleavages observed for test peptides. (a) Diagram of possible cleavages. (b) CID cleavage
for each possible cleavage type is compared as percent of the possible cleavages. In the longer loop case,
C88L C90L SNAP25 peptide, a significant number of double peptide backbone cleavages and heterolytic
disulfide cleavages are generated. Random is a pool of 1000 randomly selected masses generated at each Q
depth. Q depth between 3 and 10 was typical for later searches, as these optimized the signal to noise ratio.
(c) C85L C92L SNAP25B peptide generates far less double and heterolytic disulfide cleavages.
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Da shift to the fully reduced species. The double backbone cleavages use b-fragmentation and yfragmentation schemes described by Hunt et al.160 and Clark et al.173 Heterolytic and homolytic
disulfide cleavages, which generate persulfide/dehydroalanine and cysteine/ thioaldehyde,
respectively, were predicted on the basis of the mechanism described by Choi et al. 171
4.4

Results

Figure 4.3: MS/MS spectra of the oxidized peptide FCGLLVLPCNK (C88L C90L mutant). The fragmentation of the
peptide with CID shows robust double backbone and heterolytic cleavages. *Unaccounted peaks in the statistical
analysis were checked manually for their identity. From the left: y10, z11-CO, y11–CO, and z11. The Q depth of
this analysis was set to Q= 10, and details of the peaks are presented in Supplemental Data Table. The +SSH and H
denote the cleaved fragments of the disulfide bond via heterolytic disulfide bond cleavage via collision-induced
dissociation (persulfide and dehydroalanine, respectively). Peaks under the bold black lines (×5 and ×2) are
magnified as designated.
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First, we demonstrate that double backbone and heterolytic disulfide cleavages occur in the ion
trap and present a method for deductively resolving the three patterns of double disulfide bonds
that are possible in a peptide with four cysteines. We then use this method to confidently
identify all three complex disulfide bond patterns of the four cysteine peptides of SNAP25B.
Finally, we confirm the identifications with an analysis of triple backbone cleavage fragments.
4.4.1

Double peptide backbone and disulfide cleavages in an ion trap

As a test case to characterize the propensity for double backbone cleavage and disulfide
(heterolytic/homolytic) cleavage events in an ion trap (Figure 4.2a), we fragmented two single
disulfide peptides, where two cysteines in SNAP25B are substituted with leucines (peptides
shown in Figure 4.2b–c). To characterize the mode of fragmentations at different levels of
intensity, MS/MS spectra were divided into 100 Th bin, and top N number of highest intensity
peaks were extracted from each bin and analyzed (the value of N is referred as Q(queue) depth in
this article). This method of MS/MS spectra optimization is used in the proteomic search engine
Andromeda.23 The propensities for different cleavage types were monitored by calculating
%observed/predicted fragments for each Q depth. The first SNAP25B C88L C90L mutant
peptide (with a longer disulfide loop) showed significant double backbone cleavage fragments,
with comparable intensity to single cleavage fragment ions (Figs 2(b) and 3 and Supplemental
Table). For this peptide, heterolytic disulfide cleavage occurs well above background levels but
less commonly than the single or double backbone cleavages. The second SNAP25B C85L
C92L mutant peptide (with a shorter disulfide loop) showed less double backbone cleavages and
heterolytic disulfide cleavage, with single cleavage being the dominant type (Figs 2(c) and 4 and
Supplemental Table ). In both cases, homolytic disulfide cleavages followed the same trend as
random fragments, suggesting that homolytic disulfide cleavage is not occurring under these
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conditions. The fragmentation pattern observed here is consistent with the study by Choi et al.
that reported frequent observation of C–S bond cleavages and rare occurrence of S–S bond
cleavage under CID.171
4.4.2

In silico MS/MS fragmentation

Figure 4.4: MS/MS spectra of the oxidized peptide FLGLCVCPLNK (C85L C92L mutant). The fragmentation of the
peptide with CID shows few double backbone and heterolytic cleavages at low intensity. *Unaccounted peaks in the
statistical analysis were checked manually for their identity. From the left: a2, a4, y10-CO, z11-CO, y11-CO, b11,
and z11. The Q depth of this analysis was set to Q= 10, and details of the peaks are presented in supplemental data
table. The +SSH and −H denote the cleaved fragments of the disulfide bond via heterolytic disulfide bond cleavage
via collision-induced dissociation (persulfide and dehydroalanine, respectively).
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Theoretically, the SNAP25B cysteine-rich region may form three different bonding patterns
upon double disulfide bond formation. We postulated that double backbone cleavage
fragmentations would generate diagnostic fragments unique to a specific disulfide patterns,
whereas heterolytic disulfide cleavages would generate fragments that could be employed to give
the primary amino acid sequence.
To confirm our hypothesis, in silico MS/MS fragmentation simulations were performed on the
SNAP25B cysteine-rich region of the three disulfide bond variants, considering single, double
backbone, and double backbone/heterolytic cleavages. The different disulfide patterns of
SNAP25B resulted in different and unique MS/MS fragmentation upon single, double backbone,
and double backbone/heterolytic cleavages (Table 4.1). However, the cross-over pattern with the
double disulfide did not produce unique diagnostic fragments upon in silico MS/MS
fragmentation.
Table 4.1: The number of m/z fragments predicted for each fragmentation scenario in the SNAP25B cysteine-rich
region. The numbers inside the parentheses are fragments that uniquely occur in each specific disulfide bond
pattern. These fragments can be used to detect each disulfide pattern.

Cleavage Type
Single
Pattern

Single

Double
Double

Backbone/heterolytic

backbone

disulfide

Open

10 (4)

16 (6)

20

Parallel

6

21 (10)

20

Cross-over

6

9

20
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These patterns are generalizable to all four cysteine-containing peptides: the cross-over pattern
will not generate unique fragments when considering single or double fragmentation events and
therefore is not uniquely identifiable, unlike the open and parallel patterns. Regardless of the
peptide sequence, a crossover pattern will always produce double cleavage fragments that are
subsets of the open and parallel patterns. Nevertheless, two approaches, both employed for this
project, can be used to ascertain the identity of the cross-over pattern: (1) deductive identification
conditioned on chromatographic separation and confident identification of the other patterns and
(2) expansion of the fragmentation scheme to include triple backbone cleavages that do produce
unique fragments for the cross-over pattern.
4.4.3

Complete chromatographic separation

Triple backbone cleavage had never been previously demonstrated in the literature, and
therefore, we developed a scheme to confidently identify all three patterns on the basis of
complete chromatographic separation and deductive logic (Figure 4.5). The following

Figure 4.5: Decision tree logic supporting the correct identification of each disulfide pattern.

conditions must be met to deduce the identity of bonding patterns that yield no unique fragments:
(1) the MS/MS fragments must confirm that the peptide is in fact the linked peptide in question
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(i.e., a member of the set of possible bond arrangements and not some other peptide), (2) the
various linked peptides must be separated chromatographically, and (3) the other LC peaks and
their corresponding patterns must be confidently identified.
4.4.4

Scoring method

Following this logic tree, we developed a software that utilized an identification algorithm based
upon the proteomic search engine, Andromeda,23 with some modifications to account for the
double backbone and heterolytic disulfide cleavages. The observed MS/MS spectrum is
compared with the predicted spectrum and assigned a goodness of fit score on the basis of the set
of shared fragmentation ions from all possible disulfide bond patterns. The maximal score is
calculated from the set of scores obtained from matching the shared predicted fragments with
experimental spectra at Q depths of 1–10, where the Q depth that maximizes the score is
accepted. The score is calculated using a cumulative hypergeometric distribution statistical
model in lieu of the binomial distribution.178,179 We generate two scores, (1) a primary sequence
score that confirms the primary amino acid sequence of the peptide and (2) a pattern diagnostic
score that is used to identify specific disulfide patterns, where

.

The primary sequence score is analogous to a conventional Andromeda score, representing the
match quality of the fragment ions to the predicted fragment ions (Table 4.1). The pattern
diagnostic score represents the significance of the match to the unique fragment ions of each
predicted disulfide pattern (Table 4.1). These two values are used to evaluate the presence of a
pattern (Figure 4.5). An overview of the program is provided in Supplemental Material (S1).
To be stringent in identifying the primary amino acid sequence of the peptide, 99,999 decoy
fragmentation spectra, composed of 33,333 unique, scrambled FCGLCVCPCNK sequences each
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with all three possible disulfide bond patterns represented, were matched against the
experimental spectrum. The primary amino acid sequence was validated only when the primary
sequence score of the target peptide was statistically significant and the highest among the
primary sequence scores of the 99,999 decoy spectra.
4.4.5

Identification of the three different disulfide patterns

The three double disulfide bond patterns were separated and identified from an in-gel tryptic
digest of oxidized and affinity purified SNAP25B protein. To prevent spectral overlap between
the single and the double disulfide species of SNAP25B, we treated the sample with NEM to tag
open sulfhydryls on any single disulfide species. This induces a 250-Da mass shift to the single
disulfide species, to prevent spectral overlap between the different oxidation states. This is
crucial because the parent mass of the single and the double disulfide species differ by 1 Th at z
= +2, which is sufficient to cause spectral cross-contamination between the different oxidized
states when isolating the parent mass within the ion trap. The resolving power of our column
was sufficient to clearly separate three species at the parent mass (Figure 4.6a). We extracted the
MS/MS data of each LC peak and calculated the extent of identity for the three possible patterns:
open, parallel, and cross-over.
For each of the three chromatographic peaks, the primary sequence score (optimized Q depth =
7, 6, 4 for the first, second, and third LC peaks respectively) generated by the target sequence
FCGLCVCPCNK was highest among scores generated by the decoy peptides (Figure 4.6c–e),
demonstrating a confident match by sequence for the known SNAP25B cysteine-rich region.
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Figure 4.6: Identification of the three different disulfide patterns. (a) Extracted ion chromatogram for the mass
range of 591.73–591.74 at +/_8 ppm, where the theoretical monoisotopic m/z for a +2 charge state is 591.748,
showing three distinctly resolved peaks. The MS/MS spectra were extracted at retention times 68.03, 71.94, and
77.90 minutes for each respective LC peak. (b) Unique fragment scores. LC elutions of peaks 2 and 3 show the
presence of open and parallel patterns (respectively). The dotted line is the 99% confidence line for the presence of
a pattern (score = 20, where p-value = 0.01; nd; no detection). (C–e) All three chromatographic peaks have the
primary amino acid sequence of the target peptide double disulfide FCGLCVCPCNK. We further confirmed our
matches by running a decoy type search based upon the input peptide sequence by generating 99,999 sequence
variants and plotting the search results for each match. By this metric, we see that matches for the true sequence lie
well outside the distribution of false matches. The arrows indicate the primary sequence score for each of the three
patterns.
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We then calculated the pattern diagnostic score to determine the specific disulfide pattern for
each LC peak, with accompanying spectra shown in order of elution (Figure 4.7, Figure 4.8, and
Figure 4.9). Peaks 2 and 3 scored above a 99% confidence line for open and parallel patterns,
respectively (Figure 4.6b, Figure 4.8, Figure 4.9 and Supplemental Table). By identifying peak 1

Figure 4.7: MS/MS spectra of the precursor mass m/z = 591.73 at retention time 68.03 min. The fragmentation
of the peptide with CID shows unique peaks (red spectra = unique fragments for the cross-over pattern, blue =
shared fragments amongst three isoforms, and light blue = unique fragments for the open pattern). The numbers
next to the cysteine (C) denote the order of position in the primary sequence (FC1GLC2VC3PC4NK). The peaks
within the region beneath the bold black line are magnified by ×5. *Unaccounted peaks in the statistical analysis
were checked manually for their identity. From the left: y2-CO, c9-H2O, z11-CO, b11-NH3, y11-CO, z11, and
c10. The details of the peaks are presented in Supplemental Data Table. The Q depth of this analysis was
optimized to Q= 7. The +SSH and −H denote the cleaved fragments of the disulfide bond via heterolytic
disulfide bond cleavage via collision-induced dissociation (persulfide and dehydroalanine, respectively).
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as the SNAP25B cysteine-rich double disulfide peptide, achieving complete chromatographic
separation between the three peaks, and confidently assigning LC peaks 2 and 3 as the open and
parallel patterns, we conclude that peak 1 is the elution of the cross-over pattern (Figure 4.5 and
Figure 4.7). This result is consistent with the observation that the patterns that gave the highest

Figure 4.8: MS/MS spectra of the precursor mass m/z=591.73 at retention time 71.94 min. The fragmentation of
the peptide with CID shows significant amount of unique peaks (red spectra = unique fragments for the open
pattern, blue = shared fragments amongst the three isoforms, and light blue = unique fragments for the parallel
pattern). The peaks within the region beneath the bold black line are magnified by ×5. *Unaccounted peaks in
the statistical analysis were checked manually for their identity. From the left: c9-H2O, a5-NH3, a5, z11-CO,
b11-NH3, y11-CO, z11, a9, and z10. The details of the peaks are presented in Supplemental Data Table. The Q
depth of this analysis was optimized to Q= 6. The +SSH and −H denote the cleaved fragments of the disulfide
bond via heterolytic disulfide bond cleavage via collision-induced dissociation (persulfide and dehydroalanine,
respectively).
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primary sequence score (refer to Figure 4.6c–e) are consistent with the identification of unique
fragments for the respective patterns (Figure 4.6b).
4.4.6

Triple backbone cleavages

In an ion trap, a cross-linked molecule may break multiple times internally before a breakage
results in separate fragments that then fall out of resonance. The likelihood of multiple
breakages occurring is related to the proportion of amino acids involved in circular paths and
also their fragmentation propensities. After showing that double cleavage events can be a
dominant fragmentation pattern when the disulfide pattern favors it, we reasoned that triple
cleavage events may occur in doubly crosslinked molecules by the same principle of sustained
excitation within an ion trap. The cross-over pattern has a high probability of maintaining its
initial mass after single or double backbone cleavages because of the presence of the two
overlapping disulfide bonds and therefore may have a significant probability of triple backbone
cleavages. We calculated that the cross-over pattern can produce nine unique fragments upon
triple backbone cleavage (Supplemental Table). We calculated the pattern diagnostic score of
the MS/MS spectra of the first chromatographic peak (Figure 4.6a), deductively assigned as the
cross-over pattern, for triple cleavage events. In strong support of our assignment, we detected
two out of nine of these unique fragments 774.36 and 831.60 with a pattern diagnostic score of
17.3, which is above the 95% confidence (where 95% confidence threshold is 13.0; Q= 4; Figure
4.7 and Supplemental Table). In contrast, neither MS/MS spectra of the second or third
chromatographic peaks reached statistical significance for these unique cross-over fragments at
any of the Q depth from 1–10 (Supplemental Table). Consistent with the enhanced
fragmentation at X-Pro bond via CID, both of the observed triple cleavage fragments have a
breakage at the X-Pro bond. Although the thorough validation of triple backbone cleavage by
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CID in an ion trap is beyond the scope of this work, this analysis does provide substantial
corroborating evidence that we did indeed correctly identify the cross-over peak based on
deduction (Figure 4.6b).
4.5

Discussion and conclusions

Here, we report, for the first time, statistically significant identification of all three disulfide
patterns for double disulfide species of SNAP25B using CID. Recently, Foley et al. showed that
some of the cysteines within the SNAP25B’s cysteine-rich region are oxidized in the rat brain.180
They hypothesized that this is through an intradisulfide bond formation. Our data show that this
is sterically feasible between all four cysteine residues.
Although the result demonstrates the capacity to identify the three different bond patterns for the
initial peptide by using low-intensity peaks, there are clearly limitations inherent with this
approach based on the complexity of the problem. First, a mix of the patterns in a single
chromatographic peak cannot be resolved to full identification because of the high degree of
similarity between each fragmentation spectra – even a small amount of a different coeluting
bond pattern can confound identification as the parent masses are inseparable in ion trap
fragmentation precursor ion selection. Further, the cross-over variant has no unique fragments
after double cleavage and so is only identified by a lack of diagnostic fragments and a higher
primary sequence score than the other two variants. Deduction and complete chromatographic
separation were sufficient in this case, but a more generalized solution may need to incorporate
triple fragmentation cleavage for successful identification.
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Figure 4.9: MS/MS spectra of the precursor mass m/z = 591.73 at retention time 77.9min. The fragmentation of
the peptide with CID shows significant amount of unique peaks (red spectra = unique fragments for the parallel
pattern, blue = shared fragments amongst the three isoforms, and light blue = unique fragments for the open
pattern). The peaks within the region beneath the bold black line are magnified by ×5. *Unaccounted peaks in
the statistical analysis were checked manually for their identity. From the left: z11-CO, b11-NH3, y11-CO, z11,
and c10. The details of the peaks are presented in Supplemental Data Table. The Q depth of this analysis was
optimized to Q= 4. The +SSH and H denote the cleaved fragments of the disulfide bond via heterolytic disulfide
bond cleavage via collision induced dissociation (persulfide and dehydroalanine, respectively).

This study relied on lower resolution ion trap spectra, although MS/MS spectra could potentially
have been collected in the Orbitrap at higher resolutions. Two considerations motivated the use
of LTQ-generated low-resolution spectra. Primarily, we noticed that unless we sampled near the
peak apex, we often did not accumulate enough ions to observe peaks generated from lower
frequency breakage events. Furthermore, the spectra we collected away from the apex were
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typically contaminated with the other disulfide variants that were closely eluting. In particular,
intense unique fragments generated by single backbone fragmentation of the open patterns
dominated the MS/MS spectra of the other two LC peaks when the separation by LC was
insufficient or MS/MS spectra were not taken around the peak apex of the respective LC peaks.
This spectral contamination can be observed in spectra from the first and the third peaks of the
chromatogram (Figure 4.6a), which both have spectral contamination from the open pattern
(661.20 m/z; Figure 4.7 and Figure 4.9). The higher scan speeds of the LTQ ion trap allow
sampling near the apex of the chromatographic peaks and thus generate spectra with minimal
contamination between the three patterns. The second reason for using spectra derived from the
ion trap is that it increases the accessibility of the method to include low-resolution instruments.
Future studies will explore the tradeoff between high resolution, spectral contamination, and
sampling rate; however, our current statistical analysis and stringent decoy search using lowresolution spectra are clearly adequate to identify and distinguish the patterns under
investigation.
Resolving singly bonded patterns on peptides with more than two cysteines is, in some ways, a
more challenging endeavor than the double disulfide case. The four cysteines on the SNAP25B
cysteine-rich region can form six patterns of single disulfide species. Still, the general approach
we have outlined here for dealing with double cross-links should be applicable to the single link
patterns and is currently in progress. Perhaps the most significant advantage of the approach
used in this work is that it is generally compatible with standard ion trap-based shotgun
proteomic analysis. Because ions stay in resonance until they fragment into distinct molecules,
only typical ion trap MS/MS CID is required to achieve the double and even triple fragmentation
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events necessary to assign identities. It should be possible to review ion trap data sets where no
reduction and alkylation were performed and to extract new identities and linking patterns. It
should also be possible to add disulfide bonds to the list of searchable modifications with
relatively unobtrusive alterations to standard search algorithms. However, special consideration
must be given to searching for interpeptide cross-links (whether derived from interprotein or
intraprotein events) because of the combinatorial expansion of the search space.
An additional challenge in examining disulfide bond patterns routinely is that disulfide bonds
may undergo an interchange reaction with neighboring cysteines at alkaline or neutral pH. The
primary purpose of this study was to show that the various disulfide bond patterns of the
cysteine-rich region in SNAP25B could be identified, so no action was taken to avoid disulfide
interchange during sample preparation. Future studies seeking to examine the relative ratios of
disulfide patterns will need to be undertaken at lower pH (2–6), although this must be balanced
with concern for diminishing tryptic activity.[26] Sample handling at a pH of 6.0 may be an
optimal solution and indeed has been shown to minimize disulfide shuffling while allowing
tryptic activity.[14]
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Chapter 5

Automatic lipid classification by machine learning

Author’s Note: This chapter describes an automatic classification tool, trained on the LIPID
MAPS ontology to provide simple classification for any lipid structure. I wrote the algorithms
and the paper. These results are under review in Bioinformatics. 4
3F

5.1

Abstract

Motivation: Modern lipidomics is largely dependent upon ontologies because of the great
diversity exhibited in the lipidome; no automated lipid classification exists to facilitate this
partitioning. The size of putative lipidome far exceeds those currently classified, despite a
decade of work. Ongoing classification of unknown lipids will require automated tools to reduce
the time requirement, improve the resulting accuracy, assist in manual classification workflows,
and facilitate mass spectral analysis.
Results: We introduce a 99% accurate automated classification tool of any given lipid into the
LIPID MAPS ontology as well as all feature sets required for alternative implementations. The
classification is trained by machine learning upon simple chemical characteristics. The decision
trees produced are intelligible and can be used to clarify implicit assumptions about the current
LIPID MAPS classification scheme. By applying the classifier to the LIPID MAPS database, we
also discovered many hundreds of lipids that are currently misclassified, strongly underscoring
the need for an automated classifier like this.
Availability: Source code and chemical structure lists as SMARTS search strings are available
under an open-source license at https://www.github.com/princelab/lipid_classifier

4

Publication authors are Taylor RM, Miller RM, Miller RD, Porter M, Dalgleish J, Prince JT
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Supplemental information: Supplementary data are available at Bioinformatics online.
5.2

Introduction

Lipids are a fundamental component of biological systems and perform diverse roles in many
cellular pathways. They comprise several thousands of structurally distinct species whose
diversity is preserved by dedicated cellular systems 181. The lipid composition of a cell is linked
to its function, hence lipids are excellent subjects for gaining insight into biological systems and
predicting abnormalities 182. Indeed, lipids are known to play a major role in diverse diseases
afflicting millions, including obesity 183–185, diabetes 186,187 , asthma 188,189, hypertension 190 ,
arthritis 191 , and cancers 192,193. Lipidomics—the analysis of the lipid composition, localization,
and activity of a cellular or physiological system— is a burgeoning field of research 194.
One major difficulty in working with lipids is dealing with their great structural diversity. To
help address this challenge, the LIPID MAPS Consortium has created and been refining the
LIPID MAPS Lipid Classification System (LMLCS) which has become the de facto ontology
used in lipid research. With this ontology, the lipid research community is able to discuss
predicted lipid properties and cellular functions in ways that would otherwise be impossible.
Indeed, classification of biomolecules is a prerequisite to any systems biology approach

195

. This

is particularly true in the area of mass spectrometry identification, where theoretical
fragmentation spectra (used for matching with each experimental spectrum) are generated by
different sets of rules based on a biomolecule's type (protein, metabolite, etc.). The principle
holds true for lipids: nearly all existing identification approaches require that a lipid be classified
(although sometimes implicitly) in order to generate a theoretical spectrum from a lipid's
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structure 196–199. Classification makes possible restricted search space structural comparisons and
even such fundamental tasks as representing lipids in a systematic fashion 200.
The benefits resulting from classification are definite; these benefits are currently inaccessible to
lipids which have not been previously classified. Over the last ~15 years, LIPID MAPS has
classified over 38,000 lipids, an enormous feat. Still, there are likely in excess of 120,000 lipid
species 199 and probably more when considering oxidative modifications, yet undiscovered
natural products, and unanticipated future synthetic modifications. And, although automatic
classification tools have been alluded to 200, currently there is no publicly available software for
the automated classification of lipids. Although classification can be performed manually,
manual classification cannot be used in any automated software pipelines, does not scale well,
and may not always be accurate (Danziger et al., 2011).
We present an approach to generate a classifier trained on the LIPID MAPS ontology and
structural database (LMSD) which can be used to classify novel lipids automatically and assist in
manual classification workflows.
5.3

Methods

More extensive methodology is given in the methods supplement.
5.3.1

Chemical Language and Identifying features

We used Rubabel, a cheminformatics software suite built upon the OpenBabel library, to provide
programmatic representation of chemical structures 201 which were searched by SMILES
Arbitrary Target Specification, or SMARTS, search strings to produce a list of chemically
identifying structural characteristics, as detailed in Supplemental Table 1. Each identifying
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structural characteristic formed a binary variable indicating presence of a feature 202 , or
representing a numerical count of feature matches.
5.3.2

Classification by Machine Learning

WEKA machine learning algorithms 203 were compared by several numerical performance
measures (see Algorithm Selection supplemental). The J48 decision tree algorithm was selected
based on performance, speed, and interpretability. Classification accuracy was optimized upon a
15% subset of the LMSD. The WEKA-produced decision trees contain a rule-by-rule
determination of lipid classification based on the identifying structural characteristics and were
trained upon a randomized 90% sampling of the entire training dataset.
Each lipid of the training dataset, which consisted of the entire LMSD, was structurally analyzed
to produce a structure feature list which was then split into the hierarchal levels of the LMSD
ontology (see Figure 5.1, panel A). Each feature list was then analyzed by WEKA to produce
decision trees representing the classification steps at every hierarchical level.
This generated hierarchy of classification trees are dynamically loaded into a programmatic
classification system (see Figure 5.1, panel B) implemented in Ruby, which provides a
classification for a given lipid structure, by 1) generation of a structural feature list, and 2)
application of each hierarchical decision tree.
The Ruby classification system was evaluated for accuracy across all hierarchical levels by
examination of the entire LMSD. Each classification was considered a miss or hit in two
categories, category classification and category-internal classification. These two scores present
scores for both the complete classification and the relative importance of category selection.
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Classification model accuracy was confirmed by manual evaluation of all misclassified lipids
and annotated any potential ontology changes. When the classification models assigned lipids to
categories that were not indicated by their structure, we identified relevant structural features

A

Training Set

Structural
Feature List

Structural
Analysis

Split by hierarchy

Feature Sets
Root

Category

Class

Subclass

Analysis by Machine Learning

Decision Trees
Category

Root

B

Class

Subclass

Decision Trees
Root

Category

FA

Class

02

Structural
Feature List

Subclass

03

Classification
LMFA0203*

Structural Analysis

Novel Lipid

Figure 5.1: Lipid classification workflow schematic. Panel A) A lipid classification is constructed from a training
set of lipids with known classifications. Each lipid in the training set is analyzed structurally to produce a list of
structural characteristics which can be used for machine learning analysis. These feature sets are split into
hierarchal groups according to their classification. Machine learning analysis builds a distributed set of decision
trees at each hierarchal level. Panel B) A novel lipid is analyzed structurally, then the structural analysis is
analyzed by consultation with the WEKA produced decision trees at each hierarchal level to generate a complete
classification. Overlaid boxes highlight the contributions of each hierarchical layer to a complete classification.
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which could provide correct classification assignment.
5.3.3

Evaluation of novel lipids

Evaluation of the trained classifier was performed upon an extracted subset of the LipidBank
database 204 , which consisted of some 1195 molecules, many of which are similar to molecules
which are contained in the LMSD. Accuracy was measured by manual evaluation to determine
if these lipids were 1) properly categorized into, and 2) fit within the LMSD ontology. Hits and
misses were only counted when the lipid could be classified into the LMSD.
5.3.4

Statistical considerations and model validation

Algorithm selection was performed by split-percentage validation at 66%. WEKA derived
accuracy scores for these data were compared with the J48 model based on 90% of the training
dataset with cross-validation.
5.4

Results
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Figure 5.2: Representative decision trees for LMSD classifications. A) Glycerolipid category (GL) into 6 class
levels, GL00-GL05, based upon chemical features. B) Fatty acyl (FA) category demonstrates increasing
complexity.

5.4.1

Classifier and feature selection

The structural characteristics and machine learning algorithms chosen ensure the classification
model decision trees are human understandable (see Figure 5.2). The resulting comprehensive
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classification provides an automatic classification that retains human interpretability. Analysis
of a lipid can be performed in less than a second, making automated, and on-the-fly classification
possible.
5.4.2

Classifier model performance

The comprehensive reference implementation in the Ruby language provides less than 1.2%
error across all classification levels (see Misclassifieds supplemental). An equivalent
implementation trained on a 66% split percentage yields 3.0% error, and suggests that the
chemical features selected are largely robust attributes for classification. At the category level,
we reach 99.98% accuracy (as described in Table 5.1) when suggested improvements to the
existing ontology are followed as outlined in the supplemental tables 2 and 3.
Table 5.1: Classifier performance for entire LMSD and categories slices of the LMSD. Category level errors
represent misclassifications which put a lipid into the wrong category and are excluded from ‘within category’ error
counts. Within category errors represent any misclassification of a lipid other than a category level error.
Number of
lipids
Entire LMSD
Fatty Acyl [FA]
Glycerolipids [GL]
Sterol Lipids [ST]
Prenol Lipids [PR]
Sphingolipids [SL]
Polyketides [PK]
Sphingolipids [SP]
Glycerophospholipids [GP]

5.4.3

Category Level
Error counts (%)

36785
5763
7538
2561
1193
1293
6744
3934
7759

3
1
0
0
1
0
0
0
1

Novel lipid analysis

(0.01%)
(0.02%)
(0.00%)
(0.00%)
(0.08%)
(0.00%)
(0.00%)
(0.00%)
(0.01%)

Within Category
Error counts (%)
426
3
1
16
0
0
11
385
10

(1.16%)
(0.05%)
(0.01%)
(0.62%)
(0.00%)
(0.00%)
(0.16%)
(9.79%)
(0.13%)

Evaluation of classified lipids from the LipidBank database demonstrates the capability of this
classification to handle novel lipid classes. In 656 novel lipids, we correctly classified 70% of
the lipids which were manually determined to be within the current LIPID MAPS ontology (see
Novel Lipid Analysis supplement).
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5.4.4

Ontology modifications

We carefully inspected the results of the model built upon cross-validation training and
discovered ~150 lipids that are misclassified in LIPID MAPS (as detailed in the Misclassified
supplemental). The number of misclassified lipids indicates the difficulty of hand-curating a
database the size and complexity of LIPID MAPS. In addition, the ability of our classifier to
find these misclassified lipids strongly supports the utility of our automated approach.
5.5

Discussion
5.5.1

Classifier design and performance

Despite a number of misclassified lipids, the high degree of accuracy we achieved suggests that
the LIPID MAPS ontology is structurally coherent. Additionally, despite an origin in synthetic
pathways, the 2009 revision of the ontology is largely structurally derived, making an analysis
like this successful. The chemical characteristics chosen provided robust machine learning
attributes across a majority of potential classifier algorithms (see the Algorithm Selection
supplement). The J48 algorithm was chosen because it provided nearly identical performance to
the highly performant LMT algorithm, but at 1/200 th of the analysis time.
While the classifier performance is largely acceptable, the neutral glycolipid class of the
sphingolipid [SP] category remains a source of error. This is due to several factors, one of which
is the degree to which the ontology fails to encompass the diversity of the glycolipids. There are
~ 3000 lipids within this class and many classifications of these lipids are dependent upon sugar
oligomer length to differentiate nomenclature precedence. Thus, resolution of this issue will
require 1) consideration of ontology changes to better reflect the diversity of neutral glycolipid
structures, and 2) consideration of structural characteristics beyond the SMARTS systems
currently employed, such as a longest-path finding algorithm. The current diversity of
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glycolipids within the LMSD fails to encompass possible diversity, as there are only a few sugar
monomers contained therein, fucose, mannose, galactose, and glucose. We suggest that future
efforts investigate this diversity more fully and propose more sweeping ontology changes, such
as subclasses which allow for classification of unrepresented sugar monomers, and which only
contain lipids with a specified sugar root structure.
5.5.2

Novel lipid analysis

Evaluation of a novel lipid library demonstrates the capacity of our classifier to streamline novel
lipid analysis. It still further demonstrates need for further refinements within the established
ontology, as many of these lipids would be very appropriately grouped into ontology which is
not yet represented within the LMSD
5.5.3

Ontology modifications

Many of the aforementioned misclassifications are due to small structural differences. Lipid
LMGP04040006 is classified as a dialkylglycerophosphoglycerol. Examination of the structure
demonstrates an acyl group in place of an alkyl group, corresponding to our classifier's
assignment for this lipid as a 1-acyl, 2-alkylglycerophosphoglycerol, or LMGP0411. The fatty
acid LMFA01010053, in the straight chain fatty acid class, is clearly branched, corresponding to
the reclassification suggested by our analysis.
The model excelled at assigning lipids that contain multiple structural features. Several fatty
acids are both branched and unsaturated. These fatty acids are distributed among both the
unsaturated fatty acids and the branched fatty acids even though they are structurally similar.
The model followed the established ontology that branching takes precedence over unsaturation
and assigned these lipids to the correct classification.
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In accordance with IUPAC guidelines 205–210 , neutral glycosphingolipids were assigned a group
based on their root sugar chain, the first four sugars and their linkage to the sphingolipid. LIPID
MAPS suggested nine groups (or series, LMSP0501-09). There are several sets of distinct lipids
within the Neolacto subgroup that do not ﬁt into it nor any other group. These sets
(LMSP0505DC-F and LMSP0505DM-N) contain 32 and 16 lipids with two unique roots. We
suggest implementation of two new ontology groups for these distinct roots: gluco-globo
(LMSP0510) and galacto-lacto (LMSP0511). Gluco-globo highlights the similarity to the
isoglobo (LMSP0506) series, excepting the terminal N-acetyl glucosamine. Galacto-gluco
illustrates the relationship to the Gala series (LMSP0509) as it contains repeated galactose
monomers and highlights the terminal glucose monomer. These new ontologies would represent
the incorrectly classified lipids in their own ontology and are suggested to improve classiﬁcation
of current and future neutral glycosphingolipids.
5.5.4

Future Directions

Future work should expand the classification system to classify non-lipids into general
categories, and improve upon some existing limitations of the extensive sugar nomenclature
within the sphingolipid category. Future efforts will shorten analysis time per lipid. Future work
should evaluate whether the need for an alternative ontology which enables multiple
classifications for a given lipid exists, such as the aforementioned branching and unsaturation
precedence. An ontology capable of multiple labels might more accurately reflect the diversity
of the lipidome.
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Chapter 6

Msplinter: a structure driven approach to lipid fragmentation prediction

Author’s Note: This chapter introduces a fragmentation prediction algorithm for lipids which is
capable of predicting the complex cyclization products published in lipid fragmentation studies.
I present the implementation and application to experimental spectra and biological shotgun
lipidomic analysis. 5
4F

6.1

Abstract

Motivation: Current lipid fragmentation algorithms do not predict the products of complex
fragmentation mechanisms which are well characterized in published literature. Many
identifications cannot be made from MS1 data alone, requiring MS/MS based identification
algorithms. Current fragmentation models do not predict complex fragmentation events as
evidenced in published literature. A chemically derived fragmentation model can provide
chemically sound fragmentation products which more accurately reflect the reality of lipid
fragmentation pathways as determined by decades of fragmentation research.
Results: We introduce a chemically derived fragmentation model which predicts lipid
fragmentation products by electron-pushing mechanisms implemented in code. The predicted
masses are accurate and provide statistically relevant discrimination of ceramide lipids from
among theoretical and experimental datasets.
Availability: All relevant source code can be found at
https://www.github.com/princelab/msplinter .

5

Publication authors are Taylor RM, Miller RH, Anthonymuthu TS, and Prince JT
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6.2

Introduction

Lipids are fundamental components of biological systems and perform diverse roles in vital
cellular pathways. The lipid composition of a cell is highly predictive of cellular system
abnormalities182 and lipid abnormalities play causative or contributory roles in diverse
diseases.183–193 Lipidomics—the analysis of the lipid composition, localization, and activity of a
cellular or physiological system— is a field of rapidly increasing importance.
Mass spectrometry (MS) provides the throughput, sensitivity, and concurrency required to
quantify and identify lipids; however, converting MS signal into lipid identities is highly
challenging. The bottleneck in mass spectrometry based lipidomics is still data analysis,16,22 and
arguably the most difficult step lies in identifying lipid species from fragmentation spectra.
Several lipids generate characteristic reporter ions or neutral losses. While these patterns are
helpful in identifying particular head groups, they are only a first step towards obtaining

Coverage

No Training Set
Requirement

Sensitivity

Specificity

On-the-fly

Flexibility

Abundances

Complex
fragment
prediction

Table 6.1: Comparison of approaches for MS/MS lipid fragmentation prediction algorithms.

Experimental library

−

−

+

=

−

+

+

+

Characteristic ion fragment tables

=

=

−

+

+

=

−

−

Bond cleavage models

−

−

+

+

−

−

+/−

−

CDF(proposed)

+

+

+

=

+

+

=

+

Characteristics

confident identifications by MS/MS. For instance, isobaric and/or closely eluting lipids often
produce chimeric spectra upon fragmentation. Disentangling the fragment ion contributions
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from 2 or more spectra are highly challenging without predictions of the complex and unique
product ions characterized in literature.
6.2.1

Current prediction algorithms are deficient

Current lipid fragmentation approaches are deficient in one or more ways: they provide
identifications only for certain lipids, lack the capability to predict complex fragmentation
events, and/or require a significant investment in generating a new experimental training set in
order to analyze new lipids. Table 6-1 summarizes the relative strengths and weaknesses of
common approaches.
Current lipid fragmentation approaches can be divided into three primary categories, 1)
experimental library18,211 lookups, 2) tables of characteristic fragments,11,21,212–217 and 3) bond
cleavage models. 19,20
Libraries of experimentally collected fragmentation spectra represent complete truth for lipid
identification but the requirement for spectral collection can be especially prohibitive when
purified lipids are not available. Experimental spectra must typically be collected on similar
instrumentation with similar experimental parameters for comparative identification methods to
be successful. Experimentally derived standard spectra are valuable contributions but they
cannot be applied to previously uncharacterized lipids without considerable effort.
Tables which predict characteristic fragments are easily implemented because they consider only
the easiest and most predictable fragmentation events by lipid group. Bond cleavage models
consider all possible bond cleavages and are subsequently scored by energy to determine the
most likely fragmentations. However, neither approach predicts the complex fragmentation
schemes which are well characterized in primary literature.218–240
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Current lipid fragmentation algorithms fail to capture the rich and diverse fragmentation
pathways characterized by decades of research into lipid and metabolite fragmentation pathways.
These data are neglected or implemented only indirectly by existing software tools. As they
stand, current implementations cannot perform the low level chemical manipulations required to
fully detail complex fragmentation schemes such as the cyclizations observed in published
literature.
6.2.2

Chemically derived fragmentation model

To address the limitations of existing models, we introduce a chemically derived fragmentation
(CDF) tool which models, in silico, the behavior of fragmentation as ‘electron pushing’ schemes
familiar to chemists. Each scheme is derived directly from literature studies of fragmentation
pathways.
Lipids from different lipid classes fragment differently from one another241,242 and a wellestablished practice in fragmentation software treats lipids on a class-by-class basis, or in a
'divide-and-conquer' approach.196–199 We have adopted this approach as well, as the complex
fragmentation schemes are highly specific to specific lipid classes. We evaluate the CDF
approach upon lithiated ceramide lipid samples from literature and experimental sources as
characterized by Hsu et al. in 2002.
6.3

Methods
6.3.1

Model each lipid chemically

Each analyte molecule is programmatically loaded as a chemical model, in any of the 125
different chemical file formats supported by the OpenBabel C++ chemical toolkit.244 Each
chemical model is manipulated using Rubabel,201 a framework built on top of OpenBabel, which
we recently developed in order to rapidly and easily implement fragmentation events.
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6.3.2

Fragmentation scheme implementation

Each fragmentation pathway was implemented as chemical structure test cases, according to
principles of behavior driven development.245 Once a test case was implemented, the mechanism
of the reaction was encoded in chemically derived steps which act upon the chemical model, as

Figure 6.1: An overview of the fragmentation schemes implementation. Each published fragmentation scheme as
seen in the top right figure is implemented as code as seen at bottom right. To the left, we diagram the input
structure and the application of this rule on that molecule.

shown in Figure 6.1, and refined until all test cases were passed.
6.3.3

Search model for known fragmentation motifs

Each chemical model is searched by SMARTS search string246 for all known fragmentation
motifs and appropriate fragmentation methods are selected to be applied to the molecule. Each
model is processed to set the experimental adducts, ion mode, and fragmentation mode. These
parameters are set so fragmentation schemes can be selected as compatible with the experimental
conditions.
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6.3.4

Application of fragmentation schema

Each reaction occurs as a combination of bond formation, cleavage, and movement of electrons
within the chemical model, precisely as the published fragmentation schemes indicate. The
products of the algorithm are themselves chemical models. Rules are signified as primary
fragmentation pathways, as secondary rearrangement pathways, or both, which governs how the
fragments are further processed.
6.3.5

Comparison to characterized product ions

The performance of the rule sets was initially evaluated by correlation of predicted product ion
masses with the published ion masses.
6.3.6

Spectral scoring algorithms

In order to assess spectral matching quantitatively, we implemented several spectral scoring
algorithms: F1 score, spectral hit count, and the probabilistic score from the proteomics tool
Andromeda.23
F1 score is the harmonic mean between recall and precision, and provides a robust statistical
measure of absolute Type I and Type II errors. Recall and precision are defined in terms of true
positives (TP), false positives (FP) and false negatives (FN). Recall is defined as
and precision is defined as

.
1

The spectral hit count is a simple weighted measure of hits, misses and unpredicted ions between
the two spectra. X, Y, and Z represent scaling factors which were manually optimized to
produce an approximate ‘no-match’ threshold value near 0 for preliminary spectra, making
X=10, Y=1, and Z=2.
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2
The Andromeda score is derived from the probability of matching a certain peak, and is
optimized by q, or the number of peaks in a given ~100 m/z bin which are considered in the
analysis. The formula is given here,
∑

(

)

3

where n is the total number of theoretical ions, and k is the number of matching ions in the
spectrum. As this fragmentation model has not been implemented before, each score was
compared to determine the best score for lipidomic comparison upon the experimental dataset.
Preliminary work suggested that the F1 and HitCount scores are more robust at differentiating
spectral matches. All scores were generated and reported at an optimized q depth, analogous to
the Andromeda algorithm scores but considered without the 100 m/z bin.
6.3.7

Experimental Spectra

Ceramide class lipid standards from Avanti Polar Lipids (Alabaster, AL) were suspended in
Folch reagent (2:1 chloroform:methanol)247 with 15 mM LiCl as the adduct species, except for
the ceramide phosphate sample which required 30 mM LiCl. Samples were injected at 8 μL/min
using a direct-inject Thermo Scientific (Waltham, MA) IonMax electrospray ionization (ESI)
soft-ionization spray head from a Hamilton (Reno, NV) GASTIGHT glass syringe. The spray
voltage and capillary were maintained at 5.0 kV and 275 C with an arbitrary sheath gas (N 2) flow
rate of 8. The selected 7 ceramide class lipids are listed in Table 2. All MS/MS and MS3
fragmentation spectra were collected at 100k resolution in the FT mass analyzer of an Orbitrap
XL (Thermo Scientific) mass spectrometer. Spectra were post-processed into a normalized
cumulative spectrum containing both MS2 and MS3 peaks by Mspire.177,248
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We validated algorithm accuracy by conducting comparison searches upon each experimental
spectra against all lipids within +/- 5 amu from the parent mass as selected from the LIPID
MAPS structural database (LMSD). 66,249 Each lipid was identified by consensus spectral scores
by highest score. For the F1 and spectral hit count scores, statistical relevance was estimated by
sigma deviations from the mean, where anything greater than 3σ was considered significant.
6.3.8

Complex samples preparation

For isolation of lipids, murine lung cell pellets were re-suspended in 900 μl ice-cold
chloroform/methanol (1:2) and incubated for 15 minutes on ice, then briefly vortexed.
Separation of aqueous and organic phases required addition of 400 μl of ice-cold water and 300
μl of ice-cold chloroform. The organic phase was collected into a fresh vial, and lipids were
dried in a vacuum centrifuge (Eppendorf Concentrator Plus). Lipids were characterized and
quantified using a shotgun lipidomics technique on a Thermo Scientific LTQ Orbitrap XL mass
spectrometer. Evaporated lipid samples were re-suspended in a 2:1 chloroform:methanol Folch
solution (200 μL). The re-suspended lipids were then combined with a Folch solution with 15
mM LiCl acting as an ionizing adduct species. A cocktail of internal standards was spiked into
each sample for mass calibration and characterization data alignment. Samples were analyzed
using a 10 minute mass-window scanning method in positive-ion mode at a resolution
of 100,000 (FWHM at 400 m/z) for all primary MS1 scans. MS2 fragmentation data was also
collected and manually verified to give additional confidence to the correct identification of
abundant lipid species. Samples were injected at 8 μL/min using a direct-inject Thermo
Scientific IonMax electrospray ionization (ESI) soft-ionization spray head from a Hamilton
GASTIGHT glass syringe. The spray voltage and capillary temperature were maintained
at 4.5 kV and 275° C respectively. Fragmentation events were performed on the most abundant
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peak from each survey scan (150-2000 m/z) with dynamic exclusion settings of 500 items, which
expire after 600 seconds.
6.3.9

Shotgun lipidomic analysis

We produced a reference identification and quantitation analysis by our standard workflow as
follows. Data were analyzed using an in-house developed peak summarization, recalibration,
and MS1 lipid identification software using lipid database information from the LIPID
Metabolites and Pathways Strategy (LIPID MAPS) Lipidomics Gateway database. To ensure
high-confidence identifications, an intensity threshold estimated to be 5% above instrumental
static signal was implemented. The lipid species identified across different ionization states or
with adducts were totaled together. Quantification was completed by normalizing total ion
counts to the relative abundance of the internal standard that was spiked into each sample.
We analyzed the shotgun lipidomic data set by comparing them against CDF generated spectra.
Potential lipid matches were extracted from the LIPID MAPS database in a +/- 50 ppm window.
For each potential match, fragmentation masses were predicted by CDF and compared against
the experimental fragmentation spectra by the above scores. Statistical significance was again
estimated by sigma level.
6.4

Results

We successfully captured the schemes reported by Hsu et al. in our chemically derived
fragmentation model. The coded implementation retains chemical relevance by using chemical
terminology. Each rule is itself modular and independent and can be selected as needed. We
tested each fragmentation rule on chemical test structures derived from published schemes
individually to ensure that each rule produces the expected fragment ions.
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Table 6.2: Collision induced dissociation ions characteristic of selected Ceramides from Hsu et al., 2002. Green shading indicate cyclized product ions.
Additional fragmentation comparison data is found in the supplemental materials. d indicates a diagnostic ion which is unique to that lipid or fragmentation
pathway, as characterized in the original publication.

common ions (m/z)

Fatty acyl ions (m/z)
d1a

d2ad

400d

374d

356

288d

270d 264d

618

398d

372d

354

288d

270d 264d

496

508

288d

262d

244

288d

270d 264d

LMSP02010006 554

524

536

316d

290d

272

288d

270d 264d

LMSP02020012 640

610

622

400d

374d

356

275 308 290d

272 266d

LMSP02020008 556

526

538

316d

290d

272

275 308 290d

272 266d

LMSP02020029 544

514

526

304

233

278

275d 308d 290d

272

300

LMSP02020030 572

542

554

332

261

306

275d 308d 290d

272

300

LMSP02030015 560

530

542

304

233

278

291d 324d 306d

288

316

LMSP02030004 656

626

638

400d

428

416

374d

356

291

306

288d

LMSP02030005 684

654

666

428

456

444

402d

384

291

306

288

LMID

a1

a2 (a1-30)

a1-18

c2a

LMSP02010012 638

608

620

LMSP02010009 636

606

LMSP02010004 526

c3a'd

b1ad

Long chain base ions (m/z)
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b2ad

d3b e1b e2b + e2b' e3b' e3b'' f3b'

We tested all the fragmentation rules on a consensus set of 11 lipids found in both the Hsu et al.,
2002 paper and the LMSD. We compared published fragment masses for these 11 lipids against
our CDF tool in Table 6.2. For these 11 lipids, we successfully predict all of the major fragment
masses.
We compared our lipids to 7 experimental spectra (as listed in Table 6.3 and the
Spectral_comparison supplement) against the predicted fragments of isobaric species. This
analysis was performed on high mass accuracy data and requires greater accuracy in chemical
composition to match than the comparison to the published masses. The CDF scores identify
each the candidate lipid from all other isobaric species in the LMSD selection.
Table 6.3: Msplinter prediction scores of 7 experimental spectra against isobaric species +/- 5 amu from the
experimental peak. The identity is assigned by highest scores in the HitCount metric. F1 scores largely tracked
HitCount scores and can be found in the Spectral_comparison supplement. The C6 ceramide is not represented in
the LMSD as is instead referenced by SMILES and file name.
LMID or SMILES

Name

Predicted identity

LMSP02010014
CCCCCCCCCCCCC/C=
C/[C@@H]([C@@H](C
O)NC(=O)CCCCC)O
LMSP02010002
LMSP02010001
LMSP02010020
LMSP02020012
LMSP02050002

C2 Ceramide
C6 Ceramide

C12 Ceramide
C14 Ceramide
C17 Ceramide
C24 Sphinganine
N-Palmitoyl-Ceramide
Phosphate
N-Stearoyl-phytosphingosine

LMSP02030001
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σ Significance

LMSP02010014
C6.mzML

Hit
Count
104
77

LMSP02010002
LMSP02010001
LMSP02010020
LMSP02020012
LMSP02050002

81
17
107
133
72

12.36655111
7.204528068
9.364938564
11.71072543
10.18440042

LMPK12020069

10

4.182847713

19.82105653
17.4396082

Shotgun lipidomic identifications are presented in the Shotgun supplementary tables. Statistical
analysis of the CDF results demonstrate 4 distinct species which were significant above a 3σ

Figure 6.2: Comparison between CDF predicted fragment ions and published fragmentation products (inset) for
ceramide LMSP02010009. The cyclized fragmentation products in the published spectra and in the CDF spectra
are highlighted for emphasis. CDF modeled fragment ions were arbitrarily assigned intensity values for the
purpose of this visual comparison.

level, out of the 21 unique fragmentation spectra collected. The MS1 based reference analysis
identified over 300 lipids. The majority these lipid identifications are unique, with only one
specific lipid being confidently identified in both samples.
6.5

Discussion

We have introduced and demonstrated the capability of a CDF based fragmentation model to
predict complex fragmentation products. Each product is a molecule itself and this recursive
algorithm structure allows for prediction of fragment ion products which only exist as the stable
end-products of chemical fragmentation events.
Our three scoring methods demonstrated varying abilities to discriminate between spectral
matches. We found that the Andromeda algorithm was unable to differentiate trues and falses
from our CDF fragmentation algorithm, as seen in the supplemental tables, which we attribute to
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the small number of matched fragment ions. This discrepancy is a product the limited
fragmentation efficiency of MS2 vs an optimized multi-level MS(n) fragmentation protocol. The
F1 score didn’t perform as consistently as the HitCount metric which we attribute to a
dependency upon false positive estimation from match, miss, and unpredicted counts.
6.5.1

Importance of modeling cyclizations

The importance of cyclization events in predicting ion spectra is shown in Figure 2 by
highlighting the contributions to a fragmentation spectra which arise from the complex
fragmentation event. Major fragmentation products are products of cyclization reactions which
provide diagnostic ions for identification purposes (see Table 1). Without consideration of these
cyclizations, unambiguous identification is often not possible 243.
6.5.2

Published spectra comparison

CDF models are able to predict the majority of fragment species as elucidated by Hsu et al. No
existing lipid fragmentation software claims to model the predicted cyclized fragmentation
products. Among these 11 lipids, we demonstrate consistent performance which demonstrates
the reliability of a chemically derived model.
6.5.3

Experimental spectra comparison

When used to match theoretical spectra against experimental spectra, the Msplinter CDF model
is capable of discriminating the true lipid from among 200-400 isobaric lipid species in nearly all
cases. The comparison is biased towards ceramides by the limitations of the currently available
fragmentation rules which only characterize ceramide fragmentations. The phytosphingosine
standard exemplifies this, as it is poorly predicted because of the significant structural
differences which eliminate many of the ceramide fragmentation pathways. A phytosphingosine
example was intended to demonstrate the capabilities of this CDF model to predict specific
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fragmentation events. Implementation of fragmentation schemes appropriate to
phytosphingosine appear to be necessary to successfully identify the lipid by MS2 fragmentation
alone.
For our experiments matching experimental spectra we used a broad, 10 m/z window. Thus,
there were a considerable number of compounds that had opportunity to match with the spectra
(200-400, see supplemental tables). Coupling an MS/MS database search with a more realistic
precursor tolerance (e.g., 5ppm) would, of course, yield additional discrimination over what was
demonstrated here.
6.5.4

Shotgun Lipidomic Comparisons

Preliminary comparisons between the reference shotgun lipidomic analysis and CDF derived
analysis demonstrates the complimentary nature of a MS1 and MS2 analysis. We confirmed the
presence of 2 lipids which were identified in both analyses and which both identifications
agreed, despite this lipid being a glycerophospholipid. The limited applicability of ceramide
rules to other lipid classes highlights the strengths of our modular approach. The rest of the CDF
identifications demonstrate much higher scores on ceramide samples which demonstrates the
capability of CDF models to selectively and specifically predict the fragmentation of a specific
class of lipid.
In comparison to phytosphingosine and to general lipid extractions, we observe that without
specific rules, fragmentation spectra cannot always be adequately predicted. Our CDF
implementation rules are entirely modular and can be selected as needed to optimize for specific
analysis needs, or compared against standard spectra to ascertain which rules can predict the
observed masses. CDF can therefore be used as chemically grounded building blocks for a
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machine learning derived selection of fragmentation rules for previously uncharacterized
fragmentation conditions.
6.6

Conclusions

A decade of work in lipid fragmentation pathway characterization is available as a basis for
chemically derived fragmentation models. We present replication of experimentally observed
fragment ions including highly diagnostic cyclization product ions. We demonstrate that we can
correctly identify ceramides from among isobars, even without high mass accuracy precursor
mass selection. This work is complimented by a recently developed automatic lipid
classification tool based on machine learning and analysis of novel lipids to determine which are
amenable to these ceramide fragmentation schemes.250
In future work, we will consider the feasibility of a more flexible programmatic reaction scheme,
such as SMIRKS (Daylight CIS). We will also implement additional fragmentation prediction
schemes to add fragmentation predictions for additional lipid classes. Further efforts will
examine machine learning as a method for optimizing rule selection to increase specificity of
current predictions, better match fragmentation conditions, and to predict fragmentation of
previously uncharacterized lipids.
The basic framework now exists to implement additional sets of fragmentation prediction
reactions based upon other published works which target alternative experimental conditions,
sample preparations, and lipid classes.
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Chapter 7
detection 6

Massifquant: open-source Kalman filter based XC-MS isotope trace feature

5F

Author’s Note: This chapter represents an open source implementation of a Kalman filter
capable of detection of isotope traces from MS survey scan data. I contributed to the distillation
of ideas and preparation of the manuscript. These results were published in Bioinformatics.75
7.1

Abstract

Motivation: Isotope trace detection is a fundamental step for XCMS data-analysis that faces a
multitude of technical challenges on complex samples. The Kalman filter application to isotope
trace detection addresses some of these challenges; it discriminates closely eluting isotope traces
in the m/z dimension, flexibly handles heteroscedastic m/z variances and does not bin the m/z
axis. Yet the behavior of this Kalman filter application has not been fully characterized since no
cost-free open-source implementation exists and incomplete evaluation standards for isotope
trace detection persist.
Results: Massifquant is an open source solution for Kalman filter isotope trace detection that has
been subjected to novel and rigorous methods of performance evaluation. The presented
evaluation with accompanying annotations and optimization guide sets a new standard for
comparative isotope trace detection. Compared to centWave, matchedFilter, and MZMine2—
alternative isotope trace detection engines—Massifquant detected more true isotope traces in a
real LC-MS complex sample, especially low-intensity isotope traces. It also offers competitive
specificity and equally effective quantitation accuracy.

6

Publication authors are Conley CJ, Smith R, Torgrip, RJO, Taylor RM, Tautenhahn, R, and Prince JT
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Availability: Massifquant is integrated into XCMS with GPL license > 2:0 and hosted by
Bioconductor: http://bioconductor.org. Annotation data is archived at
http://hdl.lib.byu.edu/1877/ 3232. Parameter optimization code and documentation is hosted at
https://github.com/topherconley/optimize-it.
Contact: cjconley@ucdavis.edu or jtprince@chem.byu.edu
7.2

Introduction

The most important automated data-analysis step in a typical quantitative -omics XC-MS
analysis pipeline is isotope trace (IT) detection.255 In liquid or gas chromatography mass
spectrometry (LC-MS or GC-MS, with either specified as XC-MS) analytes elute with
chromatographic separation and are subsequently measured by the mass spectrometer. IT
detection is the first and essential step in enumerating the signals of these analytes.
IT detection is a trivial task when performed on data derived from simple mixtures, but can be
highly challenging for complex mixtures because there are 1) large numbers of analytes which
coelute, many show interlocking or overlapping isotope envelopes; 2) an unknown number of
analytes; 3) an abundance of ITs with low signal to noise ratio; 4) significant intensity variation
in the signal composing lower abundance ITs due to dynamic range limitations of the
spectrometer; and 5) heteroscedastic m/z variance as a function of intensity for most mass
spectrometers. Unisotropic m/z variance results in that the data comprising the tails of an IT have
larger m/z variance than the data around the mode, and that low abundance ITs have a larger m/z
variance than high abundance ITs.
Though difficult to achieve, increasing the sensitivity and accuracy of IT detection software
influences the entire downstream analytical pipeline.256 An example: Vast numbers of peptides
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go unidentified in proteomic analyses;31 a more sensitive IT detection would allow researchers to
track and quantify these peptides, leveraging identifications acquired in other samples. It goes
without saying that accurately determining IT boundaries and distinguishing signal from noise
improves quantitation results. Furthermore, accuracy in IT detection can also result in more
accurate precursor mass estimates and therefore yield an increase in both the number and quality
of peptide identifications.
Most IT detection software, such as matchedFilter, relies on the creation of fixed width m/z bins
(buckets) to facilitate finding and quantifying eluting analytes. Though bucketing is
computationally efficient, for complex data sets it is impossible to find a bin size and position
that excludes closely co-eluting ITs while also being broad enough to fully capture the IT of
interest. To address this shortcoming, Tautenhahn et al.257 developed a software package,
centWave, which uses a binless pre-scan to first identify regions of interest composed of
centroids. A centroid is a (m/z, intensity) measurement pair at a given time scan of the
chromatographic dimension. Once a region is specified, the centroids are then collapsed into a
one-dimensional chromatogram and wavelet-based curve fitting is performed to separate closely
eluting ITs. The approach is appealing because the initial algorithm identifies zones of interest
in a binless way and because the algorithm used for detecting ITs using intensity fluctuation in
the time domain is sophisticated. However, in this approach subtle shifts in m/z value are
ignored when data are combined into a one dimensional chromatogram. ITs which are very
close in m/z or with poor chromatographic profiles may not be properly resolved.
The same year Aberg et al. developed TracMass, a binless IT detection algorithm which fully
utilizes m/z information in distinguishing ITs.258 TracMass uses a chromatographically
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traversing 2-dimensional Kalman filter model (KF)—one dimension focused on m/z values and
the other on intensity values—to determine which centroids belong with each extending IT. The
decision to incorporate a centroid is made by carefully weighing all previous m/z and intensity
evidence of that IT, so misincorporation of centroids is rare as the KFs incorporate more data.
Furthermore, the KF accounts for the heteroscedastic variance within the same IT as intensity
values change. The KF approach can disentangle even the most closely eluting chromatographic
ITs. Furthermore, for the nonexpert user, TracMass requires few user parameters for effective
operation.
Despite its apparent promise for IT detection in complex samples, no peer-reviewed publication
had compared TracMass performance to leading options259,260 until just recently with
TracMass2.261 This is not an isolated deficiency—most IT detection algorithms are not
rigorously evaluated because of the difficulty of establishing ground-truth data, especially for
lower abundance ITs.32,260 Indeed, other compelling binless methods for quantitation may benefit
from a similar evaluation as presented here.29,262
Here, we make available an open source implementation of the TracMass algorithm, called
Massifquant, and integrate it into the popular XCMS software suit. 257,263 Like TracMass,
Massifquant uses a two-dimensional Kalman filter to quickly, accurately, and adaptively find ITs
in highly complex samples without resorting to binning, and its open license (GPL ≥ 2.0) enables
further extension and inspection. We indicate how the KF adapts to m/z variance and describe
two major modifications which mitigate known limitations of TracMass. We detail novel
metrics for evaluating XC-MS IT detection and use these metrics with manually annotated data

123

to perform a detailed evaluation of Massifquant, centWave, matchedFilter, and MZMine2 17
performance on different LC-MS platforms.
7.3

Methods
7.3.1

Description of the Massifquant algorithm

Massifquant relies on 2D Kalman filters to identify ITs in XC-MS data. A single KF’s purpose
is to track the m/z and intensity coordinates of an IT over the chromatographic dimension. A
track is an instance of a KF model, which predicts the existence of a centroid in the next time
scan. If the prediction is close enough to a real centroid, it incorporates the real centroid to the
track. Closeness is determined by quasi-confidence intervals centered about the prediction. The
KF then updates its estimate of the underlying “true” centroid and predicts again. When the
signal of the IT disappears (i.e., we have reached the end of a chromatographic IT) the KF will
fail to predict a centroid on successive scans and tracking will be terminated.
With many ITs to be discovered, Massifquant manages a host of active KFs. For a given scan,
each active KF claims the centroid that best fits its predicted location. Unclaimed centroids
trigger new instances of KF tracks in the expectation that these are the beginning of new ITs.
The process is then repeated on the next scan until all scans have been examined. In this way,
every centroid is either claimed by an existing KF or triggers the creation of a new KF. After an
entire sample has been parsed, spurious KFs are discarded based on simple filters for minimum
length, intensity, expected m/z deviance, or consecutive missed predictions.
We will describe the Kalman gain to highlight the model’s adaptive nature and how it can be
tuned. After the KF predicts a centroid, it refines the prediction by carefully weighting the
model prediction error through a modeling device known as the Kalman Gain. This device is
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largely a function of (i) the estimation error covariance, which is initialized by the modeler, but
evolves over time based on prediction performance; (ii) and the assumed measurement error of
the Mass Spectrometer, also defined by the user. So the modeler may tune the Kalman gain
based on these parameters. A smaller Kalman gain means that the model prediction, which is
based on previous observations, is trusted to be closer to the true centroid location than the newly
acquired observation. The default settings of Massifquant create a Kalman gain that places more
trust in early acquired observations (i.e. the first 4-30 scans) as illustrated in Figure S1 in the
supplementary materials. The idea is to find the IT’s location quickly and not deviate once it has
been found; the default works for a variety of situations, but can also be tuned to a particular
dataset. The fact that the KF continuously adapts its centroid prediction estimates based on the
information it has previously amassed and the variance it encounters makes it an effective tool
for identifying ITs with their own specific heteroscedastic variance. For a more mathematical
discussion, an introduction to the theory behind the discrete Kalman Filter/Gain are described in
Welch and Bishop264 and section 2 of the supplementary materials.
Massifquant implements most of the core of the TracMass algorithm; however, it is difficult to
determine how much the two algorithms differ since the latter’s source code is not available.
There are a few known major differences. The initialization of the P is likely different.
Moreover, the intensity component of the Scheffe-type quasi-confidence intervals—used to
classify whether a next-scan centroid belongs to a KF prediction–was not found to be sufficiently
discriminatory. Massifquant only uses the m/z dimension to determine a successful prediction.
Retaining the intensity estimation in the KF does seem to aid in resolving competing KFs that
claim the same centroid (by virtue of comparing their two dimensional prediction distances).
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Massifquant also implements a function to ensure continuity of identified ITs that is not found in
TracMass (discussed in section 3 of the supplementary information). We found that a KF will
periodically lose the position of the IT, stop tracking it en route, triggering a new KF track which
will finish estimating the IT’s other data points (see supp. file Figure S2). Since each KF track
corresponds to an IT, we call the undesirable phenomenon “segmentation”. The segmentation
problem was addressed by an ad-hoc t-test comparing the m/z locations between these
problematic KF. The conservative test combines many of the segmented tracks into a unified IT.
A more thorough description of the Massifquant implementation is given in the supplementary
material (see the section ”Reimplementing the Kalman filter model”). The supplement
highlights some differences with TracMass and a discussion of the logic behind specific design
decisions. The description will be useful to anyone seeking to modify or extend the algorithm.
Massifquant was written in C++ and has been integrated into the XCMS pipeline available
through Bioconductor.263,265 It plays the same role as centWave, matchedFilter, or MZMine2’s
isotope trace detection algorithm in the differential analysis workflow.
7.3.2

Annotation

7.3.2.1 Data sets
We chose two very different LC-MS data sets to assess IT detection flexibility. The first
annotated data set, MM14, is a subset from a UPLC-ESI-QTOF analysis of 14 plant metabolites
resulting in 46 annotated ITs. The centWave developers originally showcased their method of
parameter optimization on the entire data set, and its provenance is detailed in Tautenhahn et
al.257
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The second data set, MOUSE, is one fraction from a larger mouse brain phosphoproteomic
analysis. Briefly, 408.8 mg of brain tissue was homogenized/boiled in SDS-lysis buffer and
clarified. Proteins were then digested and peptides purified following the FASP protocol 266 to
yield an estimated 7.3 mg of peptides. 25 mg of Titanspere TiO2 beads (GL Sciences) were used
to enrich for phosphorylated peptides. 3M Empore Anion Exchange disks were packed into a
200 l pipette and Britton & Robinson buffer was used to elute at pH 11 (the fraction termed
’MOUSE’ in this work), 6, 5, 4, and 2. MS analysis was performed with an LTQ-Orbitrap XL
fed by an Eksigent NanoLC UHPLC system. A Nano Acquity (1.7m, 130 C18 bead BEH, 75m
m x 150mm) column run at 375 nL/min in a linear gradient from 2.5% to 10% ACN (with water
and 0.1% formic acid as the second buffer) for 60 minutes, then to 28% ACN for an additional
220 minutes. The complete raw file is available upon request, and virtually all parameters may
be accessed using the cross-platform unfinnigan software (see
https://code.google.com/p/unfinnigan/). The relevant parameters are: MS1 data collected
between 375–1800 m/z at 60,000 resolution with an MS/MS data dependent scan collected after
each MS scan. The section chosen for hand-annotation generally spans retention time 5429.5–
7306.2 seconds and 600.0003–637.3923 m/z. In total, this area contained 589 annotated ITs
which show variation in length, shape, and variance.
7.3.2.2 Data annotation
The MOUSE and MM14 datasets were manually annotated to be used as ground truth for
assessing the automated IT detection abilities. A tuned LC-nanoESI system is capable of
producing consistent chromatographic IT shapes. However, when running complex samples,
even on the best tuned system, fundamental dynamic range limitations will unavoidably produce
IT shapes that are far from ideal. The lack of characteristic IT shapes among lower abundance
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ITs, the number of overlapping ITs (in m/z and time), and their sheer number and density makes
manual annotation difficult. For the MOUSE data, any IT that did not exceed a maximum
intensity of 1×105 was ignored to preserve the integrity of the annotation.
Because IT annotation in complex data sets is challenging, we established guidelines for what is
called a true IT. These guidelines consider within-IT and between-IT characteristics to ensure
the best annotation possible. To be defined as an IT, a series of centroids should typically
exhibit the following properties:
Within

1. The m/z error variance structure is influenced by intensity. Toward the tails of
an IT, the m/z observations show mostly symmetric and increasing deviations
from the mean. The body and apex centroids deviate less. From a bird’s eye view
(i.e., looking down the intensity axis), the m/z-time projection has the shape of a
string fraying at the edges.
2. The collective centroids should have a chromatographic IT shape. Dramatic
oscillations in intensity from scan to scan could disqualify an annotation.

Between

1. The detected ITs should have approximately the same m/z ppm variance.
2. Within an isotopic envelope, ITs should have very similar mode and shape,
although length typically varies.

In each case, great effort was made to balance the benefits of the systematic application of these
rules with human judgment. Each IT was individually annotated (based on all criteria) and then
wrapped into appropriate isotopic distributions where possible.
We executed this annotation scheme on the MM14 and MOUSE data sets using Topp-View267 as
follows: From a global 2- D view, the annotator identified mass traces satisfying mentioned
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properties. After zooming, a 3-D inspection confirmed similar chromatographic length and shape
for a given isotopic distribution. Once confirmed, the IT’s centroids were selected and
collectively saved into an .mzML file. Candidate mass traces that did not sufficiently satisfy all
the criteria, but still had some resemblance to an IT, were labeled as questionable and saved as
.mzML files; these were excluded from the algorithm performance analysis since they were
deemed liable to interfere with true algorithmic specificity and sensitivity. Objectively
determining an IT’s chromatographic boundaries is difficult, especially since there is so much
diversity among IT shape and length. Generally, we tried to include as much of each IT tail as
possible and to be as consistent as possible across each data set.
7.3.3

Performance Evaluation

Different algorithms select different portions of an IT when attempting to identify ITs (any
attempted IT classification we call a candidate). Because the extent and location of the mapping
from a candidate to the true IT may vary widely, gauging the success of a candidate can be
challenging. For example, a method that identifies 30 centroids directly in the middle of the high
intensity region of an IT should be given more credit than one that identifies 35 centroids but that
are all in the very low intensity tail region. In another example, credit should be given to an
algorithm that successfully captures an entire IT with three distinct candidates, but it should not
receive as much credit as an algorithm that identified the IT with a single candidate. These
examples motivated the development of two ways of examining success: at the IT-level and at
the entire sample-level.
7.3.3.1 Isotope trace-level evaluation
Classifying the success of an algorithm at the IT-level requires the classification to be general
enough to handle a variety of IT shapes and yet still be precise. To classify the successful
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identification of an IT, we defined metrics that consider how a candidate’s centroids individually
contribute to the overall intensity of the annotated IT, namely, the true area under the curve
(

). The centroids clustered into a candidate are either true positives, false positives, or false

negatives. Restricting attention to the true positives, a candidate’s true area under the curve is
denoted as

. Naturally, a candidate’s relative correct identification of an IT within the

context of intensity is defined to be
the

annotated IT if

. Now, an algorithm is said to sufficiently identify

, where

. For the following analysis, we took

because requiring a candidate to capture more than 50% of an IT’s total intensity ensures that the
main body of a IT has been identified, while still allowing for differences in opinion on exact IT
boundaries. In short, this criterion abstracts away the difficulty of varying shapes and
algorithmic-selection bias.
Conversely, the false positive and false negative centroids contain precise information as to
where a candidate is accurate and by how much. To be clear, the AUC quantitation error is
taking evaluation precision beyond classification. Let AUC_ be the quantification reported by the
algorithm, which includes true and false positive centroids alike and excludes false negative
centroids. Then the AUC percent error is simply

|

|

. Dramatic variation

in IT intensity motivated the percent error representation.
Another issue is that true negative ITs are impossible to define. So an algorithm’s ITidentification accuracy was measured by the commonly used metrics of precision and recall
(sensitivity) for information retrieval. Isotope trace sensitivity ( ) is the number of ITs correctly
identified by the algorithm divided by the number of true ITs. Isotope trace precision (
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) is the

number of ITs correctly identified by the algorithm divided by the number of algorithm-claimed
ITs. High sensitivity means the algorithm successfully identifies most true ITs, while high
precision is a measure of identification reliability. The harmonic mean of these is the

score,

; it summarizes the overall identification performance.
7.3.3.2 Sample-level evaluation
Finally, sample-level metrics allow us to define how much of the entire sample AUC was
correctly identified without regard for individual ITs. It is a way to quantify the level of intensity
information found by an IT detection without regard to how the centroids are actually clustered
into ITs. The sample sensitivity is defined as

∑
∑

. This is the total algorithm-identified

true raw intensity divided by total true raw intensity. On this global level, a true negative can be
defined as the sample noise, or the centroids that don’t contribute to any real ITs. Thus, the
sample specificity equals

∑
∑

∑

. This taken to be the total correctly algorithm-

ignored raw intensity (true negative signal) divided by total noise raw intensity of the sample
(including false positives of the algorithm). These last two metrics are useful as a global
measure of accuracy in contrast to the IT-specific accuracy in the preceding metrics.
7.3.3.3 Evaluation by IT type
An evaluation should indicate how certain IT types influence performance. Simpson’s paradox
further motivates an evaluation by type since conclusions based on the aggregate annotation are
sometimes reversed when analyzed by type.268 We classified ITs by intensity, ppm error, and
length. Annotated ITs were grouped by the variable of interest into 8 percentile categories {|0,
12:5%), |12:5%, 25%) . . . , |87:5%, 100%)}. For example, the longest IT was categorized in
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[87.5%, 100%]. The recall was computed for each category; precision was approximate because
mapping the algorithm-identified ITs to the right annotation-based category was not always
right. For instance an algorithm-identified IT length might be shorter or longer than the
annotation length and the mapping can only be corrected if the IT identification is correct.
7.3.3.4 Optimization
With the goal of maximizing the F1-score, we optimized parameters for the two algorithms on
each dataset. Initial values for centWave on MM14 were selected from the paper Tautenhahn et
al.257; the manual annotations provided a baseline of minimum IT length, height, and ppm
deviation. Where prior knowledge was absent, liberal parameter grids were explored for
parameters like snthresh for centWave, or criticalValue for Massifquant. Paired parameters, or
parameters that were thought to have interactions, were explored simultaneously in two
dimensions. For instance, the (min, max) IT length form a natural pair and exhibited interactions
in F-score performance for centWave. The most important parameters for both algorithms,
(snthresh, ppm) in centWave, and (criticalValue, consecMissedLim) in Massifquant were
searched simultaneously. Their respective F-score surface plots exhibited near-concavity, a
desirable property for parameter tuning. It appears unique to Massifquant that all F-score surface
plots had near-concavity. The optimizations were conducted with R (http://www.r-project. org)
and Matlab scripts (MATLAB version 7.14.0.739, The Mathworks Inc., Natick, Massachusetts)
scripts and detailed procedures to reproduce results are available on GitHub (see Availability).
Other details of the optimization are included in the supplementary file. Table 1 compares
centWave performance on MM14 based on reported optimized parameters from the original
centWave publication and the optimized parameters resulting from this new evaluation. The two
different evaluation settings yield similar parameters and
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-scores, suggesting this new

annotation and evaluation effort is valid. For matchedFilter and MZMine2, all combinations of
the suggested ranges for each parameter were exhaustively evaluated (see supplement for the full
list).
Table 7.1 centWave optimization on MM14 improved with identification performance and the parameters are in the
same vicinity.

version

ppm

snthresh

peakwidth

peakfilter

F1 -score

original

30

2

(5,10)

(2,400)

0.8936

our evaluation

18.4

2.5

(3,11)

(1,511)

0.9438

7.4

Results
7.4.1

Overall Evaluation

As detailed in the methods section, we developed an independent, open-source implementation
of Aberg et al.’s TracMass algorithm, and call it ‘Massifquant’. The algorithm uses 2dimensional Kalman filters to adaptively find chromatographic ITs in the m/z domain without
bucketing the data. We compared Massifquant’s ability to sensitively and accurately find ITs
with centWave, a sophisticated and well-known algorithm used in the XCMS platform for labelfree IT detection, matchedFilter, the original binning-based XCMS method for IT detection, and
MZMine2, a non-XCMS platform for MS data processing.
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We manually annotated ITs in two data sets, chosen to have different characteristics, following a
set of rational guidelines. The MM14 data set is a run of 14 plant metabolites on a lower

Figure 7.1: Optimized performance metrics by dataset and algorithm. Massifquant is the performance of
Massifquant without correcting IT segmentation. This and other figures used reshape2 and ggplot2 R packages
(Wickham, 2007, 2009)

resolution UPLC-ESI-QTOF. The MM14 reveals the performance of an IT finder under close to
ideal circumstances (viz. low sample complexity, good signal-to-noise, good chromatography).
134

The MOUSE sample was run on an Orbitrap mass spectrometer and is typical of many highly
complex proteomic analyses. While chromatographic IT shapes are smooth for high abundance

Figure 7.2: A comparison of log-transformed percent quantitation errors (log ϵ) for
successfully identified ITs. Massifquant outperforms centWave’s quantitation error on both
data sets.

ITs, the intrinsic dynamic range limitations result in greater m/z and intensity variability for
lower abundance analytes. The heterogeneity of IT sizes and shapes encountered in the MOUSE
data is ideal for discovering the limitations of an IT detection algorithm.
Figure 7.1 shows that Massifquant reported uniformly higher sensitivity values than centWave
and the t-test union of segmented ITs improves Massifquant performance on MOUSE. As for
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identification reliability, precision was in the same neighborhood for both datasets, yet centWave
shows higher sample specificity in MOUSE since it rarely found a false IT. Massifquant
exhibited a better F1-score on MOUSE since it identified substantially more ITs than centWave.

Figure 7.3: A comprehensive view of manually annotated ITs on the MOUSE data set and
detected ITs, for A) centwave and B) Massifquant. Correctly identified ITs are color-coded
according to the percent quantitation error (ϵ): dark blue < 10% , aqua < 20%, green < 40%,
orange > 40%. False ITs are labeled in red; all other noise was excluded. ITs missed by the
algorithm (i.e., false negatives) are labeled black.
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Both algorithm’s MM14 performance is effectively equal for all metrics but sensitivity. The
matchedFilter algorithm was only able to identify 33 of the 589 ITs in the MOUSE dataset after
optimization over 215 parameter settings. MZMine2’s best performance was worse, with only
20 isotope traces correctly identified under optimal parameter settings (see supplement).
Because matchedFilter and MZMine2 perform so poorly compared to centWave and
Massifquant, we omit the results from the charts in this paper.
Comparing algorithms’ quantitation accuracy is controversial because defining IT boundaries is
not clear-cut and in this analysis most error comes from the tails—knowledge afforded because
of the evaluation criterion. No statistical test comparing the two algorithm’s was done since the
spatial components, length, shape, m/z variance, etc. likely create dependence among ITs.
Nonetheless, Figure 7.2 illustrates that Massifquant and centWave quantitation errors are
generally in the same small neighborhood.
7.4.2

Evaluation by IT Type

An evaluation is incomplete without identifying what types of ITs were missed within certain
types of samples. For example, both algorithms are perhaps equally excellent at detecting ITs in
a simple sample like MM14 with high signal-to-noise (see supp. data Figure S3). On the other
hand, Figure 7.3 shows that Massifquant excels at finding low-intensity type ITs in the MOUSE
complex sample and quantifies them very well, whilst these are not identified by centWave.
The “Evaluation by IT Type’ strategy’, described in section 2.3, addresses whether the high
number of low-intensity ITs relative to high-intensity ITs in the MOUSE data unfairly benefited
Massifquant in aggregate statistics (viz. F1 -score). Figure 7.4 summarizes the results of IT-typed
performance for characteristics thought to vary widely within MOUSE. centWave’s IT
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sensitivity improves as the intensity increases and the estimated ppm error decreases, both in a
linear fashion. Massifquant’s sensitivity varies little across all categories, irrespective of the

Figure 7.4: Isotope trace detection performance by quantiles for IT characteristics of the
MOUSE data set. The left-most percentile bins generally represent the hardest cases for
IT detection algorithms (short, low intensity, broad ITs) while bins on the right are
generally easier (long, high intensity, narrow ITs). The sensitivity panel is at the IT-level.

variable, and without a doubt outperforms centWave. With respect to IT precision, the effect of
each variable seems present for both algorithms. Both have similar approximate precision
results. Not surprisingly, Massifquant shows improved precision as length, narrowness, and
max-intensity increase.
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7.5

Discussion & Conclusions

In Massifquant, we have implemented an open-source Kalman filter-based IT detection
algorithm based on Aberg et al.258 We have evaluated its performance using two manuallyannotated data sets, and compared the performance of Massifquant with centWave, a waveletbased IT finder, and matchedFilter and MZMine2, binning-based IT finders. A protocol for how
IT detection algorithms should be evaluated has not yet been established, so we first discuss the
evaluation process; then, we address algorithmic performance and suitability for use, and finally
conclude with some thoughts about the use of m/z information in MS IT detection generally.
7.5.1

The evaluation process

Comparative evaluation of algorithms in MS-omics is often lacking Smith et al., and Zhou et al.
recently suggested that the quantitative evaluation of IT detection algorithms is long
overdue.32,260 We believe the general lack of evaluation is related to the difficulties associated
with creating data sets to effectively test these algorithms and also to a lack of clear and explicit
metrics for assessing success. In order to facilitate further efforts in this area, we discuss some
of the challenges and successes we met using a manually annotated data set approach.
Hand-annotation, especially of low abundance ITs, is extremely challenging. It requires
concerted effort over a long period of time. The authors spent several weeks of dedicated effort
in order to annotate the two data sets, and the MOUSE data set is only a small subset of the
complex LC-MS sample from which it was derived. Despite our best efforts to be accurate and
consistent, we conclude that the manual annotation process is still somewhat subjective. Indeed,
we simply had to exclude the evaluation of ITs below a certain threshold because we felt human
judgment was inadequate for the task. Despite these challenges, the annotation data itself is a
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useful model for future validation efforts. Moreover, it contains isotopic-level information that
could be of use in other projects.
We validated the manual annotation efforts through a holistic visual inspection (see Figure 7.3
for example) and analysis of histograms of ppm deviation (see supp. Figure S4 for example) to
ensure that there were no outliers. So, despite the inherent difficulty of manual annotation, we
conclude that the endeavor was largely successful. Several aspects of the process are worth
considering in more depth: 1) we used semi-rigid guidelines for annotation that we believe
worked well across a variety of ITs with different characteristics. We could have generated and
applied very strict rules for annotation at the outset, but this may have resulted in even worse
systematic bias considering the highly variable ITs we encountered. The proposed guidelines
should serve useful for future annotation efforts. 2) We used a single annotator for both data sets
to eliminate person-to-person variability in the interpretation and application of IT criteria.
However, tools for community sourcing annotations would be an interesting solution and has
been already been discussed in genomic contexts.269 3) We used ToppView, the MS viewer
associated with OpenMS, to help us find and annotate ITs. 25,267 Additional add-ons such as colorcoding and flagging of already-annotated ITs and producing a community based validation
would also improve the annotation process.
Among the previous efforts to evaluate IT detection algorithms, we found that most of them
focused solely on questions of identification, but lacked in detail of what constituted an
’identified’ IT. For IT detection, the identification criterion is critical for fair evaluation—and
we additionally argue that the evaluation should probe quantitation accuracy if possible. We
evaluated identification at IT and sample levels, and also calculated the percent quantitation error
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for each IT. The precisely defined metrics may now be more easily employed, modified, or
improved.
This multi-metric evaluation exposes two risks other evaluations take when relying purely on the
F1-score. 1) Precision values show that Massifquant does at least as well if not better at IT
identification reliability for MOUSE at low intensity. However, the sample specificity, along
with Figure 7.3, provide stronger evidence that centWave effectively discriminates low-intensity
non-ITs better than Massifquant. Hence, precision and consequently the F1-score can be
misleading. To our knowledge, this is the first evaluation that has proposed a true specificity
measure for IT detection, which helps avert wrong conclusions. 2) By our evaluation standards,
and likely others, accurate quantitation does not always imply a favorable IT detection F-score
and vice-versa. On the MOUSE dataset centWave ignores many low-intensity ITs, giving it a
low F-score; however, the ITs that it does identify are generally quantitatively accurate with a
median ϵ = 8:663%. Thus, quantitative accuracy is somewhat distinct from IT detection
sensitivity or precision.
7.5.2

Algorithm performance

On the simple data set MM14, Massifquant showed similar performance to centWave. On a
highly complex sample, MOUSE, Massifquant performed much better. In particular,
Massifquant excels at finding ITs with a variety of characteristics such as differing intensity,
widths, and lengths. Massifquant outperforms centWave in IT detection sensitivity across every
size and shape of ITs in the complex sample tested. As for reliability, Massifquant is
competitive with centWave with the exception that it finds more false low-intensity ITs; the
excess false positives and multi-modal artifacts are two deficiencies of Massifquant which can
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complicate downstream analysis in sample-to-sample comparisons. Future extensions of
Kalman Filter IT detection will need to make intensity estimation more robust. An attempt to
combine centWave’s wavelet intensity estimation with Massifquant has not proven to be
effective (see supplement section 4). In spite of these deficiencies, both algorithms reported
similar quantitation accuracy for the quantified ITs; Massifquant just found far more ITs.
A possible objection to our general comparison is that a large number of small ITs might bias the
evaluation in Massifquant’s favor. However, Figure 7.4 removes any suspicion of unfair
advantage; even if low-intensity or very broad ITs (e.g. first four bins) were removed from the
analysis, Massifquant still identifies ITs better on the MOUSE data set.
As shown in Figure 7.1, our effort to address the problem of IT segmentation with Massifquant
was successful—on the MOUSE and MM14 data set, the precision increased from 0.7391 to
0.7894 and 0.9185 to 0.9355, respectively. However, some ITs were erroneously combined (see
supp. data Figure S2). For algorithmic simplicity, future efforts should attempt to address the IT
segmentation problem from within the framework of the Kalman filter. Ideally, such an
approach would also be more effective than the ad-hoc method we applied in this study to treat
IT segmentation.
7.5.3

Ease of use

Massifquant parameters can be readily optimized through visual confirmation instead of scorebased methods (e.g. f-score) that require an annotation. Visual optimization is more time
efficient, intuitively simple, and almost as accurate. Similar in purpose to Tengstrand et al.,261
the visualization tools at https://github.com/topherconley/optimize-it illustrate precise changes in
IT detection induced by differing parameter input. The documentation offers a step-by-step guide
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how to optimize Massifquant to new data sets, especially controlling the number of false
positives. Further, the score-based method shows a concave f-score surface when varying
Massifquant’s parameters, indicating a very predictable parameter behavior (see supp. data
Figure S5, S12, S13, and S14). Massifquant’s appeal is due, at least in part, to the fact that
several internal KF parameters are learned from the data—in an initial prescan, and then later for
each individual IT being tracked.
Massifquant operates on centroided MS data, which means it can analyze data taken in centroid
mode or profile mode (after centroiding), whereas algorithms requiring profile data cannot

Figure 7.5: Real-world application test. Massifquant
identifies differentially expressed ITs between wild type (WT)
vs. knock-out (KO) conditions in the faahKO dataset for (A)
trivial cases and (B) non-trivial cases.
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operate on centroid data because the centroiding process is not readily reversible. Further,
running Massifquant is as easy to run and modular as other XCMS IT detection options. The
same differential abundance (DA) workflow applies. Figure 7.5 illustrates a Massifquant-based
DA analysis in on the FAAH knock out LC/MS data set, 270 (see
http://bioconductor.org/packages/devel/data/experiment/manuals/faahKO/man/faahKO. pdf for
details).
7.5.4

The use of m/z information in IT detection

Can the success of Massifquant on a complex sample be generalized? ITs in a highly complex
sample—particularly low abundance ITs—are different from ITs derived from a simple mixture:
limitations in a mass spectrometer’s dynamic range produce much greater intensity variability for
ITs from a complex sample. Because of this, at least for mid-to-high mass accuracy/resolution
mass spectrometers, m/z measurements will tend to be far more helpful at distinguishing closely
eluting species than IT shape. Indeed, we found that Massifquant performs at a high level
because of its m/z estimation (despite extremely poor intensity estimation). Most IT detection
algorithms focus on IT shape, but we suggest that on highly complex samples an algorithm
should be focused mainly on subtle changes in m/z. Algorithms that bin data from closely related
ITs in order to do IT shape analysis lose the richest information available for distinguishing those
ITs. Distinguishing convolved isobaric compounds and near isobaric compounds will, of course,
require chromatographic IT shape analysis, but new algorithms will likely see the greatest
improvement gains by working to fully utilize the m/z information found in closely eluting
analytes.
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Chapter 8

Metriculator: quality assessment for mass spectrometry-based proteomics

Author’s Note: This chapter describes novel software for tracking, monitoring, and automating
performance metric generation for mass spectrometers. While the discussed application is
proteomics, the software is applicable to all MS based omic studies. I wrote the archival, data
extraction, and data management algorithms, created the custom visualization, and built much of
the web interface. These results were published in Bioinformatics.271 7
6F

8.1

Abstract

Summary: Quality control in mass spectrometry-based proteomics remains subjective, laborintensive and inconsistent between laboratories. We introduce Metriculator, a software designed
to facilitate long-term storage of extensive performance metrics as introduced by NIST in 2010.
Metriculator features a web interface that generates interactive comparison plots for contextual
understanding of metric values and an automated metric generation toolkit. The comparison
plots are designed for at-a-glance determination of outliers and trends in the datasets, together
with relevant statistical comparisons. Easy-to-use quantitative comparisons and a framework for
integration plugins will encourage a culture of quality assurance within the proteomics
community.
Availability and Implementation: Available under the MIT license at
http://github.com/princelab/metriculator.
8.2

Introduction

As omics-level experiments increase in size and complexity, assessing the quality of a dataset
can be a laborious undertaking. This is particularly true of mass spectrometry (MS)-based
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proteomics, where the spectrometer and associated chromatography exhibit variable—and
sometimes erratic—performance. Researchers would like to analyze more samples and in
greater depth (i.e. fractionation), but maintaining high quality across the set—and knowing that
the set is of high quality—is a mounting challenge in proteomics.
Typically, highly trained technicians spend significant time adjusting capillary plumbing,
working to achieve stable nanoelectrospray and calibrating and tuning the mass spectrometer.
The quality of a large analysis is then assessed by visual inspection of the 2D or 3D ion trace.
Assessing reproducibility is particularly challenging when datasets involve runs collected over a
period of weeks or months. Furthermore, human assessment of quality is both time-consuming
and a potential source of bias.68 Software tools to aid in quality assessment are needed and can
improve confidence in published proteomic datasets.272
An extensive set of quality/performance metrics was introduced by NIST to begin to assess data
quality in MS proteomics.273 These 284 metrics include measures of chromatographic
performance, ion source stability, ion signal intensity and data-dependent sampling efficiency.
These measures can significantly augment manual interpretation of data quality, but their utility
depends on contextual comparisons between datasets. Comparing metrics over time is the key to
leveraging them for quality assessment. Subsequent work has attempted to expand metrics
across vendor platforms, and to provide curated metrics, such as those demonstrated by
QuaMeter,274 indicating the value of metrics to the proteomics community.
A similar suite of software designed to monitor lock mass and quality control evaluation at the
instrument and identification level, called SIMPATIQCO, was recently released. 275 It provides a
similar web-based interface designed to assist instrument operators in monitoring quality control
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samples, yet it lacks interactive graphing and comparison capabilities, which enable applicability
to any questions of performance differences, as well as augmentation to existent workflows.
Additionally, there is a commercial product, MassQC,276 which provides a utility for submitting
metric information for longitudinal comparison, but does not provide automation. There remains
a need for an open-source configurable method for tracking and comparing performance metrics,
as well as integration into a proteomics workflow.
8.3

Software

Here we introduce Metriculator, an easily installable database backed web service that generates,
stores and compares metrics across datasets for quality control purposes. We also provide
archival features to facilitate automatic metric generation of the NIST metrics and workflow
integration. This package is meant to serve as a framework for an automated workflow
customizable by each research group. We chose Ruby to enable users to easily extend the
framework through our integration plug-in setup; Ruby is easy to learn, 177 boasts a large number
of off-the-shelf utilities for web programming, and is gaining traction in the scientific
community.277
8.3.1

Implementation

Metriculator is cross-platform, tested on *NIX systems and Windows, and only requires an
installation of Ruby (version ≥1.9) to function. The interface is built on Rails, the popular web
framework, and provides interactive graphs through the HighCharts library. 278
8.3.2

Metric generation

Metriculator automates generation of the 284 NIST performance metrics from LC-MS run
*.RAW files and stores them in a database to ensure that relevant meta-information can be
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compared over time even if raw data are lost. The NIST metrics are generated by the NIST
MSQC software, which is platform specific for Windows, as detailed by NIST. 273
8.3.3

Web interface

The browser interface is designed for easy access to the stored metric information. Through it, a
user can access any of the meta-information about a run and can generate a comparison of all
metric values between two lists of msruns. These comparisons provide graphs designed to
provide at-a-glance evaluation of the metric information. The website also provides for email
based alerts, customizable via a QC_alerts configuration file, which specifies a notification
threshold, in deviations from the historic mean for each metric, to trigger an alert email,
notifying technicians of instrument problems immediately. This utility could easily be expanded
to hook into any notification systems.
8.3.4

Visualization

The graphs incorporate a time-rendered plot of the data points for each set of msruns, as well as a
visual comparison of the two populations by beanplot. 279 Beanplots provide a compact visual
summary and comparison between two distinct populations without sacrificing visualization of
potentially interesting individual datapoints. They consist of two vertically plotted density plots,
with a univariate plot of individual datapoints. Each plot provides at-test comparison, as well as
an immediate visual summary of any trends or significant differences in the comparison sets of
msruns. These plots are generated dynamically via Javascript and are interactive to enable
simple identifications of anomalous metric values (Figure 8.1).
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Figure 8.1: Visualization Plot example. It is representative of those generated by the software, showing the
combination of a bean plot with the associated time plot for a Visualization Plot, representative of those generated
by the software, showing the combination of a bean plot with the associated time plot for a single metric, comparing
7 values with 13 values in a second dataset.

8.4

Ms-archiver—integration with a workflow

Metriculator is ideally integrated into a workflow to ensure that metrics are generated for every
run. Metriculator allows for automated data off-loading/backup and metric generation on run
completion, to reduce loading of data acquisition systems. Communication between computer
nodes is accomplished by a simple file system-based queue; the automation framework only
requires access to a shared storage location, common to most laboratories. Complete automation
can be achieved through the use of a cascading set of settings files in the archival directory and
use of the integration capabilities provided.
In its current scope, Metriculator fills a niche role not covered by existing Laboratory
Information Management Systems and analysis software (e.g. CPAS). Although other software
provides some utility, the ease of use and plotting capabilities of Metriculator provide more
intuitive investigation of metric datapoints, as well as an extensible framework for pipeline
management. An open customizable code-base allows others to expand on the software to suit
their needs through integrating their own automation tools to the integration plugin framework
provided by Metriculator, thereby encouraging metric adoption in the proteomics community.
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Chapter 9
Mspire-Simulator: LC-MS Shotgun Proteomic Simulator for Creating Realistic
Gold Standard Data 8
7F

Author’s Note: This chapter represents the first software capable of simulated mass spectrometry
data useful for establishing comparisons between data analysis algorithms. I contributed the
algorithms for charge state estimation. These results were published in the Journal of Proteome
Research.280
9.1

Abstract

The most important step in any quantitative proteomic pipeline is feature detection (aka peak
picking). However, generating quality hand-annotated data sets to validate the algorithms,
especially for lower abundance peaks, is nearly impossible. An alternative for creating gold
standard data is to simulate it with features closely mimicking real data. We present MspireSimulator, a free, open-source shotgun proteomic simulator that goes beyond previous
simulation attempts by generating LC-MS features with realistic m/z and intensity variance along
with other noise components. It also includes machine-learned models for retention time and
peak intensity prediction and a genetic algorithm to custom fit model parameters for
experimental data sets. We show that these methods are applicable to data from three different
mass spectrometers, including two fundamentally different types, and show visually and
analytically that simulated peaks are nearly indistinguishable from actual data. Researchers can
use simulated data to rigorously test quantitation software, and proteomic researchers may
benefit from overlaying simulated data on actual data sets.
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9.2

Introduction

A single liquid chromatography−mass spectrometry (LC-MS) run is inherently capable of
quantifying upward of 100,000 peptides. 31 Unfortunately, in a typical analysis, the majority of
this data is discarded due to difficulties in identifying and accurately picking chromatographic
peaks, especially those of lower abundance. Increasing the accuracy of peak picking results in
the detection of more features that can be compared across runs. More accurate peak picking can
also influence mass estimates and therefore yield an increase in the number and quality of
identifications.29 It ultimately simplifies cross-run comparisons of feature abundances and
increases the overall accuracy of those quantitative comparisons. In other words, peak picking
quality influences the entire downstream analysis.
For these reasons, it is undoubted that the most important step of a proteomic workflow is feature
detection, for which many algorithms exist.29,255,281 However, very little has been done to fully
test or compare the performance of these algorithms. In large part, this is due to the challenging
nature of creating gold standard data. Fully annotating actual complex proteomic data sets, or
even small portions, is extremely time-consuming, difficult, error prone, and subjective.
Because MS/MS annotation is rare for small peaks and because they have intensities near the
signal-to-noise threshold, accurate human annotation of small peaks in a complex sample is very
likely impossible.
Simulation is routinely used in related fields when gold standard data is difficult to come by
(e.g., systems biology network simulation)282 or the cost of performing each experiment is high
(simulated ion movement in MS fields).283 For quantitative mass spectrometry, an attractive
alternative to using hand-labeled data sets is to simulate actual data using noise parameters
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derived from experimental data. An ideal simulator would generate data sets where all aspects of
the data are known, the various noise components are adjustable, and the peak characteristics
conform to those found in biologically derived data sets. Such data sets would be invaluable for
comparing algorithms because accuracy can be comprehensively and quickly ascertained
programmatically. The speed of this feedback will also aid in the creation of new, more
sophisticated algorithms.
Because simulators can produce fully defined peaks of any size, data sets produced by simulation
are particularly well suited to test algorithms for their ability to detect and accurately quantify
small LC peaks. Small peaks are highly desirable targets for identification and quantitation
because: (1) seminal biological events may occur at low quantities (e.g., upstream signal
transduction), (2) a change in state to low quantity may be as significant as an increase in
quantity, (3) post-translational modifications may manifest themselves as a drop in the
unmodified peptide’s concentration, and (4) lower abundance peaks constitute the majority of
peaks in an LC-MS run and these are inaccessible by current MS/MS regimes. By quantifying
low abundance peaks, proteomic and individual protein coverage may improve, and intraprotein
variation can be tracked.
Many proteomic workflows allow users to examine their experimentally derived fragmentation
spectra alongside a representation of the theoretically matched spectrum (i.e., an MS/MS
fragmentation view). With a simulated LC/MS data set in hand, a somewhat analogous view
could be generated for the user where simulated MS1 data is layered on top of actual data. This
view would encourage a researcher to examine their MS1 output to reconcile what they can
observe with what they expect to observe. A peak that went unidentified may still be present,
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and researchers would then know where to look within their MS1 data. Alternatively, a peak that
should have been present may be absent prompting researchers to simulate data with conjectured
post-translational modifications in an effort to locate the modified peak. Simulated data sets
have the potential to augment the traditional proteomics workflow in which researchers often
neglect to thoroughly examine their MS1 data.
While previous MS1 proteomic simulators284,285 have been created, a simulator that mimics the
intensity and m/z variance found in real data sets is critical for testing peak-picking/ quantitation
algorithms. Here we present a full featured LC/ MS shotgun proteomics simulator, MspireSimulator, which generates peptide peaks with realistic m/z and intensity variance and elution
profiles. Machine learning is used to generate peaks with a realistic retention time distribution as
well as peak heights reflecting peptide ionization efficiency.
9.3

Methods

Mspire-Simulator takes as its input FASTA files containing the protein sequences that are to be
in the simulated run. Using one of 16 proteolytic enzymes and relevant digestion parameters
each protein sequence is in silico digested into peptides. Each peptide’s charge, mass, and
theoretical spectrum, including the isotopic distribution, is calculated. These calculations are
currently used to create centroided data. The simulator will be extended to create profile data in
the future. Centroided data will be most useful initially because most analytical software deals
with this type data. The simulator is implemented in the Ruby programing language and makes
use of and extends the mspire177 (mass spectrometry proteomics in Ruby) library. It is available
under the MIT license and works out of the box with sensible defaults. Customization to data
from different instruments is achieved through an included Ruby script, which uses a genetic
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curve fitting algorithm. This script produces SVG files that visualize the fits as well as the
necessary parameters for Mspire-Simulator to adapt its simulations.
The actual data used to create our default simulation model were obtained from our in-house
LTQ-Orbitrap mass spectrometer coupled to reverse-phase liquid chromatography using
nanospray ionization. The data are derived from an LCMS shotgun proteomic run of complex
Human Embryonic Kidney (HEK-293T) cells. We used a Waters Nano Acuity column (15 cm
long). ‘A’ solvent used was 95:5 water to acetonitrile and 0.1% formic acid and ‘B’ solvent was
acetonitrile and 0.1% formic acid. Gradient was formed by 5−60% solvent mix over 70% of the
run. These data along with all files produced and used are deposited at https://
chorusproject.org/anonymous/download/experiment/17116340021687089 and at
ProteomeXchange (http:// proteomecentral.proteomexchange.org) via the PRIDE partner
repository286 with dataset identifier PXD000477. The MM14 data are already available at
http://msbi.ipb-halle.de/msbi/centwave/, and the Orbitrap-Velos data are available upon request.
Orbitrap-Velos data were generously provided by the Christine Vogel lab and were from an
ubiquitin pulldown from Saccharomyces cerevisiae (Eksigent NanoFlow Plus, LC gradient
2−90% acetonitrile over 4.5 h at flow rate 400 nL/min). MM14 data are from the Bruker
MicrOTOF-Q instrument and are described by Tautenhahn et al.; details can be found in that
publication.257
9.4

Results

Mspire-Simulator models elution, variance in intensity, and variance in the mass to charge ratio
(m/z) and predicts retention times and intensities for peptides. We follow the convention of
Cappadona et al. and refer to a peptide feature as the full chromatographic profile of a peptide (at
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a given charge state) and a peptide peak as an individual isotopic component of a feature. 255
Figure 9.1 outlines the overall process of simulation, and we consider each component in turn.
9.4.1

Retention Time and Intensity Prediction

A peptide is first situated along the retention time axis (See Figure 9.1A.). Both retention time
and intensity are predicted for each peptide using a machine learned model built in WEKA. 287
We used the M5Rules288 algorithm for retention time prediction and the M5P289 algorithm for
intensity prediction, both of which gave the best correlation coefficients for our test data, ~0.96
and ~0.74, respectively, using the internal WEKA 10-fold cross validation technique. The test

Figure 9.1: Overall process of simulation from theoretical spectrum to realistic peaks. The underscored 3d box in
parts B and E designates the specific peak shown in the following parts. (A) Theoretical spectrum calculated for a
certain peptide. (B) Ideal elution profiles are given to the spectrum. (C, D) Intensity variance is calculated for
each peak in the elution profile. (E, F) Mass to charge variance is calculated for each peak in the elution profile.

data can be downloaded as indicated in the methods section. These prediction models were
trained on in-house data, which contained amino acid counts, average m/z value, the charge state,
mass, retention time, and a binned intensity value for 1484 peptides. The intensity values were
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binned into 10 bins based on magnitude ranges. This allowed for a better prediction of
intensities. The user may replace the default models with custom/better ones to mimic other
configurations and instruments. For each peptide a single retention time and intensity is
predicted; these values are used as starting points from which the retention times and intensities
of all centroids related to a particular peptide are generated. The retention times are coerced into
times that conform to a user-specified sampling rate (e.g., one scan per 2 s). Elution profiles are
generated by sampling from the normal distributions of parameters t and f.
9.4.2

Feature Shape

Peptide features are modeled along the m/z axis (Figure 9.1A) by predicting the charge states and
isotope distribution of a peptide. For charge-state prediction, a user specifies a pH, after which a
standard iterative procedure is used to determine the ratio of charge states that would be
observed (e.g., for the peptide DRVYIHPF at a pH of 2.0, 29.045% of this peptide would have a
charge of +2 and 70.959% a charge of +3). We label this parameter “ionized pH” to indicate that
it represents the acidity of the peptide as it enters the mass spectrometer and not necessarily in
LC buffer. Isotope distributions are calculated by FFT convolution.290
The elution profile (Figure 9.1B) is produced by function composition of a dynamic standard
deviation with a Gaussian function. The standard deviation (σ) is based on the relative position
along the elution curve:
4
where x is the relative retention time index from the starting retention time of the feature, t is the
tailing factor, and f influences the shape at the front of the profile. The elution profile is then
given by substitution of σ into a Gaussian function:
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(

5

)

where i is the intensity at that point in the elution, μ is where the apex of the curve is located, x is
as above, and h is an initial height factor, which determines the maximum height of the peak and
is the same for each peptide. Thus, i is a generalized intensity that is later modified by a variance
model and predicted intensity values as previously mentioned. This produces a skewed elution
profile that fits peaks derived from a wide variety of elution conditions, as shown for data an
LTQ-Orbitrap (Figure 9.2Figure 9.2A), a Quadrapole Time-of-Flight (Qq-TOF) (Figure
9.2Figure 9.2B), and an Orbitrap-Velos (Figure 9.2Figure 3.2Figure 9.2C).

Figure 9.2: Elution peak shape. Max intensity normalization was used in each case. The noisy gray line shows a
peak from actual data. Dashed line shows the function that the simulator uses. The simulator’s model can be
modified to fit many elution profiles present in real data. (A) LTQOrbitrap, (B) Orbitrap-Velos, and (C) Qq-TOF.

For the mass spectrometer types we examined there was a global relationship between the
intensity of a peak and the variance of its measurement. We observed larger intensity variance in
more intense features and thus also nearer the apex of an eluting peak (Figure 9.1C, D). An
inverse exponential function captures this relationship:
(

)

6

where σ defines the standard deviation in intensity given the intensity value, i. The c, d, and m
parameters represent experimentally derived constants that can be used to fine-tune the function
for different mass spectrometers or run conditions (Figure 9.3A, B). σ is then composited into a
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Gaussian function for each peak, again like above, and the ideal intensity is modified by drawing
stochastically from this distribution. Our intensity variance model adequately mimics real data.
When compared with actual data we observe an RMSD of 0.9051 (Figure 9.3A, B).

Figure 9.3: Intensity and m/z variance. Circles show simulated standard deviation variance and pluses show actual
standard deviation variance. Max intensity normalization was applied in each case. The x axis is on a log10 scale.
(A, B) Standard deviation is calculated along intervals of 10 peaks across the elution profiles. (A) The simulator
models this behavior from a LTQ-Orbitrap accurately with a small RMSD between actual and simulated of 0.9051.
(B) It can also model Qq-TOF data accurately; RMSD of 1.1167. (C) Inset is one actual elution peak and the large
image is four combined (RMSD = 0.1153). (D) m/z variance from Qq-TOF data. (C, D) This shows the general
trend of measured m/z values varying more at low-intensity signals and less at high intensity signals as well as the
simulator’s ability to mimic this observation.

The m/z variance is a function of intensity and therefore may vary between peptide features and
also within each elution profile contained in a feature (Figure 9.1E, F). This is modeled by the
following function:
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7
where σ is the standard deviation, i is the relative intensity of the feature at that point in its
elution profile, and y is another experimentally derived constant that can be fit to different data
types. The standard deviation function is composited with a Gaussian function, similar to the
above elution functions, and is then randomly sampled from to give the quantity of m/z variance
in either direction. The m/z variance model produces realistic results based on the comparison of
simulated m/z variance to actual m/z variance (Figure 9.3C, D).
Feature shape is further modeled by given protein abundances. The abundances can be specified
in the FASTA file header by a “#” symbol, followed by a value representing the percentage of
that protein in the sample. If no abundances are given, equal molarity is assumed. These values
are then used to modify the total area under the function that determines feature shape by a
simple scaling procedure.
9.4.3

Drops and Noise

At certain retention times, in real LC-MS runs, entire scans where very few if any peaks are
observed are referred to as “drops” (e.g., PeptideAtlas accession PAe000142 contributed by S.
Markey). Our model also simulates drops at random retention times by a specified percentage of
the total run time. This elevates the realism in the simulation and adds another dimension of
control when using simulated data to test analytical software.
The simulator has the ability to add white noise to the spectra based on density and intensity
factors specified by the user. The higher the density factor, the more white noise there is in each
spectrum. Intensities are pulled from a uniform distribution that varies between a maximum and
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minimum value given by the user. These parameters, along with the option to turn off the white
noise completely, give the user complete control for testing purposes.
9.4.4

Merging Overlapping Peaks

As a final processing step, overlapping peaks are detected and merged. This is accomplished by
using a ppm range to define whether two peaks are sufficiently close to be overlapping or not.
The intensities of the peaks to be merged are summed, and the new m/z value is calculated by a
weighted average of the original m/z values weighted by the intensities of the respective peaks.
We use 1/4 of the m/z variance in ppm to define the range that we use to detect overlapping
peaks, and this parameter is adjustable by the user.
9.4.5

MS/MS

Theoretical fragmentation spectra are produced by generating fragment ion formulas for all
possible cleavages and calculating the mass for each ion at the predicted charge states. The ion
types are configurable, and masses can be average or monoisotopic. The fragmentation spectra
are produced by the MS-fragmenter gem, freely available from Rubygems.org.
9.4.6

Modifications

Mspire-Simulator has the ability to add modifications to specified residues and termini.
Modifications are read in by the user specifying a modification ID from the PSI-MOD.obo and
which residue/terminus to apply it too. These modifications are then used in the calculation of
each spectrum. Because there will always be modifications in peptide samples, this is an
important part of simulation.
9.4.7

Output

The simulated run is written to an mzML file that can be visualized with any mzML file viewer.
The mzML format is the standard de jure and is quickly becoming the standard de facto for mass
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spectrometer data. Cross-platform converters like Proteowizard26 can convert mzML into
mzXML291 or other formats. Alternatively, the code base itself could easily be extended to
directly output other representations of the data as well. The program also creates a SQLite,
XML, or CSV file, which contains information on all of the data in the simulated run, which can
then be used to validate peak picking and quantitation software.
9.4.8

Parameter Fitting Automation

Simulating data from different mass-spectrometers and operating conditions requires some
customization of noise and variance parameters. We developed a genetic algorithm to discover
parameters from actual data. Figure 9.4 demonstrates the automatic fitting of Orbitrap Velos

Figure 9.4: Visual output from the curve fitting algorithm. Max intensity normalization was used for each. This
is a fit of Orbitrap Velos data. The blue dots show the actual data, and the red smooth lines represent the curve
fit. This shows the ability to quickly generate parameters needed to simulate different types of data. This output
took ∼5 min.
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data, and it works equally well on the many peaks and instrument types we have tested.
9.4.9

Using the Simulator to Assess Quantitation Performance

The lack of quantitative comparison of data processing and wet lab protocol is due in large part
to the daunting task of obtaining labeled data.32,256 The size and complexity of MS data sets
precludes obtaining labeled data without a significant outlay of resources. Mspire-Simulator
provides a facile method for generating any quantity of labeled simulated data. As a case study,
consider Smith et al., where Mspire-Simulator data used in conjunction with hand-labeled real
data allowed the use of qualitative metrics to evaluate the accuracy of a peak summarization, a
data-processing step in non-chromatographic studies.248

Figure 9.5: Comparison of simulated and actual MS features.Left side shows simulated features and right side
shows the actual features. (A) Visual comparison of LC-MS feature from the peptide: HLVDEPQNLIK (single-letter
code amino acids). See Table 1 for analytical comparison. (B) Detail of a single elution profile showing m/z
variance characteristics. Simulated m/z variance is very similar to actual (see Table 9.1; row 1−5).
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Figure 9.6: Comparison between simulated and actual MS runs. Simulated BSA run (top left) is compared with an
actual BSA run (top right). As can be seen, there are differences in retention times and intensities between the two
runs indicating that refinements can be made to these two prediction models. A detail segment (bottom) of the
simulated (left) and real (right) BSA runs shows that for each there are labels not found in the other (red) while
there are many that are found in both (black).

9.5

Discussion and conclusion

Mspire-Simulator succeeds at creating highly realistic LC-MS peptide features, as demonstrated
by the comparison between actual and simulated data shown in Figure 9.5. Under macro- and
microscopic inspection, analytically and visually, the two features are virtually indistinguishable
(Table 9.1). An entire simulated run of bovine serum albumin (BSA) (Figure 9.6) shows the
similarity between the simulated data and what is commonly observed in performing an actual
BSA digest during quality control runs. Mspire-Simulator can also produce highly complex runs
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(Figure 9.7) as well as simulate data from different mass spectrometers (Figure 9.2 and Figure
9.3).
With Mspire-Simulator’s abilities, layering simulated data next to or on top of actual data,
visually or analytically, could become standard practice in proteomics, much the way MS/MS
spectra are layered onto predicted b and y ion series to identify potential database matches. By
comparing actual data with the model and then refining the model, a feedback loop is created
that has utility not only in affirming what is known but in pointing out what is missing. Is an
expected peptide missing because it has been modified? Are changes in the ratios of charge
states indicative of pH or electrospray voltage aberrations? These and other aspects of a run can

Figure 9.7: Bird’s-eye view of a simulated complex human cell run. 50 000 peptides were taken from the human
FASTA database and simulated in two charge states creating 100 000 features. The run was generated in ∼31 h on
a single 2.50 GHz core and used ∼1.9 GB of RAM. White vertical lines represent dropped/lower signal and are
intentionally included. The run demonstrates the simulator’s ability to generate highly complex runs. Purple peaks
are the highest intensity, then red, yellow, and gray is the lowest. Viewed in TOPPView. 267
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now be queried, and this process will inevitably result in more complete, more refined models of
shotgun proteomics.
Refinements to Mspire-Simulator will focus initially on technical aspects of a LC-MS proteomic
experiment. These include: a more explicit model of a peptide’s ionization efficiency; 292,293 the
pH of a solution as buffer concentrations change and as influenced by the electrospray process;
the relative rates of tryptic digestion as a function of adjacent amino acid residues; 294 profile data
simulation; exploring the relationship between variance parameters and m/z and retention time;
and improvements in peak merging.
Table 9.1: Statistics comparing the two features shown in Figure 9.5
statistic

actual

simulated

difference

m/z variance isotope index 1

0.095

0.215

0.120 ppm

m/z variance isotope index 2

0.071

0.137

0.066 ppm

m/z variance isotope index 3

0.239

0.373

0.134 ppm

m/z variance isotope index 4

0.247

0.203

0.043 ppm

m/z variance isotope index 5

0.032

0.296

0.264 ppm

intensity variance

26.3

25.8

0.52

elution time interval length (seconds)

43.385

43.360

0.025

normalized intensity mean

21.9

21.35

0.55

normalized intensity median

8.2

8.081

0.119

number of samples/peaks used

73

85

12

21

21

0

(least abundant)

(most abundant)

(peaks >0.9 normalized abundance)
number of peaks in quartile 1:
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number of peaks in quartile 2:

27

25

2

number of peaks in quartile 3:

15

21

6

number of peaks in quartile 4:

10

16

6

Mspire-Simulator could also be extended with more sophisticated modeling of biological
phenomenon. More rigorous post-translational modification or splice-variant prediction would
alter the landscape of predicted peptides. Protein-level enrichment could easily be added in,
reflecting predictions about localization in a fractionated sample for instance. While biological
questions are appropriately addressed after analysis of the raw data, it is nonetheless intriguing to
consider mapping the biology as a simulated data set onto the raw data in an effort to generate
putative identities for unanticipated peaks.
As simulated data becomes more sophisticated, we are aware of the possibility of its
inappropriate use. The mzML file format is open and completely editable. As it currently
stands, we see no way to prevent a simulated mzML file from being tampered with to be passed
off as actual data, but the problem is not as hopeless as it might seem at first glance: the mzML
format encourages the use of a file hash tag audit trail, so instrument produced data should
always point back to a vendor produced raw data file. Deciding whether a file was simulated is
roughly equivalent to deciding whether a file was tampered with and that is checking against a
vendor-produced raw data file. The potential for the fraudulent use of simulated data should
serve, then, to encourage what researchers should be doing anyway: providing access to raw data
and using audit trails. In any event, we suggest that the potential benefits of simulation software
far outweigh the challenges presented by potential misuse.
Mspire-Simulator will be useful initially in testing and developing algorithms for peak picking
and quantitation. Simulated data are not meant to replace testing on actual data but to facilitate
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more rigorous testing of algorithms. Data may be simulated with a range of peak and noise
characteristics and strengths or flaws in algorithms uncovered. Mspire- Simulator will be
especially useful in testing algorithms for their ability to accurately detect and quantify small
peaks because the provenance of every centroid is known. Simulated data may ultimately
facilitate workflows that find and quantitate an order of magnitude more peptides than is
currently possible.
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Chapter 10

Conclusion

This work describes efforts to improve upon the analysis methods and technologies available to
identify and quantify biomolecules. As the challenges are diverse, we have introduced a
complementary set of tools which have enabled novel discoveries, invited improvements to
common practices, facilitated data quality, and provided novel identifications.
We have introduced a proposed nomenclature to clarify discussion of data analysis concepts in
MS algorithm development. This project initiates a discourse about how to establish common
ground and eliminate redundant efforts in algorithm development.
We have employed traditional mass spectrometry analysis and novel laboratory techniques to
identify the protein components of a novel virus. We have elucidated complex structural motifs
by MS analysis coupled with custom software implementations by both targeted MS3 and by
consideration of statistical models for cyclized fragmentation.
Our independent implementation of the Kalman filter for peak detection outperforms competing
algorithms by successfully identifying and quantifying isotope area with greater accuracy. This
drastically improves accurate MS1 quantitation and feature finding. This work also reinforces
the importance of the nomenclature introduced in Chapter 2 as necessary to efficiently express
MS data analysis algorithms.
Lipid diversity complicates much of the identification and quantitation desired for lipidomic
analyses. The most common approach to this complexity is segmentation of the problem space
to provide reduced complexity to subsequent analysis. We introduced an automatic
classification tool which is capable of classifying an unknown and uncharacterized lipid into
reduced domain space for subsequent analysis. It is trained from the manually curated LMSD
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and suggests improvements to that ontology, as well as providing an intelligible representation of
classification logic in decision tree format.
We have introduced an algorithm to predict lipid fragmentation which is capable of predicting
the complex cyclization products known to occur in lipids unlike existing solutions which fail to
address the extremely diverse fragmentation schemes observed in lipid fragmentation studies.
This work delivers a lipid fragmentation prediction software tool which follows published lipid
fragmentation schemes to deliver a chemically-sound lipid fragmentation models which
outperform existing solutions to identify selected lipids by their fragmentation spectra.
I have developed a software suite capable of automating performance metric generation designed
to facilitate performance metric use by instrument operators and to improve general instrument
performance. This suite archives performance metric and sample analysis runs and provides
innovative graphical comparisons and statistical analysis in comparison to periodic control
samples. The suite is web based and available on all major software platforms. This paper
provides a tool and suggested MS omic workflow which incorporates automated and
comprehensive quality control at the instrument stage.
We have provided the first LC/MS data simulation allowing for true ‘gold standard’ comparisons
between analytical methods. The capabilities of this utility make it ideal for establishing an
understanding of the relative strengths and weaknesses of proteomic MS data analysis.
Collectively, these projects have produced influential developments in the MS omic fields by
encouraging quality control and rigorous comparisons among data analysis techniques,
improving quantitation tools for label-free experiments, and introducing tools to identify
complex peptide structural motifs and lipids. These developments have aided biomolecular
169

understanding of neurotransmitter SNAP-25B structure, characterized a novel virus structure,
and facilitated a variety of other experimental projects. The virtues of the techniques,
algorithms, and tools developed will drive further biomolecular discoveries and innovations.
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